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6Abstract
Neural crest cells are a transient population of cells which differentiate into multiple 
derivatives.  How these derivatives become specified is not well understood but Sox10 
is known to be important in many of them.  We are interested in defining the precise 
role of Sox10 in zebrafish melanophores.  Current evidence suggests that the only 
vital function that Sox10 performs in melanophores is to induce expression of the 
melanocyte master regulator mitfa (Elworthy et al. 2003).
We explored a model for Sox10 function in melanophores, based upon a model for 
Sox10’s role in mouse sympathetic neurons (Kim et al. 2003), and tested the following 
predictions: as well as inducing expression of mitfa, Sox10 will repress expression of 
genes downstream of Mitfa thus, Sox10 must be downregulated, via Mitfa, to allow 
melanophore differentiation.  We observed derepression of melanophore marker genes 
in sox10t3 mutants, supporting the hypothesis that Sox10 represses these genes in wild 
type melanophores.  We documented Sox10/sox10 downregulation in developing 
melanophores and generated transgenic lines to test whether this is necessary for 
differentiation.  Unfortunately our experimental lines did not express our transgene 
so we were unable to test this hypothesis.  However, transgenic lines, generated as 
controls, which express CFP in melanophores or xanthophores will be useful tools in 
their own right.  Finally we conducted RNA injection experiments to explore regulation 
of melanophore genes by Sox10 and Mitfa.  We found that injection of mitfa induces 
expression of all our melanophore markers whereas co-injection of mitfa and sox10 
does not.  We also found that the 7.2 kb sox10 promoter contains six Mitf binding sites 
and is Mitfa responsive.
Our data broadly support our original model but also suggest that it does not describe 
the complete network.  We propose a modified model for the role of Sox10 in the 
genetic regulatory network controlling melanophore development.
7α-MSH Anti Melanocyte Stimulating Hormone
α –DIG Anti Dioxygenin
AMH Anti Mullerian Hormone
ATR-16 Alpha Thalassemia Retardation
Bcl2 B-cell Leukaemia/Lymphoma 2
BH4 Tetrahydrobiopterin
bHLH-Zip Basic Helix Loop Helix Leucine Zipper
BLAST Basic Local Alignment Search Tool
BMP Bone Morphogenic Protein
bp base pairs
BSA Bovine Serum Albumin
cAMP cyclic Adenosine Monophosphate
CBP cAMP Binding Protein
ChIP Chromatin Immunoprecipitation
Cls Colourless
CNS Central Nervous System
Col2a1/11a2 Collagen Type 2 alpha 1/Type 11 alpha 2




df Degrees of Freedom
DHICA Dihydroxyindole-2-Carboxylic Acid
DIC Differential Interference Contrast Microscopy
DMSO Dimethyl Sulphoxide
DOM Dominant Megacolon
dpf Days Post Fertilisation
DRG Dorsal Root Ganglia
E and P Mouse staging, E, Days postcoitum or P, Days Post Birth
(E)CFP (Enhanced) Cyan Fluorescent Protein
(E)GFP (Enhanced) Green Fluorescent Protein
EDN3 Endothelin 3
EDNRB/1 Endothelin Receptor B/bl
EF-1 alpha Elongation Factor 1 alpha
ES cells Embryonic Stem cells
FGF Fibroblast Growth Factor
Foxd3 Forkhead box D3





HMG High Mobility Group
Hpf Hours Post Fertilisation
Id3 Inhibitor of DNA Binding 3
ISH In Situ Hybridisation
kb kilo base pairs
LacZ β-Galactosidase
LB Luria Broth
Lef1 Lymphocyte Enhancer Binding Factor 1
Ltk Leucosine Tyrosine Kinase
MAG Myelin Associated Glycoprotein
MAP kinase Mitogen-Activated Protein Kinase
Mash1 Mammalian Achaete-Schute Homologue 1
Mitf/a Microphthalmia
Mi Mouse Mitf Mutant
MPZ Myelin Protein Zero (P0)
Msx Muscle Segment Homeobox
Nac nacre, Zebrafish mitfa Mutant




OCA1 Oculocutaneous Albinism Type 1A
OMIM Online Mendelian Inheritance in Man
p300 E1A Binding Protein p300
PAGE Polyacrylamide Gel Electrophoresis
Paics Phosphoribosylaminoimidazole carboxylase
Pax3/7 Paired Box Transcription Factor 3/7
PBS Phosphate Buffered Saline
PCR Polymerase Chain Reaction
PFA Paraformaldehyde
Phox2a/b Paired-like Homeobox 2a/b
Pias3 Protein Inhibitor of Activated STAT 3
Pmel17 Pre-Melanosomal Protein 17
PRE Pigmented Retinal Epithelium
PTU 1-Phenyl-2-thiourea
RET ‘Rearranged during Transcription’ proto-oncogene
RT-PCR Reverse Transcription PCR
SAP Shrimp Alkaline Phosphatase
SDS Sodium Dodecyl Sulphate
SE Standard Error
Sox8/9/10 SRY-box containing gene 8/9/10
SRY Sex Determining Region Y
SSC Sodium Chloride Sodium Citrate
SUMO Small Ubiquitin-like Modifier
SV40 Simian Virus 40
Tbx2 T-box Transcription Factor 2
Tcf ‘Transcription Factor’ family
TF Transcription Factor
Tfe3/b/c Transcription Factor Binding to IGHM Enhancer 3/b/c
TGFβ Transforming Growth Factor beta
TUNEL Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling
TYR Tyrosinase
Tyrp1/b/a Tyrosinase-related Protein 1/1b/1a






1.1 Induction and Specification of the Neural Crest
The neural crest is a group of cells which arise during neurulation at the junctions 
of neurectoderm and prospective epidermis and become the tips of the neural folds 
(Le Douarin and Kalcheim 1999).  In fish, neurulation involves a thickening of the 
neurectoderm to form the neural keel and the most dorsolateral part of this becomes 
neural crest (Eisen and Weston 1993, Raible and Eisen 1994).  Two major signaling 
pathways, BMP and Wnt, converge to induce neural crest (LaBonne and Bronner-Fraser 
1998).  BMP signaling at low levels appears to establish competency to become neural 
crest in cells at the edges of the neural plate; Wnt signals from adjacent ectoderm and 
underlying mesoderm then promote formation of neural crest (LaBonne and Bronner-
Fraser 1998, Raible 2006, Nguyen et al. 1998).  Other signaling pathways, FGF and 
Notch, also play a role in induction of Neural Plate Border Specifiers such as Msx, Pax3 
and Pax7 (Meulemans and Bronner-Fraser 2004, Sauka-Spengler and Bronner-Fraser 
2006, Sauka-Spengler and Bronner-Fraser 2008).  In turn, these Neural Plate Border 
Specifiers modify the effects of BMP, FGF and Wnt signaling to induce expression of 
another set of genes termed Neural Crest Specifiers (Monsoro-Burq, Wang and Harland 
2005, Steventon, Carmona-Fontaine and Mayor 2005).  These genes include Sox9 and 
Sox10, Snail and Snail2, Foxd3, Twist and Id3, the expression of which identifies neural 
crest.  Neural Crest Specifiers are interdependent, regulating each other (Meulemans 
and Bronner-Fraser 2004, Sauka-Spengler and Bronner-Fraser 2008) as well as 
inducing expression of a wide variety of target genes which regulate specification and 
differentiation of the neural crest into its various derivatives (Figure 1.01).
Once specified as neural crest, these cells undergo an epidermal to mesenchymal 
transition and dissociate from the neural folds or neural keel.  Neural crest cells 

















Neural Plate Border Specifiers
Neural Crest Specifiers
Neural crest derivative specification genes
Figure 1.01 Genes involved in the formation of neural crest
A simplified diagram of the relationships between genes involved in neural crest 
formation.  BMP, Wnt, FGF and Notch signalling induces expression of Neural Plate 
Border Specifiers (1).  These genes modify the effects (2) of BMP, Wnt, FGF and 
Notch signalling on the expression of Neural Crest Specifiers (3).  The expression of 
Neural Crest Specifiers identify cells as being neural crest.  These genes are able to 









different derivatives including neurons, glia, craniofacial cartilage and pigment cells. 
There are two pathways in the trunk that these cells migrate along, a lateral pathway 
between the epithelium and the somites and a medial pathway between the neural tube 
and the somites.  In mouse, pigment cells migrate only on the lateral pathway and all 
other neural crest derivatives can be found on the medial pathway (Le Douarin and 
Kalcheim 1999).  In zebrafish most neural crest derivatives, including some pigment 
cells, migrate on the medial pathway while only pigment cells migrate on the lateral 
pathway (Le Douarin and Kalcheim 1999, Raible et al. 1992, Kelsh 2004).
By in vitro primary culture of premigratory mouse, rat and Xenopus neural crest cells 
and by cell lineage tracing in zebrafish and chick, workers have demonstrated that 
neural crest cells are multipotent (Stemple and Anderson 1992, Stemple and Anderson 
1993, Bronner-Fraser and Fraser 1988, Baroffio, Dupin and Le Douarin 1988, Collazo, 
Bronner-Fraser and Fraser 1993).  Even migrating cells in chick have been shown to 
be multipotent in this way (Fraser and Bronner-Fraser 1991).  Similar work has also 
shown that mammalian and avian neural crest cells can, in addition, be self renewing 
(Stemple and Anderson 1992, Baroffio, Dupin and Le Douarin 1991, Bronner-Fraser 
and Fraser, 1991).  Within the embryo, multipotent neural crest cells become specified 
and then committed to specific fates and differentiate into the various neural crest 
derivatives.  Fate specification has been defined as when a multipotent cell begins to 
display characteristics of a particular fate, e.g. a multipotent cell becomes a melanoblast 
when it begins to express melanocyte specific genes such as Dct or Mitf (Kelsh 2006). 
However, a cell which is specified may still ultimately differentiate as a different cell 
type.  A cell becomes committed to a particular fate when it is unable to respond to 
signals that specify another fate.  For example, a cell is committed as a melanoblast when 
it can no longer respond to glial specification signals, such as Notch signaling.  Finally, 
differentiation describes the process between the time when a cell is fate specified and 
the time it becomes a fully specialized cell which displays all of the characteristics of 
a specific cell type.  For example, a melanophore must express survival and migration 
genes such as kit as well as melanogenic enzymes such as Tyrosinase.  However, it may 
be that cells are only committed to a specific fate under particular in vivo conditions 
and that this can be reversed if conditions change.  If differentiated melanocytes are 
grown in specific culture conditions they can be encouraged to de-differentiate so that 
they express early crest marker genes; in doing so, a single melanocyte can then give 
rise to cells which are both multipotent and self-renewing (Real et al. 2006).  
Whilst it is possible that neural crest-derived cells are directly fate specified from 
multipotent progenitors, evidence to date suggests that it is more likely that progenitors 
undergo progressive fate restriction.  Here, multipotent cells become restricted to 
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form different precursors which have the potential to form an ever decreasing set of 
derivatives (Kelsh and Raible 2002, Henion and Weston 1997, Baroffio et al. 1991). 
For example, sox10 mutants have defects in their non-skeletogenic derivatives 
(pigment cells, neurons, glia) but not in their skeletogenic derivatives (cartilage and 
fin mesenchyme) (Dutton et al. 2001, Southard-Smith, Kos and Pavan 1998, Herbarth 
et al. 1998), suggesting that the multipotent crest becomes restricted to precursors for 
each of those sub groups of crest cells (Dutton et al. 2001, Southard-Smith et al. 1998, 
Herbarth et al. 1998, Kelsh, Schmid and Eisen 2000).  Neuronal and pigment lineages 
have also been demonstrated to segregate from one another during development 
(Henion and Weston 1997).
Exactly when specification occurs, particularly in relation to the timing of neural crest 
cell migration, is not clear and may vary between neural crest derivatives.  In the case 
of pigment cells, labeling studies and observations of pigment cell markers in zebrafish 
suggest that these cell types may already be specified before migration and that cells 
have certainly become, or are becoming specified during migration (Raible and Eisen 
1994, Lister et al. 1999, Kelsh et al. 2000, Parichy et al. 1999).    Non-skeletogenic 
neural crest cells, including pigment cells, fail to specify in the zebrafish sox10 
mutant and most of these unspecified cells die in a premigratory position suggesting 
that specification occurs before, and may be necessary for, migration (Dutton et al. 
2001).  By transplantation of neural crest cells and differentiated melanocytes to 
different thoracic levels in chick embryos it has been shown that cells in this organism 
are required to be specified as melanocytes for them to be able to migrate along the 
dorso-lateral migration pathway (equivalent to lateral pathway in fish) (Erickson and 
Goins 1995).  Indeed, specification of melanoblasts is delayed in Silkie chick embryos 
and cells do not begin to migrate in these embryos until they have become specified 
(Reedy, Faraco and Erickson 1998).  However, some non-skeletogenic cells are able 
to migrate a short distance in zebrafish sox10 mutants and these generally move to a 
DRG position (Dutton et al. 2001).  The DRG contains progenitor cells which give 
rise to neurons later in development so even during wild type development these cells 
would be required to migrate without specifying.  This suggests that specification is 
not necessary for migration per se but is important only in certain cell types or only in 
cells which migrate along the lateral pathway.
Many of the signals which are involved in neural crest induction are important again 
when individual neural crest derived cell types are specified.  For example, Wnt 
signaling has been shown to be necessary early for neural crest induction but is also 
important later for specification of neural crest derived melanophores and cranial 
neural crest cells in the branchial arches (Lewis et al. 2004).  Wnt signaling may also 
13
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play a role in the balance between pigment and neuronal cell types.  However, different 
species appear to respond differently to increased Wnt signaling which promotes 
neuronal fates in mouse (Lee et al. 2004) and pigment fates in zebrafish (Dorsky, 
Moon and Raible 1998).  Complex genetic interactions such as these make the study of 
the genetic regulation of neural crest cell differentiation an interesting field to work in. 
In particular, we are interested in the genetic interactions which regulate neural crest 
derived pigment cell differentiation.
1.2 Pigment Cells 
Whilst mammals and birds only have one pigment cell type arising from the neural 
crest, the melanocyte, zebrafish have three: black melanophores, yellow xanthophores 
and silver reflective iridophores (Lister et al. 1999).  These cell types differ in their 
migration pathways; melanophores migrate on both the medial and the lateral pathway, 
iridophores migrate only along the medial pathway, and xanthophores migrate only on 
the lateral pathway (Le Douarin and Kalcheim 1999, Raible et al. 1992, Kelsh 2004). 
By 5 days post fertilisation (dpf) the pigment cells have reached their final destinations 
and their patterned distribution in the developing fish is clear.  This consists of four 
stripes of melanophores one dorsally, one laterally, one ventrally and one under the 
yolk sac.  All but the lateral stripe also contain iridophores.  Xanthophores give a 
yellow cast to most of the embryo but are more concentrated dorsally (Figure 1.02).
1.2.1 Melanocyte development
Melanocytes make the pigment melanin, of which there are two kinds: black/brown 
eumelanin and red/yellow pheomelanin (Jackson et al. 1992, Zdarsky, Favor and 
Jackson 1990).  Both of these are present in mice and humans, however zebrafish 
only have eumelanin.  In melanocytes melanin is contained within organelles called 
melanosomes.  In zebrafish these melanosomes remain within the melanophores but in 
mammals they are usually transported from melanocytes into keratinocytes to colour 
the skin/hair (Lin and Fisher 2007).  This pigmentation provides both pattern to the 
skin/hair of individuals and important photoprotection which can diminish the risk of 
skin cancer (Kollias et al. 1991).
In zebrafish, melanoblasts can be identified in a premigratory neural crest position even 
before they pigment; from approximately 18 hpf they express melanoblast specific 
genes such as mitfa and dct (Kelsh et al. 2000, Lister et al. 1999).  In mouse however 
melanoblasts can only be identified, by expression of Dct, once they are migrating at 
E10.5 (Steel, Davidson and Jackson 1992).  Zebrafish melanoblasts migrate away from 












Figure 1.02 Zebrafish pigmentation
A-C Images taken from Kelsh (2004).
A. Melanophores are black and have a stellate morphology.
B. Iridophores are reflective and shine silvery under incident light.
C. Xanthophores have a yellow colouration.
D. Melanophores form four stripes in the zebrafish embryo the positions of which 
are illustrated in this diagram.  Iridophores are also present in the dorsal, ventral and 




(Kelsh et al. 2000, Lister et al. 1999) and pigmentation occurs even whilst the cells are 
migrating from approximately 25 hpf.  Mouse melanoblasts migrate along the lateral 
pathway only before they pass through the dermis to take up their final locations in 
the epidermis and hair follicles.  It is only once they are at their final locations in the 
epidermis that mouse melanoblasts differentiate into melanocytes and pigment (Le 
Douarin and Kalcheim 1999).  Hair follicle melanoblasts remain unpigmented and 
become melanocyte stem cells which then give rise to differentiated progeny (Lin and 
Fisher 2007).
We have already mentioned two genes expressed specifically in melanocytes, Mitf and 
Dct, and there are many others.  Some of these genes play a role early in melanoblast 
development, to specify cells as melanoblasts and promote their differentiation; others 
encode enzymes necessary for melanin synthesis and processing.  We will outline 
some of what is known about the melanocyte specific genes most relevant to our work 
here.
1.2.1i Mitf
Mitf is a basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factor.  In 
mammals there are multiple isoforms of Mitf with different expression domains 
(reviewed Yasumoto et al. (1998)).  We will be referring to the Mitf-M isoform which 
is expressed in the pigmented retinal epithelium (PRE) as well as in neural crest 
derived melanocytes (Nakayama et al. 1998, Lister et al. 1999).  Zebrafish have two 
mitf genes which are expressed in the same cell types in zebrafish as Mitf-M is in 
mouse; mitfa is expressed in neural crest derived melanophores and the PRE and mitfb 
is only expressed in the PRE (Lister, Close and Raible 2001).
Mitf is used as a very early marker of melanocyte specification (reviewed Levy, 
Khaled and Fisher (2006), Goding (2000), Steingrímsson, Copeland and Jenkins 
(2004)).  It is described as the master regulator of melanocyte differentiation.  This role 
is clear in mouse Mitf (Mi) homozygous mutants which lack all neural crest-derived 
melanocytes and have a loss, or severe reduction, in cells expressing melanophore 
markers (Opdecamp et al. 1997).  Depending on the mutant allele, Mi mutants may 
also be deaf, have small eyes or reduced numbers of mast cells (Lister et al. 1999, 
Hodgkinson et al. 1993).  Zebrafish mitfa (nacre) mutants have a similar phenotype to 
the Mi mutants showing a loss of melanophores as well as a decrease in xanthophores 
and a 40 % increase in iridophores (Lister et al. 1999).  Mutations in Mitf in humans 
have comparable phenotypes to those of the mouse and zebrafish mutants resulting in 




Several Mitf overexpression studies have shown Mitf to be sufficient to cause cells to 
adopt a melanocyte fate, again demonstrating the importance of Mitf for melanocyte 
development.  In chicken and quail neuroretinal cells, expression of Mitf induces 
rapid pigmentation of the cells (Planque et al. 1999) and injection of mitfa RNA into 
zebrafish embryos results in the formation of ectopic melanophores (Lister et al. 
1999).  Tachibana et al. (1996) showed that overexpression of Mitf in a fibroblast cell 
line causes the cells to take on a melanocyte morphology and express melanogenic 
genes such as Dct.  However, this study has the caveat that the cell line used is already 
able to express Dct even before overexpression of Mitf.  In a more recent paper, 
expression of Mitf in ES-like medaka cells produced what the authors reported to be 
fully differentiatied melanocytes (Béjar, Hong and Schartl 2003).  Overexpression of 
Mitf can cause melanocyte differentiation because Mitf is capable of regulating many 
genes characteristic of melanocytes.  These include melanogenic enzymes (discussed 
in more detail later in this chapter) and survival factors such as c-Kit (Steingrímsson 
et al. 2004).  However, other work implies that although it is necessary for Mitf to 
be expressed in a cell for it to adopt a melanocyte fate, Mitf expression alone is not 
sufficient for adoption of a melanocyte fate.  Hou, Arnheiter and Pavan (2006) found 
that Sox10 is also required to be expressed in conjunction with Mitf for cells to express 
all of the melanocyte specific genes examined and fully differentiate as melanocytes. 
One report, from work carried out in a mouse melanoma cell line which already 
expresses melanogenic enzymes, shows that overexpression of Mitf in cell culture 
does not lead to increased expression of melanogenic enzymes (Gaggioli et al. 2003). 
The authors suggested that this shows that Mitf is not sufficient to induce expression 
of melanogenic genes. However, since the cells were already expressing these genes 
before the introduction of Mitf the work actually shows that Mitf is not sufficient to 
increase, rather than induce, expression of melanogenic genes.  Cells from neural tube 
explants of KitW-LacZ mice, which have reduced melanocyte survival, also have reduced 
levels of Mitf protein.  Although this level of Mitf is sufficient to induce expression of 
melanogenic proteins Dct, Pmel17 and Tyrp1 it is not sufficient to induce expression 
of Tyrosinase, another melanogenic enzyme.  This suggests that low levels of Mitf 
are not sufficient for complete melanocyte differentiation but is not informative about 
whether or not higher levels, perhaps above a threshold level, would be sufficient for 
cells to fully differentiate as melanocytes.  c-Kit is also required for post-translational 
phosphorylation of Mitf (Hemesath et al. 1998) which both recruits the co-activator 
CBP/p300 to Mitf (Price et al. 1998) and marks Mitf for degradation (Wu et al. 2000). 
Thus, loss of c-Kit from these mice could result in reduced functionality of any Mitf 
protein that is present.  This further complicates attempts to draw conclusions from the 
KitW-LacZ mutant mouse about the necessity of Mitf for melanocyte differentiation.
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Control of Mitf expression and thus of melanocyte specification is complicated, 
involving transcription factors such as Sox10, Pax3 and Lef1 (Watanabe et al. 1998, 
Bondurand et al. 2000, Potterf et al. 2000, Takeda et al. 2000, Lang et al. 2005) and 
signaling pathways such as α-MSH, cAMP and Wnt (Takeda et al. 2000, Bertolotto 
et al. 1996, Kamaraju et al. 2002) as well as there being the possibility that it can 
regulate itself (Steingrímsson et al. 2004).  However, in zebrafish only Sox10 and Wnt 
signaling have been shown to be involved in regulating mitfa expression (Elworthy 
et al. 2003, Dorsky, Raible and Moon 2000), although this is not to say that other 
factors and pathways are not also involved.  As will be discussed in more detail in 
1.5.2, it has been demonstrated, both in vivo and in vitro, that Sox10 can bind to and 
activate expression from the mouse and human MITF and zebrafish mitfa promoters 
(Bondurand et al. 2000, Lee et al. 2000, Potterf et al. 2000, Verastegui et al. 2000, 
Elworthy et al. 2003).  Similarly, Pax3 binding sites have been identified in mouse and 
human MITF promoters and in vitro and in vivo activation of expression from these 
promoters by Pax3 has been demonstrated (Bondurand et al. 2000, Lee et al. 2000, 
Potterf et al. 2000, Verastegui et al. 2000, Watanabe et al. 1998).  Further, some mouse 
and human cell culture studies have found that SOX10 and PAX3 can act synergistically 
to activate expression from the MITF promoter (Bondurand et al. 2000, Potterf et al. 
2000).  Conversely, others have found that in human cells, activation by SOX10 is 
not affected by co-expression of PAX3, nor by the loss of the PAX3 binding site (Lee 
et al. 2000, Verastegui et al. 2000).  There is also a potential cAMP response element 
(CRE) in the Mitf promoter (Goding 2000).  Further, increased cAMP can alter Mitf 
expression (Bertolotto et al. 1998) perhaps by mimicking signaling through the c-Kit 
receptor and activation of the MAP kinase pathway (Hou, Panthier and Arnheiter 2000). 
Wnt signaling also seems to regulate Mitf expression; in mouse culture, addition of 
Wnt-3a will upregulate expression of Mitf.  Lef-1 is a downstream effector of Wnt 
signaling and a Lef-1 binding site exists within the human MITF promoter to which 
Lef-1 has been shown to bind (Takeda et al. 2000).  By mutating the Lef-1 binding site, 
Takeda et al. (2000) reduced MITF expression demonstrating the significance of Lef-
1 in MITF regulation.  The same group went on to show that, in human melanocyte 
and melanoma culture, increased LEF-1 and β-catenin will upregulate reporter gene 
expression from the MITF promoter.   Further, they showed that the positive effect 
of Wnt-3a on MITF expression can be attenuated by addition of a dominant negative 
LEF-1, illustrating the importance of LEF-1 as an effector of Wnt signaling in this 
instance.  Additional supporting evidence for this relationship between Wnt signaling 
and Mitf expression comes from zebrafish.  Lef1 is expressed in the early zebrafish 
embryo and in the neural crest at least at 16 hpf (Ishitani et al. 2005, Lee et al. 2006). 
The mitfa promoter also contains Tcf/Lef binding sites which were shown to bind Lef1 
in vitro (Dorsky et al. 2000) and again, dominant negative Tcf will repress expression 
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from a reporter construct containing the mitfa promoter.  Importantly however, Dorsky 
et al. (2000) were able to show that this has significance in vivo where mutation of 
the Tcf/Lef binding sites prevents Lef1 from binding to these sequences and prevents 
reporter gene expression.
The Mitf protein, like other bHLH-Zip transcription factors, recognises and binds to 
the sequence CATGTG, called an E-box.  In melanocytes, the E-box must be flanked 
by a 5’T and/or a 3’A for Mitf to bind (Aksan and Goding 1998).  The promoters of 
many melanocyte specific genes such as Dct, Tyrp and Tyrosinase contain an M-box, 
an 11 bp sequence which contains an E-box.  Mitf is able to bind to these M-boxes and 
this enables it to regulate expression of Dct, Tyrp and Tyrosinase in vitro (Yasumoto 
et al. 1997, Bentley, Eisen and Goding 1994, Ganss, Schütz and Beermann 1994, 
Bertolotto et al. 1998).  The ability of Mitf to regulate melanocyte differentiation genes 
can be altered in a number of ways.  Phosphorylation of Mitf, via the MAP kinase 
pathway may alter, positively or negatively, the activity and stability of Mitf (reviewed 
in Goding 2000).  In addition, Mitf binds to M-boxes either alone as a homodimer or 
as a heterodimer with related partner proteins Tfe3, Tfeb and Tfec (Hemesath et al. 
1994) or with various other co-factors.  These proteins will also modulate Mitf activity 
and affect melanocyte differentiation.  In mouse, Tfe3 and Tfeb are not expressed at 
times during development when Mitf is important in melanocytes (Nakayama et al. 
1998) and in samples from melanoma cell lines Tfe3 does not coimmunoprecipitate 
with Mitf (Verastegui et al. 2000) so it seems unlikely that these proteins are important 
for Mitf activity in melanocytes.  Supporting this conclusion, the only described Tfe 
orthologue in zebrafish, Tfe3a, is not expressed in neural crest at all (Lister et al. 
2001).  Two other important co-factor proteins, CBP and p300, coimmunoprecipitate 
with Mitf in samples from mouse melanocyte and melanoma cell lines.  These proteins 
interact with the same part of the Mitf protein as does E1A (Sato et al. 1997).  E1A 
can prevent transcription from the M-box (Yavuzer et al. 1995). Therefore if CBP and 
p300 prevent Mitf from interacting with E1A, they will also promote transcription 
from the M-box.  Thus, CBP/p300 are Mitf partner proteins that may be important for 
regulating Mitf activity in melanocytes in vivo.  A final example of an Mitf co-factor is 
Pias3.  It is known to repress activation of genes by Mitf (Sonnenblick, Levy and Razin 
2004).  Zebrafish equivalents for CBP/p300 and Pias3 have not yet been described, 
demonstrating the considerable gaps in our understanding of gene regulation by Mitfa 
in zebrafish.
1.2.1ii Tyrosinase Family Proteins
We have already mentioned three melanogenic enzymes: Tyrosinase, Dopachrome 
tautomerase (Dct) and Tyrosinase-related protein 1 (Tyrp1).  These three proteins 
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comprise the tyrosinase family of enzymes and are important in melanin synthesis 
(Tsukamoto, Jiménez and Hearing 1992).  Tyrosinase catalyses two steps in the 
reaction that converts tyrosine to melanin; the reaction that converts tyrosine to 
dopachrome and later the reaction that converts dopachrome to dopaquinone (Hearing 
1987, Körner and Pawelek 1982).  Mutations in this gene lead to albinism, a loss of 
pigment from the eye and from NC-derived melanocytes in humans (oculocutaneous 
albinism type 1A, OCA1, OMIM 203100), mice (Shibahara et al. 1990) and fish (Page-
McCaw et al. 2004).  Melanocytes themselves persist in these mutants; they express 
other melanocyte specific genes but simply fail to melanise.  Dct is one of the earliest 
markers of melanocyte development both in mouse and in zebrafish (Steel et al. 1992, 
Kelsh et al. 2000).  It is interesting to note that in mouse Tyrosinase and Tyrp1 begin to 
be expressed substantially later than Dct (Seo et al. 1998) but in zebrafish they are all 
expressed from 19 hpf (Camp and Lardelli 2001, Kelsh et al. 2000, Thisse and Thisse 
2004).  Dct catalyses the conversion of dopachrome to DHICA (Jackson et al. 1992). 
Mice which are mutated at the Dct locus, called slaty, have dark grey coats (Jackson et 
al. 1992).  Tyrp1 also has dopachrome tautomerase activity (Zdarsky et al. 1990) but 
its exact role is controversial as it also seems to stabilise Tyrosinase and has DHICA 
oxidase activity (Murisier and Beermann 2006).  Mouse mutants in this gene are called 
brown (Jackson 1988), a reflection of their coat colour.  As we have mentioned, there are 
two kinds of melanin, pheomelanin and eumelanin.  Dct and Tyrp1 are most important 
for eumelanin synthesis; demonstrated by the change in coat colour of mutant mice 
(Zdarsky et al. 1990) and by the loss of Dct and Tyrp1 expression in agouti mouse 
melanocytes during their pheomelanogenic phase (Kobayashi et al. 1995).
1.2.1iii Other Important Melanocyte Proteins
Another gene often used as a melanocyte marker is Silver/Pmel17, named after the coat 
colour of mice mutated at this locus (Kwon et al. 1995, Kwon et al. 1991, Martínez-
Esparza et al. 1999).  Silver is involved in the formation of the intralumenal fibrils in 
melanosomes on which melanin is polymerized (Berson et al. 2003, Kelly and Balch 
2003).  In mouse, Silver is expressed from very early in the melanocyte lineage both in 
the PRE and in the neural crest (Baxter and Pavan 2003).  Zebrafish have two copies 
of this gene, silva and silvb, but only silva is expressed in the neural crest (Schonthaler 
et al. 2005).
All of the above mentioned genes are involved in melanin synthesis or storage.  Of 
course there are other important melanocyte genes.  For example the receptor tyrosine 
kinase c-Kit, and its zebrafish orthologue, kit.  c-Kit is mutated in White spotting mice, 
which have white coats or patches of white fur among other phenotypes (Geissler, Ryan 
and Housman 1988), and in sparse zebrafish which have a reduction in melanophores 
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(Parichy et al. 1999).  The c-Kit ligand is Steel factor and signaling through c-Kit and 
Steel factor is important in melanocyte survival, proliferation and migration  (Morrison-
Graham and Takahashi 1993, Wehrle-Haller, Meller and Weston 2001, Kelsh et al. 
2000, Yoshida et al. 1996, Parichy et al. 1999).
1.2.2 Xanthophore Development
Xanthoblasts migrate only on the lateral pathway (Le Douarin and Kalcheim 1999). 
When fully differentiated they have a delicate, spidery morphology.  Xanthophore 
pigment is made up of pteridines which are yellow, visible from approximately 35 hpf. 
Pteridines also autofluoresce under fluorescent light.  The major published markers 
for xanthophores are GTP-cyclohydrolase I (gch) and xanthine dehydrogenase (xdh) 
(Parichy et al. 1999).  They both code for enzymes required for pteridine synthesis.  Gch 
functions in the pathway which converts guanosine triphosphate to tetrahydrobiopterin 
(BH4), a precursor to pteridine pigments.  Xdh is required to make xanthopterin, a 
xanthophore pteridine pigment (Epperlein and Löfberg 1990, Reaume, Knecht and 
Chovnick 1991).  However, a product of Gch activity, BH4, is also a co-factor for 
phenylalanine hydroxylase, which converts phenylalanine to tyrosine (a precursor to 
melanin), and regulates the activity of Tyrosinase (O’Donnell, McLean and Reynolds 
1989, Wood et al. 1995, Nagatsu and Ichinose 1999).  This might explain why gch is 
also known to be expressed in early melanoblasts (Parichy et al. 2000b).
1.2.3 Iridophore Development
We mention iridophores here only very briefly since they are not a focus of this thesis. 
Iridoblasts migrate solely on the medial migration pathway (Kelsh 2004).  The shiny 
nature of iridophores is due to the presence of reflective guanine platelets which 
become visible from approximately 40 hpf.  Marker genes for iridophores include 
ednrb1, which is expressed in the embryo but appears only to have a function in the 
adult fish (Parichy et al. 2000a) and ltk which has recently been shown to be key for 
iridophore specification (Lopes et al. 2008).
1.3 Neural Crest Disease and Models
Where neural crest development fails in humans, a number of genetic diseases result. 
These are collectively known as neurocristopathies.  One such disease is Hirschprung’s 
disease, the major symptom of which is aganglionic megacolon resulting from a loss 
of neural crest derived enteric neurons.  Hirschprung’s disease is often caused by 
mutations in the gene RET (Badner et al. 1990, Romeo et al. 1994, Edery et al. 1994). 
Another example of a neurocristopathy is Waardenburg syndrome.  This is in fact a 
group of four syndromes which have different combinations of a number of symptoms 
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which vary in their severity.  All neural crest derivatives can be affected to differing 
degrees in Waardenburg syndromes.  Symptoms always include loss of pigment in 
the skin, and sometimes deafness (Read and Newton 1997) as a result of loss of 
melanocytes.  WS2 is the simplest of the syndromes since patients only have the 
pigmentary defects.  This syndrome is often linked with mutations in MITF, although 
recently a case has been described where the transcription factor SOX10 is mutated 
(Tassabehji, Newton and Read 1994, Hoth et al. 1993, Bondurand et al. 2007).  WS1 
is characterized by loss of pigment cells with the addition of dystopia canthorum, 
whilst WS3 patients display these symptoms as well as limb deformities.  Thus, WS1 
and WS3 affect the formation of neural crest derived craniofacial cartilage as well as 
melanocytes.  These syndromes are associated with mutations in the transcription factor 
PAX3 (Tassabehji et al. 1992).  The fourth syndrome, WS4, combines the symptoms of 
Waardenburg syndrome with those of Hirschprung’s disease (Omenn and McKusick 
1979, Shah et al. 1981).  Mutations in several genes have been associated with this 
syndrome including endothelin B receptor (EDNRB), its ligand endothelin 3 (EDN3), 
and SOX10 (Edery et al. 1996, Attié et al. 1995, Hofstra et al. 1996, Pingault et al. 
1998, Kuhlbrodt et al. 1998b).
There are many mutants in both mouse and zebrafish which have defects in neural crest 
development (http://www.informatics.jax.org/, Eppig et al. (2007), Kelsh et al. (1996), 
Odenthal et al. (1996)).  These have enabled researchers to learn a great deal about the 
biology and genetics of neurocristopathies (Bennett and Lamoreux 2003).  The major 
genes which are mutated in Waardenburg syndromes all have equivalent mouse mutants 
which provide models for further study of the disease: microphthalmia/Mitf (Hodgkinson 
et al. 1993), splotch/Pax3 (Chalepakis et al. 1994), piebald-lethal/Ednrb (Hosoda et al. 
1994), lethal-spotting/Edn3 (Baynash et al. 1994) and Dom/Sox10 (Herbarth et al. 1998, 
Southard-Smith, Kos and Pavan 1998, Lane and Liu 1984).  Similarly, there are zebrafish 
equivalents for some of these mutants/genes and study of these also contributes to the 
understanding of Waardenburg syndrome: nacre/mitfa (Lister et al. 1999), rose/ednrb1 
(Parichy et al. 2000a) and cls/sox10 (Dutton et al. 2001).
As mentioned above, humans with WS4 have symptoms encompassing both pigmentary 
and neural phenotypes; these patients often have lesions at their SOX10 locus (Pingault 
et al. 1998).  Sox10 mutant embryos in both mouse and zebrafish mirror many aspects 
of the human phenotype closely and provide excellent models for study of the human 
disease (Herbarth et al. 1998, Kelsh et al. 1996, Dutton et al. 2001, Southard-Smith, 
Kos and Pavan 1998, Lane and Liu 1984).  The most studied mouse Sox10 mutant is 
Dominant megacolon (Dom), a spontaneous mouse mutant identified in 1984 (Lane 
and Liu 1984, Herbarth et al. 1998).  Sox10Dom homozygous mice die before 13 days 
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of gestation but mice heterozygous for the mutation show white spotting (white belly 
spots and white feet) as a result of loss of melanocytes and a loss of enteric neurons 
(leading to megacolon).  Other alleles show similar defects.  Sox10Hry is a mouse line 
with a transgene insertion that disrupts Sox10 regulatory sequences (Antonellis et 
al. 2006).   Heterozygous Sox10Hry mice do not display a phenotype beyond variable 
white belly spotting.  However, homozygous mice survive and have a complete loss 
of melanophores and a partial loss of enteric neurons.  Sox10LacZ is another transgenic 
line where LacZ is inserted into the Sox10 coding region.  The transgene in this case is 
homozygous lethal; heterozygous mice display a phenotype similar to the spontaneous 
Sox10Dom mutant (Britsch et al. 2001).  Zebrafish sox10 mutants, first called colourless 
(cls), are also deficient in all non-skeletogenic neural crest derivatives (Dutton et al. 
2001, Kelsh and Eisen 2000).  Mouse Sox10 mutants display haploinsufficiency whereby 
heterozygous mice display a non-lethal phenotype resulting from loss of function of one 
gene copy.  This heterozygous phenotype can be studied in addition to the embryonic 
phenotype of homozygous embryos prior to death.  One difference between mouse and 
zebrafish models is that zebrafish sox10 heterozygotes are essentially indistinguishable 
from wild types; there is no haploinsufficiency.  It is, therefore, only the homozygous 
embryos which are studied.  Like the mouse homozygous sox10 mutants, homozygous 
zebrafish mutants also die before reaching adulthood, at approximately 10 dpf.  In both 
organisms there is a loss/reduction in markers for the affected neural crest derivatives 
(Southard-Smith et al. 1998, Dutton et al. 2001) and increased apoptosis of neural crest 
derived cells (Kapur 1999, Southard-Smith et al. 1998, Dutton et al. 2001).  However, 
the detailed phenotypes of these different Sox10 mutants have not been fully explored. 
For example, we know little about how far non-skeletogenic neural crest derivatives 
may be able to develop and which genes are expressed in these cells before specification 
fails.  Further exploration of the phenotypes of the sox10 mutants available to us, 
particularly at a molecular level, may yield more clues about the precise role that 
Sox10 plays in the neural crest.
1.4 Sox Proteins 
Humans and mice have 20 orthologous pairs of proteins which comprise the Sry-like 
HMG box, or Sox, family of transcription factors (Schepers, Teasdale and Koopman 
2002).  All have HMG DNA binding domains (Laudet, Stehelin and Clevers 1993) 
and bind within the minor groove of DNA (Werner et al. 1995).  This causes bending 
of the DNA into an L-shape bringing disparate sections of DNA together (Connor et 
al. 1994, Ferrari et al. 1992, Werner et al. 1995).  This has obvious implications for 
understanding the regulation of genes where Sox proteins have an involvement since 
transcription factor binding sites which might normally be widely separated may be 
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brought closer together.  Sox proteins in general may require particular binding partners 
and often function in co-operation with other transcription factors to induce target gene 
expression (reviewed in Wegner (2005)).  This may impart specificity on a family of 
proteins which are often expressed to different effect in several cells types but which 
are very similar in the DNA sequences that they recognise (Kamachi, Uchikawa and 
Kondoh 2000, Wilson and Koopman 2002).
The Sox family is categorized into ten groups, A-J, according to similarities in their 
HMG domain sequences (Schepers et al. 2002).  The SoxE group comprises Sox8, 
Sox9 and Sox10.  These proteins can function as monomers but may also be required 
to be dimerised to function properly in some situations (Wegner 2005, Peirano and 
Wegner 2000, Schlierf et al. 2002).  Another interesting feature of the genes in this 
family is that they have both nuclear and cytoplasmic localization sequences (Gasca et 
al. 2002, Poulat et al. 1995, Südbeck and Scherer 1997).  In the case of Sox10, it has 
been shown in mouse cell culture that the protein is shuttled between the nucleus and 
the cytoplasm and can be sequestered in the cytoplasm (Rehberg et al. 2002).  Thus a 
cell may still have detectable SoxE protein but it is not functional since it is not present 
in the correct part of the cell.  However, there is as yet no evidence that this occurs in 
zebrafish.
1.4.1 Sox8
In mouse, Sox8 is expressed in the brain, more specifically in glia.  It is mutated 
in patients with ATR-16, a disease characterised by mental retardation (Cheng et al. 
2001, Pfeifer et al. 2000).  Other sites of expression in mouse include premigratory 
neural crest and neural crest derivatives such as the branchial arches, DRGs and the 
peripheral nervous system as well as the otic placode, cranial ganglia, limb buds and 
spinal cord (Sock et al. 2001).  In chick, Sox8 is expressed in many of the same cell 
types, such as premigratory neural crest, DRGs, enteric neurons and developing limbs 
(Bell, Western and Sinclair 2000).  The described zebrafish homologue (Cresko et al. 
2003) is not expressed in neural crest derivatives (Yan et al. 2005).
The exact function of Sox8 has not been described convincingly in any organism. 
A targeted mouse mutant displays a general reduction in weight, a phenotype which 
is not particularly informative when elucidating the function of Sox8.  The only 
specific effect upon any of the cell types in which Sox8 is known to be expressed is 
in Sertoli cells where mutations in Sox8 cause a deregulation of spermatogenesis and 
progressive male infertility (Sock et al. 2001, O’Bryan et al. 2008).  It is suggested 
that the lack of specific phenotypes in Sox8 mutants is as a result of compensation 
for the loss of functional Sox8 by other genes in the SoxE family.  Mice that are 
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heterozygous for mutations in both Sox8 and Sox10 have a phenotype more like that 
of a Sox10 homozygous mutant which supports the idea that there may be potential for 
functional redundancy between SoxE genes (Maka, Stolt and Wegner 2005).  In chick, 
overexpression of Sox8 can induce neural crest (Cheung and Briscoe 2003). However, 
as we mentioned previously, Sox proteins have rather generic binding sites and all of 
the genes involved in neural crest induction regulate one another, and since Sox8 is 
not expressed in presumptive neural crest it is unlikely to play a role in the formation 
of normal neural crest.
1.4.2 Sox9
Sox9 expression in mouse is mostly associated with chondrogenesis but expression is 
also present in structures such as the heart, notochord and the testes (Wright et al. 1995, 
Wagner et al. 1994).  In humans, mutations in Sox9 result in the syndrome Campomelic 
Dysplasia symptoms of which include bone malformations and sex reversal (Foster et 
al. 1994).  Heterozygous Sox9 mouse mutants display similar phenotypes to those 
described for Campomelic Dysplasia (Bi et al. 2001, Mori-Akiyama et al. 2003). 
Homozygous mutations in Sox9 are lethal in mouse. A number of targets for Sox9 
have been identified which, consistent with a role in chondrogenesis, include AMH 
(Anti-Mullerian Hormone), Col2a1 and Col11a2 (see Marshall and Harley (2000) for 
review).  Zebrafish have two homologues for Sox9, Sox9a and Sox9b, the expression 
patterns of which both overlap with and complement one another to make up the 
same expression pattern as their mouse counterpart (Chiang et al. 2001).  Sox9a is 
expressed in the brain, craniofacial cartilage, testes, ear, eye, somites and fins (Yan et 
al. 2005).  Sox9b is expressed in the brain, sensory organs and fins as well as during 
chondrogenesis (though at a later stage than Sox9a).  The zebrafish mutant for Sox9a, 
jellyfish, displays cartilage and fin defects (Yan et al. 2002).  Sox9b zebrafish mutants 
also have cartilage and fin defects, though less severe (Yan et al. 2005).  The effect 
of generating embryos mutant for both genes is additive and strongly resembles the 
mouse Sox9 mutant phenotype again providing supporting evidence for a role for Sox9 
in chondrogenesis (Yan et al. 2005).
Sox9 is also expressed in mouse presumptive neural crest; evidence of a role for 
Sox9 in this transient population of cells (Li et al. 2002).  This was demonstrated in 
chick through the induction of crest markers by overexpression of Sox9 (Cheung and 
Briscoe 2003).  Loss of function analysis in zebrafish (either as a result of mutation or 
morpholino knockdown) shows a strong reduction in the expression domains of early 
crest markers snai1b, foxd3 and sox10 (Yan et al. 2005).  Gain of function experiments, 
by mRNA injection, show that both sox9a and sox9b can induce ectopic expression of 
foxd3, sox10 and snai1b (Yan et al. 2005).  These results support an additional role for 
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Sox9 genes in zebrafish neural crest formation.
1.5 Sox10
1.5.1 Sox10 Expression
Sox10 in Xenopus is expressed in the neural crest even before closure of the neural 
tube (Aoki et al. 2003).  In human, mouse, zebrafish and chick it is not expressed 
until later, in the premigratory neural crest (Southard-Smith, Kos and Pavan 1998, 
Dutton et al. 2001, Cheng et al. 2000, Pusch et al. 1998, Bondurand et al. 1998). 
Other sites of Sox10 expression include the ear and oligodendrocytes (Aoki et al. 2003, 
Southard-Smith et al. 1998, Cheng et al. 2000).  We will concentrate on the expression 
in the neural crest (Dutton et al. 2001).  Expression of Sox10 persists in migrating 
neural crest cells including enteric neuron precursors and melanoblasts (Kuhlbrodt et 
al. 1998a, Dutton et al. 2001, Southard-Smith et al. 1998, Cheng et al. 2000, Aoki et 
al. 2003).  However, in most cell types, probably including zebrafish melanophores, 
Sox10 expression is gradually lost as cells differentiate (Britsch et al. 2001, Dutton et 
al. 2001, Sonnenberg-Riethmacher et al. 2001, Cheng et al. 2000, Aoki et al. 2003, 
Kim et al. 2003).  In glia, Sox10 expression persists into adulthood (Kuhlbrodt et al. 
1998a, Britsch et al. 2001, Sonnenberg-Riethmacher et al. 2001, Southard-Smith et al. 
1998, Cheng et al. 2000, Bondurand et al. 1998, Pusch et al. 1998).  Persistent Sox10 
expression may also be a feature of melanocytes in mouse.  Sox10 expression has been 
reported in vivo in melanocytes during late embryonic stages and after birth, although 
it is downregulated in melanocyte stem cells (Osawa et al. 2005).  There are conflicting 
reports about whether Sox10 is consistently expressed in melanocyte and melanoma 
cell lines (Southard-Smith et al. 1998, Cook et al. 2005).
1.5.2 Proposed Functions for Sox10
As has been outlined, Sox10 is expressed in many different cell types some of which 
also express other SoxE family genes.  What is it then that Sox10 is important for in 
these different cell types?  What is its function?  In fact, it would appear that Sox10 has 
many different roles within the embryo depending upon the context of its expression. 
Some of the current thinking about these roles is outlined below.
In Xenopus and chick there is evidence that Sox10 has a very early role in the 
specification of cells to become neural crest.  In both organisms, overexpression of 
Sox10 in embryos results in increased expression of neural crest markers e.g. slug 
(Aoki et al. 2003, Cheung and Briscoe 2003).  Additionally, in Xenopus there is 
an increase in pigmented melanocytes, although overexpression of slug by mRNA 
injection has the same effect.  In support of this relationship, morpholino knockdown 
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of Sox10 in Xenopus results in a reduction in the expression of slug and so a reduction 
in neural crest (Honoré, Aybar and Mayor 2003).  However, there is no failure of 
neural crest formation in either mouse or zebrafish Sox10 mutants (Dutton et al. 
2001, Britsch et al. 2001) so it would appear that an early role for Sox10 in the neural 
crest, proposed principally from work in frog, does not extend to other organisms. 
On the other hand, it has been proposed that there are variations in the potential for 
functional redundancy between the SoxE genes between species so that altering levels 
of any of those genes will have different effects in different organisms (Kelsh 2006). 
In addition, we discussed above that expression of many of the genes involved in 
early crest induction/specification are dependent on each other.  It is easy to imagine, 
therefore, that overexpression of Sox10 does not directly promote formation of neural 
crest but that it could alter the expression patterns of other genes, for example Sox9, 
which in turn affect the formation of the neural crest.  In chick and zebrafish, Sox9 is 
expressed ahead of Sox10, consistent with Sox9 having a primary role in neural crest 
formation and a role for Sox10 being slightly later in development (McKeown et al. 
2005).  These results indicate that Sox10 may be involved in the neural crest gene 
regulatory network but they do not define its role.
Other roles for Sox10 later in neural crest development have also been put forward. 
Increased cell death observed in Sox10 mutants (Southard-Smith et al. 1998, 
Dutton et al. 2001, Kapur 1999, Paratore et al. 2001, Sonnenberg-Riethmacher et 
al. 2001) has led some to suggest a role for Sox10 in undifferentiated neural crest 
cell survival (Mollaaghababa and Pavan 2003, Wegner 2005, Paratore et al. 2001). 
Indeed, morpholino knockdown of Sox10 in Xenopus leads to increased apoptosis 
and decreased proliferation in the neural folds, again supporting the hypothesis that 
Sox10 has a role in neural crest maintenance.  Alternatively, it could be that these 
results occur as an indirect effect of the role of Sox10 in specification of neural crest 
cells to their respective fates.  Thus, in the absence of Sox10, neural crest cells fail 
to become specified and, as has been demonstrated in zebrafish, die by apoptosis 
(Dutton et al. 2001, Kapur 1999, Southard-Smith et al. 1998).  A role for Sox10 in 
fate specification has been demonstrated in multiple cell types and is particularly well 
supported in the case of melanocytes.  Mitf is the master regulator of melanocyte 
differentiation (reviewed Levy, Khaled and Fisher (2006), Goding (2000)) and Sox10 
mutants fail to express it (Britsch et al. 2001, Dutton et al. 2001, Potterf et al. 2001). 
A test of whether Sox10 could regulate Mitf came from experiments in cell culture 
that showed that expression of either mouse or zebrafish Sox10 in mammalian cell-
lines could activate transcription from the Mitf promoter (Lee et al. 2000, Verastegui 
et al. 2000, Bondurand et al. 2000, Potterf et al. 2000, Elworthy et al. 2003).  These 
same authors used gel shift assays to demonstrate that Sox10 can directly bind the Mitf 
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promoter.  The ease of analysis of reporter expression in transient transgenic zebrafish 
allowed the demonstration in vivo that at least one functional Sox10-binding site in 
the mitfa promoter is necessary for mitfa expression in the neural crest (Elworthy et 
al. 2003).  In summary, in melanocytes Sox10 drives expression of mitfa, the key gene 
for a cell to become a melanocyte, and so Sox10 has an important role in melanocyte 
fate specification.
A similar specification role has been described in autonomic neurons, where Sox10 
induces expression of Phox2b, and in DRG sensory neurons where it induces 
expression of ngn1.  Phox2b is a homeobox transcription factor which, together with 
Mash1, is important in autonomic neuron specification (Guillemot et al. 1993, Lo, 
Tiveron and Anderson 1998, Pattyn et al. 1999).  It has a direct role in regulating 
neuron differentiation genes such as tyrosine hydroxylase (Pattyn et al. 1999, Lo et 
al. 1998).  Kim et al. (2003) showed that in mouse sympathetic neurons, Sox10 is 
required to activate expression of Phox2b and Mash1.  They found that most Sox10 
positive cells near the dorsal aorta in a wild type mouse are also Phox2b and Mash1 
positive and the equivalent cells in Sox10 mutant embryos are not Phox2b/Mash1 
positive.  This suggested that Sox10 is required for induction of Phox2b/Mash1 and 
thus to promote neuron specification.  However, Sox10 alone is not able to increase 
expression of Mash1 suggesting that the relationship between Sox10 and Mash1 may 
not be direct.  Instead, the authors found that BMP2 induces expression of Mash1 and 
the inhibition of this action by TGFβ can be prevented by constitutive expression of 
Sox10 (Kim et al. 2003).  In fish, morpholino knockdown of phox2b results in a loss 
of enteric neurons.  The expression of Phox2b in these neurons, and so specification of 
enteric neurons, is also dependent upon Sox10.  Again however, expression of phox2b 
is not necessarily directly activated by Sox10 (Elworthy et al. 2005).
In mouse Sox10 mutants, DRG sensory neurons form but later degenerate (Britsch et 
al. 2001).  In zebrafish sox10 mutants DRGs are severely disrupted, being reduced in 
number, misplaced in the trunk and absent from the tail (Britsch et al. 2001, Kelsh and 
Eisen 2000).  A study of glial defects in mouse DRGs was interpreted to suggest that 
Sox10 did not act directly in the sensory neuron lineage.  They reasoned that since 
glia completely fail to differentiate in Sox10 mutants (Britsch et al. 2001, Paratore 
et al. 2001, Carney et al. 2006) sensory neurons die in the DRGs because of lack of 
glial trophic support (Britsch et al. 2001).  However, a recent paper re-assessed this 
issue in the zebrafish model and demonstrated convincingly that Sox10 is actually 
required transiently in sensory neurons (Carney et al. 2006).  Furthermore, the authors 
show that its role is in fate specification of the sensory neuron lineage.  ngn1 is a gene 
encoding a pivotal transcription factor in sensory neurons and it has been shown that 
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Sox10 is able to regulate its expression (Carney et al. 2006).  Tests of whether the 
regulation of ngn1 by Sox10 is direct have yet to be performed, but overexpression 
studies in the zebrafish embryo indicate that ngn1 transcription is activated rapidly 
after, and thus perhaps as a direct response to, Sox10 expression. Whether other sensory 
neuron genes are directly regulated by Sox10 remains to be assessed, although sox10 
expression disappears rapidly from this lineage and so a late role in differentiation or 
fate maintenance is unlikely.
In contrast, a late role for Sox10 is much more likely in glia as expression persists in 
this cell type into adulthood (Bondurand et al. 1998, Kuhlbrodt et al. 1998a, Pusch et 
al. 1998, Southard-Smith et al. 1998, Britsch et al. 2001, Sonnenberg-Riethmacher 
et al. 2001, Cheng et al. 2000).  A requirement for Sox10 has been demonstrated in 
this cell type since no glial markers are ever detected in Sox10 mutants (Carney et 
al. 2006, Britsch et al. 2001), nor can glia be encouraged to differentiate in culture 
from Sox10 deficient neural crest cells (Paratore et al. 2001).  It is not clear whether 
this demonstrates a requirement for Sox10 in glial fate specification or suggests a 
continuing role in glial differentiation.  Of course, these options are not mutually 
exclusive.  Krox20 (Egr2) is a zinc finger transcription factor important in myelination 
of Schwann cells (Topilko et al. 1994).  It has been shown to induce expression of 
myelin genes such as Myelin Protein Zero (MPZ), Connexin32 and MAG (Nagarajan 
et al. 2001) and when mutated in mice it prevents promyelination (Topilko et al. 1994). 
Sox10 is able to induce expression of a reporter gene attached to a Krox20 regulatory 
element (Ghislain and Charnay 2006) indicating that it is likely to be a regulator of 
Krox20 and thus glial fate specification.  Overexpression of Sox10 in cells expressing 
MPZ (P0) will greatly increase the levels of MPZ expression (Peirano et al. 2000). 
This upregulation of MPZ may occur via Krox20 but the relationship may be more 
direct since Sox10 binding sites are present in the promoter region of MPZ.  In either 
case, this evidence would support the suggestion of an additional role for Sox10 in 
glial differentiation.  Similarly, the Connexin32 promoter also contains Sox10 binding 
sites and in cell culture, addition of Sox10 will increase the expression of Connexin32 
(Bondurand et al. 2001).  These examples provide support for a dual role for Sox10 in 
glia, in both glial differentiation and in glial specification.
One study we mentioned demonstrated that Sox10 is important in sympathetic neuron 
development via Phox2b and Mash1 (Kim et al. 2003).  The same authors also 
demonstrated that Sox10 performs a contradictory role, one of maintaining crest cells in 
a stem cell-like state, in this cell type (Figure 1.03).  They showed that BMP2 promotes 
loss of glial potential in neural crest and TGFβ promotes loss of neurogenic potential. 









Loss of gliogenic 
potential







Figure 1.03 Roles of Sox10 in sympathetic neuron differentiation
Sox10 has many roles in sympathetic neuron development (Kim et al. 2003).  It is able 
to maintain neural crest cells in a stem cell-like state by inhibiting the actions of TGFβ 
and BMP2 (1 and 2).  These factors promote the loss of neurogenic and gliogenic 
potential respectively so by blocking their action, Sox10 maintains neurogenic and 
gliogenic potential in neural crest cells.  Sox10 also acts to promote differentiation by 
inducing expression of sympathetic neuron specification genes, Mash1 and Phox2b 
(3).  This interaction is not direct but Sox10 is certainly permissive for BMP2 induced 
expression of Mash1.  Simultaneously, Sox10 inhibits the differentiation of thse cells 
by repressing expression of Phox2a (4).
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thus maintaining neurogenic and gliogenic potential and keeping neural crest cells in 
a stem cell-like state.  By similar overexpression of Sox10 in neural crest cells Kim et 
al. (2003) showed that Sox10 must be downregulated to allow the full differentiation 
of neural crest cells into neurons.  This is because, when present at high levels, Sox10 
is able to repress the expression of Phox2a, another neuron specific gene and inhibit 
differentiation.  Thus, Sox10 functions in several guises in sympathetic neurons.  It 
is able to simultaneously promote sympathetic neuron specification, prevent loss of 
gliogenic and neurogenic potential and inhibit differentiation, in so doing, keeping 
neural crest cells in a stem cell like state.
1.5.3 Role of Sox10 in Melanophores
Many different functions for Sox10 have been described in different neural crest 
derivatives and it can even have many different functions just within one cell type, 
sympathetic neurons.  However, we still do not fully understand the role that Sox10 
has within genetic regulatory networks involved in neural crest development.  The 
work presented in this thesis will focus on the role of Sox10 in melanoblasts and 
melanocytes.  We outline below the current understanding of the role of Sox10 in these 
cells and highlight the areas where we hope to add to this understanding.
One function that Sox10 performs in melanoblasts, one that is not disputed, is to switch 
on expression of Mitf  (see 1.5.2).  Both mouse and zebrafish Sox10 mutants fail to 
express Mitf or mitfa respectively (Britsch et al. 2001, Dutton et al. 2001, Potterf et 
al. 2001) and further, researchers have shown that Sox10 can bind to, and activate 
expression from, the mouse and human MITF and zebrafish mitfa promoters in vivo 
and in vitro (Bondurand et al. 2000, Lee et al. 2000, Potterf et al. 2000, Verastegui et 
al. 2000, Elworthy et al. 2003).  We outlined in 1.2.1i some other factors that will also 
modulate Mitf expression (reviewed Goding (2000)).  Transcription factors such as 
Pax3 and Lef-1 are known to bind to and regulate expression from the mouse Mitf-M 
promoter in vitro and in vivo (Watanabe et al. 1998, Bondurand et al. 2000, Potterf et 
al. 2000, Takeda et al. 2000, Lang et al. 2005) and pathways such as α-MSH, cAMP 
and Wnt signaling are required for expression of Mitf-M (Takeda et al. 2000, Kamaraju 
et al. 2002).  In addition, co-factors such as CBP/p300 will modulate the activity 
of the Mitf protein (Sato et al. 1997).  This reminds us that relationships between 
genes are not necessarily single linear relationships but many factors may influence 
the expression and activity of any given protein.  Development involves networks of 
genetic interactions of which only a small part is usually studied at any one time.  It is 
therefore important to keep in mind that the relationship between Sox10 and Mitf will 
be modified by other factors which are often not being directly studied.
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Of course, once Mitf is expressed, this master regulator is able to induce expression of 
many melanocyte specific genes and cause differentiation.  Further to the data described 
in 1.2.1i illustrating that Mitf alone is sufficient to cause melanocyte differentiation in 
vitro and in vivo (Tachibana et al. 1996, Planque et al. 1999, Béjar, Hong and Schartl 
2003, Lister et al. 1999), there is evidence that Mitf alone is able to directly induce 
expression of many melanocyte specific genes.  The promoters of all of the tyrosinase 
family genes have M-boxes and expression from these promoters can be activated by 
Mitf (Budd and Jackson 1995, Bentley, Eisen and Goding 1994, Ganss, Schütz and 
Beermann 1994, Yasumoto et al. 1994, Yokoyama et al. 1994, Jackson et al. 1991, 
Yasumoto et al. 1997, Lowings, Yavuzer and Goding 1992, Bertolotto et al. 1998, Camp 
et al. 2003).  Also, in zebrafish, overexpression of mitfa can induce expression of dct 
(Lister et al. 1999).  Silver expression is absent from mouse Mitf mutants (Baxter and 
Pavan 2003) suggesting that Mitf can also regulate Silver.  Direct activation of the Silver 
promoter by Mitf was confirmed by both in vitro and in vivo work (Du et al. 2003).  
If Sox10 is able to induce expression of Mitf, which in turn is sufficient for melanocyte 
differentiation, then it could be that this is the only role for Sox10 in the melanocyte. 
Work by Elworthy et al. (2003) showed that in zebrafish it is possible to rescue 
melanophores in sox10 mutant fish by introduction of mitfa RNA into the one cell 
stage embryo.  These rescued cells are fully pigmented, morphologically normal and 
are able to migrate normally.  Elworthy et al. (2003) also demonstrated that driving 
expression of mitfa in the neural crest was quantitatively as effective at rescuing 
melanophores in either sox10 or mitfa mutants.  This result suggests, at least in fish, 
that Sox10 is not necessary for melanophore development beyond the requirement 
for it to activate expression of mitfa.  Although expression of melanogenic enzymes 
was not directly assessed, the fact that the rescued melanophores pigment successfully 
suggests that Sox10 is not required for expression of melanogenic enzymes in zebrafish. 
Conversely, in mouse it seems that Sox10 is required in addition to Mitf to achieve 
Tyrosinase expression and subsequent pigmentation (Hou, Arnheiter and Pavan 2006). 
Hou et al. (2006) found that when cultured cells which did not have functional Sox10, 
and therefore did not express Mitf, were made to express Mitf independent of Sox10 
these cells still failed to pigment.  On closer inspection it was apparent that these 
cells were expressing melanocyte differentiation proteins such as Dct and Tyrp1 but 
stopped short of expressing Tyrosinase and becoming pigmented.  However, if these 
cells are made to express wild type Sox10 by viral infection they express Mitf and all 
of the melanocyte proteins examined, including Tyrosinase, and they pigment.  Thus, 
the authors suggest that a feed-forward loop must exist where Sox10 activates Mitf, 
which alone will activate most melanocyte differentiation genes but which must act 
in conjunction with Sox10 to activate Tyrosinase expression.  Indeed, the Tyrosinase 
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promoter does possess a Sox10 binding site (Murisier, Guichard and Beermann 2007). 
However, the work of Hou et al. (2006) was conducted in vitro.  Primary neural crest 
was cultured for 10 days after viral infection before assaying.  This is a considerable 
period of time in culture and does not reflect the timing of melanocyte gene expression 
and development in vivo.  It would be valuable therefore, to support this work with in 
vivo data before drawing firm conclusions as to whether Sox10 is necessary in mouse 
melanocytes beyond the requirement for it to activate Mitf expression.
Supporting the hypothesis of a later role for Sox10 in melanocytes beyond switching 
on Mitf expression, Sox10 has also been implicated in the activation of Dct expression. 
Sox10 can activate reporter gene expression from mouse and human Dct promoter 
sequences (Britsch et al. 2001, Potterf et al. 2001).  Two groups have gone further 
to show that in vitro, Sox10 is able to activate expression of Dct in both human and 
murine cell lines and they have identified the sites at which Sox10 binds the Dct 
promoter (Jiao et al. 2004, Ludwig, Rehberg and Wegner 2004).  Activation of Dct 
expression by Sox10 can be enhanced further by also expressing Mitf in the same cells 
(Jiao et al. 2004, Ludwig et al. 2004).  Again, this work was carried out in vitro and 
remains to be supported by in vivo data.  However, Hou et al. (2006) found that whilst 
Sox10 may be able to induce Dct expression it is not required for Dct expression; 
Dct can be induced by expression of Mitf in Sox10-deficient primary neural crest 
culture.  In zebrafish, a late role for Sox10 in melanophore differentiation certainly 
seems unlikely from the evidence of Elworthy et al. (2003) and since Sox10 has been 
briefly noted as being downregulated in melanophores as they differentiate (Dutton et 
al. 2001).  Data from human and mouse cell culture about whether Sox10 expression 
persists in melanocytes is inconclusive.  In mouse B16 melanoma cell lines and in 
human melanomas, Sox10 is expressed in significant amounts in differentiated cells 
(Kamaraju et al. 2002, Khong and Rosenberg 2002).  Of course these studies come 
with the caveat that cell culture, particularly when using altered cell lines such as 
melanomas, is not necessarily representative of in vivo events.  In an in vivo study, 
Sox10 was seen to be downregulated in melanocyte stem cells in the hair follicle but 
was also maintained in differentiating cells in the epidermis at least until E18.5 and in 
the hair follicle until P6 (Osawa et al. 2005).  However, there are some significant gaps 
in the timecourse of the data from this paper, for example they do not look at expression 
after P6.  Conversely to the data above, in human primary cell lines Sox10 has been 
shown to be downregulated in differentiating melanocytes (Cook et al. 2005).
Hou et al. (2006) postulate that the differences we see in the data we have to date 
from mouse and zebrafish about the role of Sox10 in melanocytes are due to actual 
interspecies differences.  However, the emerging picture from mouse is neither 
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consistent nor complete since a significant amount of data has been gathered in vitro, 
often in abnormal melanoma cell lines, and remains to be tested in vivo.  There is also 
more to be learnt from zebrafish about exactly which genes Sox10 and Mitfa are able to 
regulate in this organism.  We suggest that there is currently insufficient data, from either 
model organism, to confirm that differences observed between the apparent function 
of Sox10 in melanocytes versus melanophores are due to interspecies differences.  We 
would like to use zebrafish to try to reconcile some of the data surrounding Sox10 
function in melanocyte differentiation including investigating which genes Sox10 and 
Mitfa are able to regulate.
Given the many roles for Sox10 in the neural crest that we discussed in 1.5.2, it seems 
unlikely that its role in melanophores will be as simple as just switching on mitfa. 
A model proposed by Kim et al. (2003) for Sox10 function in sympathetic neuron 
differentiation is presented in Figure 1.04 and we would like to test whether Sox10 might 
function in a similar genetic network in melanophores.  Kim et al. (2003) provide both 
in vitro and in vivo data to convincingly support their model.  However, the authors 
do not claim to have demonstrated direct relationships between the constituent genes 
and this remains the only paper relating to this model.  Kim et al. (2003) demonstrated 
that Sox10 is required for induction of Mash1 and Phox2b thus promoting neuron 
differentiation (see 1.5.2).  However, they also found that this requirement may only 
be transient.  Early in development Sox10 positive cells in a position appropriate for 
sympathetic neurons are often also Mash1 and Phox2b positive but at later stages 
Mash1 and Phox2b positive cells are not Sox10 positive.  This pattern of expression 
also suggested that persistent expression of Sox10 may actually disrupt neuronal 
differentiation.  In fact, the group went on to provide evidence that overexpression of 
Sox10 can inhibit neuronal differentiation through repression of genes downstream of 
Mash1 and Phox2b.  Firstly, in wild type mice the expression patterns of Sox10 and 
Phox2a, a sympathetic neuron protein downstream of Mash1 and Phox2b, are mutually 
exclusive.  Secondly, in contrast to Mash1 mutant mice which lack Phox2a expression 
entirely, Sox10 mutant mice exhibit a derepression of Phox2a, the neuronal marker HuD 
and potentially many other neuronal markers.  Further, by overexpression of Sox10 in 
neural crest cells Kim et al. (2003) showed that these cells cannot fully differentiate 
into neurons until Sox10 is downregulated.  They also showed that overexpression of 
Mash1 or Phox2b in vitro reduces expression of Sox10.  This suggests that in vivo a 
negative feedback loop may exist whereby Sox10 is downregulated by Mash1 and 
Phox2b to allow neuron differentiation.  Another layer of complexity is added to 
this model because the opposing functions of Sox10 to promote and inhibit neuronal 
differentiation are differentially affected by levels of Sox10.  Thus, whilst expression 











































































































































































heterozygous mutants), inhibition of Phox2a requires much higher levels of Sox10 
(derepression is observed in heterozygous and well as homozygous mouse mutants).
We can draw clear parallels between the detailed model of Sox10 function in 
sympathetic neurons and what is already known about Sox10 function in melanophore 
differentiation.  Equivalent to the requirement of Sox10 for Mash1 and Phox2b 
expression in sympathetic neuron development, it has been shown that Sox10 is 
required in melanophores for expression of mitfa (Elworthy et al. 2003).  Of course the 
difference here is that this has been demonstrated to be a direct relationship (Elworthy 
et al. 2003).  In zebrafish melanophores the requirement for Sox10 may also be 
transient.  By expressing mitfa independent of Sox10 Elworthy et al. (2003) were 
able to rescue melanophores to the same extent in both sox10t3 and mitfaw2 mutants 
suggesting that the requirement for Sox10 in melanophores is only to turn on mitfa 
and thus need only be transient.  Data presented in Dutton et al. (2001) suggests that 
sox10 is in fact downregulated in differentiating melanophores, as it is in sympathetic 
neurons, providing anecdotal evidence to support the hypothesis that Sox10 may only 
be required transiently.  The question that arises therefore, is how far do these parallels 
continue?  Is it also the case that, as in sympathetic neuron development, Sox10 must 
be downregulated in melanophores to allow differentiation to proceed?  What is the 
effect of loss of functional Sox10 on the expression of genes downstream of Mitfa? 
Are they derepressed as Phox2a is in sympathetic neurons?  What is the effect on other 
pigment cell types?  
Thus, we propose a testable model, based on that of Kim et al. (2003), for the role of 
Sox10 in zebrafish melanophores (Figure 1.04).  In this model, based on the fact that 
we know Sox10 is required to activate expression of mitfa (Elworthy et al. 2003), 
Sox10 will promote differentiation but it also acts to repress expression of genes 
downstream of Mitfa and inhibit differentiation.  Therefore, Mitfa is later required 
to downregulate expression of Sox10 so that repression of downstream genes is 
lifted and the cells are allowed to develop as melanophores.  Importantly this model 
makes a number of testable predictions.  The first prediction from the model is that 
Sox10 will repress melanophore differentiation so that in sox10 mutants there will 
be derepression of genes downstream of Mitfa, a prediction we will test in Chapter 
3.  The second and third predictions are that Sox10 will be downregulated during 
melanophore development and that this downregulation is necessary for melanophores 
to differentiate (see Chapter 4).  The fourth prediction is that downregulation of Sox10 
will be controlled by Mitfa (see Chapter 5).  This work will be important not only in 
understanding Sox10 function in melanophores but also because it tests the generality 




To test a model for Sox10 function in melanophores by:
Examining closely the effect of loss of Sox10 and of Mitfa on melanophore • 
and xanthophore marker gene expression
Examining in detail the expression of Sox10 mRNA and protein in • 
differentiating melanophores
Testing whether Sox10 must be downregulated to allow melanophores to • 
differentiate
Assessing the likely direct and indirect requirements for Sox10 and Mitfa in • 





All reagents were sourced from Sigma unless otherwise stated.  Restriction enzymes 
were purchased from Promega or New England Biolabs (see Appendix).  Plasmid 
vectors used for generation of mRNA or for ISH probe synthesis (together with details 
of the appropriate enzymes) are in Table 2.01, plasmids used for other purposes are 
described in the relevant chapters.
2.2 Fish Husbandry
Wild type (AB), mutant (mitfaw2, sox10t3, sox10t3;mitfaw2) and transgenic 
(mitfa(0.9)::GFP) and Tg(-7.2sox10:EGFP) zebrafish, Danio rerio, were kept in the 
aquarium at the University of Bath.  Natural crosses were set up between fish overnight 
and the embryos collected in the morning.  Embryos were placed in embryo medium (see 
Appendix) and grown at 28.5 ˚ C.  They were staged according to Kimmel et al. (1995). 
Where embryos were to be manipulated between laying and hatching Watchmakers’ 
No5 forceps were used to dechorionate the embryos.  Embryos older than 15 hpf 
which were to be manipulated in any way were anaesthetised with Tricaine (Ethyl 
3-aminobenzoate methanesulphonate, 4 g/L stock, final concentration approximately 
0.2 % ((v/v))).  Where appropriate, melanisation was inhibited using PTU (1-phenyl-2-
thiourea) from 24 hpf at a final concentration of 0.0015 % ((v/v)) in embryo medium.
2.3 Histology
2.3.1 Antibody Staining
Embryos were fixed in 4 % (v/v) Paraformaldehyde in PBS (Phosphate buffered 
saline, Oxoid) overnight at 4 ˚C.  They were washed three times for 5 minutes in 
PBTriton (0.1 % ((v/v)) Triton X-100 in PBS) and three times for one hour in MilliQ 
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Name/gene Origin To 
linearise
Polymerase Notes
HS-sox10 RNK Asp718 SP6
HS-sox10(L142Q) RNK Asp718 SP6 Sequence of sox10m618 
mutant
CS2+ mitfaWT Dr J Lister Not1 SP6
CS2+ mitfaw2 Dr J Lister Not1 SP6 Sequence of  mitfaw2 
mutant





SacII SP6 Camp and Lardelli (2001)
tyrp1b ERG EcoRI T3 Obtained as clone number 
6894514 from Geneserv-
ice, GenBank reference 
CB353867 and subcloned 






NotI SP6 Thisse et al (2001)
dct RNK EcoRI T7
sox10 RNK SalI T7
mitfa Dr J Lister EcoRI T7
gch Dr D Parichy SalI SP6
xdh Dr D Parichy XhoI T3
paics RNK - - Plasmid and probe gener-
ated by Chipperfield and 
Nelson (University of 
Bath)
CFP ERG Sal1 T7 Subcloned as an XhoI/
NheI fragment into Blue-
script KS between XhoI 
and XbaI.
Table 2.01 Plasmids and enzymes used for RNA and ISH probe synthesis
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water.  Embryos were incubated in block (1 % (v/v) DMSO, 5 % ((v/v)) horse serum in 
PBTriton) for between 2 and 3 hours.  They were then incubated at room temperature 
overnight in polyclonal rabbit serum primary antibody (anti-Sox10, kind gift of Bruce 
Appel) diluted 1 in 10,000 in block.  Embryos were washed in PBTriton once fast and 
three times for one hour.  They were incubated overnight at room temperature in Alexa 
Fluor 488 fluorescent donkey anti-rabbit secondary antibody (Invitrogen, A21206) 
diluted 1 in 2000 in block.  Embryos were then washed once fast and three times for 
30 minutes in PBTriton.  They were placed in 50 % (v/v) glycerol for visualisation and 
storage.
2.3.2 In Situ Hybridisation
Probe Synthesis
20-40 μg DNA was linearised by cutting at the 3’ end of the sequence to be used as a 
probe.  Digestion was carried out in 200 μl for 2 hours at 37 °C with approximately 
70 units of the appropriate enzyme. 5 μl of the reaction was run a 1 % (v/v) agarose 
gel (Invitrogen) to check for complete digestion.  The DNA was purified by phenol 
chloroform extraction and ethanol precipitation (see below).  1 μg template DNA, 
2 μl NTP labelling mixture, 2 μl transcription buffer, 1 μl RNase inhibitor, nuclease-
free water to final volume of 18 μl and then 2 μl of the appropriate RNA polymerase 
(all Roche) were added to a sterile microcentrifuge tube in that order.  The mixture 
was mixed, centrifuged briefly and incubated at 37 ˚C for 2 hours.  To clean the RNA 
probe a MEGAclear kit (Ambion) was used (see 2.7.1).  2 μl of the recovered probe 
was run on a 1 % (v/v) agarose gel for 10 minutes at 100 V to check for its presence. 
The remainder had 100 μl of hybridisation mix (see Appendix) added and was placed 
at -20 ˚C for storage.
Preparation of Zebrafish Embryos
Embryos were fixed overnight in 4 % PFA/PBS at 4 ˚C.  To dehydrate them, embryos 
were washed once in PBT (PBS with 0.5 % (v/v) Tween) for 5 minutes and twice for 
5 minutes in 100 % methanol and then placed in methanol at -20 ˚C at least overnight.
Staining Day 1 – Probe Hybridisation
Embryos were rehydrated by washing twice for 5 minutes in PBT.  Embryos were 
then subjected to Proteinase K (10 mg/ml stock, Roche) digestion for varying times 
depending on age.  24 hpf embryos were incubated in a 1/10000 dilution of Proteinase K 
for 8 minutes.  Older embryos were incubated in a 1/1000 dilution of Proteinase K 
for 20-45 minutes for 27-48 hpf embryos or 45-60 minutes for 50-60 hpf embryos. 
Digestion was followed by a brief wash in PBT and refixing for 20 minutes in 4 % 
(v/v) PFA/PBS.  Embryos were then washed twice in PBT for 5 minutes each, once for 
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5 minutes in MilliQ water and once for 5 minutes in PBT.  Embryos were pre-hybridised 
in hybridisation mix for 1-3 hours in a 68 ˚C water bath.  Embryos were hybridised 
overnight at 68 ˚C in 100 μl hybridisation mix with 1/100 dilution of probe.
Staining Day 2 – Antibody Binding
Hybridisation mix with probe was removed to be kept at -20 ˚C and recycled.  The 
embryos were washed quickly in hybridisation mix at 68 ˚C and then twice for 
30 minutes in hybridisation mix at 68 ˚C, once for 10 minutes in 50 % hybridisation 
mix/50 % PBT at 68 ˚C and once for 5 minutes in PBT at room temperature.  Embryos 
were incubated for 2-4 hours at room temperature in block (PBT with 5 % (v/v) sheep 
serum, 2 mg/ml BSA).  They were incubated overnight at 4 ˚C with anti-DIG alkaline 
phosphatase (Roche) diluted 1/2000 with block.
Staining Day 3 – Colouration
The anti serum was removed.  Embryos were washed once quickly in PBT, then six 
times for five minutes in PBT and three times for five minutes in NBT/BCIP buffer 
(see Appendix).  Embryos were then incubated in staining solution in the dark at room 
temperature.  For blue staining, 200 μl NBT/BCIP solution (Roche) was diluted in 
10 ml of NBT/BCIP buffer.  Reactions were stopped by washing quickly in PBT, 
10 minutes in 100 % ethanol, briefly in PBT, 5 minutes in 0.1 M glycine pH 2.2 (Fisher 
Scientific) and again briefly in PBT.  Embryos were then stored in 4 % (v/v) PFA/PBS 
at 4 ˚C.  Before mounting for examination on a microscope embryos were transferred 
to 50 % (v/v) glycerol for at least 30 minutes.
2.3.3 LacZ Staining
Embryos were fixed in 4 % (v/v) PFA for between 30 and 60 minutes.  They were 
then incubated overnight at 28.5 ˚C in staining solution (see Appendix) with XGal 
(5-Bromo-4-chloro-3-Indoyl-B-D-Galactopyranoside, Apollo Scientific) at a 
concentration of 1 in 40. 
2.4 Microscopy
Stained fish were viewed whole mount by placing them in a drop of 100 % glycerol 
between stacks of No 1 coverslips on a slide, with a coverslip placed over the top.  Live 
embryos were anaethstised with Tricaine (0.002 % (v/v)) and mounted in this solution 
between stacks of No 1 coverslips on a slide, with a coverslip placed over the top. 
Embryos were viewed using a Nikon Eclipse E800 using either DIC or fluorescence 
microscopy as appropriate and photographed using a SPOT camera (Image Solutions) 
or Nikon sight DS-U1 camera (Nikon) together with NIS Elements F software or a 
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dual mode cooled CCD camera (Hamamatsu).  For rapid sorting/scoring embryos 
were viewed on an MZ12 dissecting microscope (Leica).
2.5 Molecular Techniques
2.5.1 Plasmid DNA Preparation for Cloning
Bacterial Growth Conditions
Bacteria were either grown on LB agar plates or in LB media containing the appropriate 
antibiotic at the appropriate concentrations.  These are: ampicillin at 50 μg/ml, kanamycin 
at 25 μg/ml or chloramphenicol at 27 μg/ml.  Most cultures were grown overnight at 
37 ˚C except for cultures with chloramphenicol which were grown at 30 ˚C.
Glycerol stocks of cells which had been transformed with a particular plasmid were 
made for ease of generating more DNA from those cells at a later date.  850 μl of 
overnight culture were vortexed together with 150 μl sterile 100 % glycerol and stored 
immediately at -80 ˚C.  A small scraping of the frozen cells can then be used to seed 
new cultures.
Midipreps
Cells from a glycerol stock were picked directly into 50 ml LB medium with the 
appropriate antibiotic and grown overnight, shaking, at 37 ˚ C.  The cells were harvested 
the next day by centrifugation of 25-45 ml culture at 6,000 g for 15 minutes.  DNA 
was prepared from the cells using a QIAfilter Midi kit (Qiagen).  Pelleted cells were 
resuspended in 4 ml Buffer P1.  4 ml Buffer P2 were added and mixed by inverting the 
tube.  This was incubated at room temperature for 5 minutes to lyse the cells.  During 
this time a QIAfilter cartridge was prepared.  4 ml Buffer P3 was then added to the 
lysate and mixed by inverting the tube.  This mixture was poured into the prepared 
QIAfilter cartridge and allowed to incubate for 10 minutes to allow the precipitate to 
separate.  During this incubation a QIAGEN-tip 100 was prepared by applying 4 ml 
Buffer QBT to the tip and allowing the column to empty by gravity flow.  Once the 
precipitate in the lysate had separated out a plunger was inserted into the cartridge and 
the cleared lysate expelled into the equilibrated QIAGEN-tip.  The tip was allowed 
to empty by gravity flow and was then washed with two 10 ml washes of Buffer QC. 
The DNA was eluted in 5 ml Buffer QF.  DNA was precipitated from the eluate by 
adding 3.5 ml isopropanol, mixing and centrifuging at 15,000 g for 30 minutes at 4 ˚C. 
The supernatant was decanted and the pellet washed with 2 ml 70 % (v/v) ethanol. 
The DNA was pelleted again with a 10 minute centrifugation at 15,000 g.  Again 





Colonies were picked from plates and were grown overnight in 3 ml LB media with 
appropriate antibiotic.  Plasmid DNA was purified using Promega Wizard miniprep 
kits.  1.5 ml culture was harvested by centrifugation for 5 minutes at 14,000 rpm 
(Techne Genofuge 16M).  The supernatant was discarded and the cells resuspended in 
250 μl Cell Resuspension Solution.  250 μl Cell Lysis Solution were added and mixed, 
followed by 10 μl Alkaline Protease Solution.  The lysate was incubated for 5 minutes 
at room temperature.  350 μl Neutralisation Solution were then added and mixed.  The 
lysate was centrifuged for 10 minutes at 14,000 rpm.  A spin column was inserted into 
a collection tube and after centrifugation the cleared lysate was applied to the column. 
This was centrifuged for one minute at 14,000 rpm.  The flow-through was discarded 
and the column washed, firstly with 750 μl and then with 250 μl Wash Solution, by 
applying the solution to the column and centrifuging for one minute.  The column was 
then centrifuged for a further 2 minutes to ensure all wash solution had been cleared 
from the column.  The DNA was then eluted from the column by placing the column 
in a clean microcentrifuge tube, applying 100 μl nuclease-free water to the column and 
centrifuging for one minute.  The DNA was checked on a 1 % (v/v) agarose gel before 
storage at -20 ˚C.
2.5.2 DNA Digestion
During cloning, plasmids were digested to obtain appropriate fragments for subsequent 
ligation into other vectors and to check for the presence of an insert after ligation and 
transformation had been carried out.  Up to 10 μg plasmid DNA was digested in a 
volume of 200 μl with 3-5 μl of the required enzyme and 20 μl of the appropriate 10x 
buffer to obtain fragments for subsequent subcloning.  Diagnostic digests were carried 
out on 4 μl miniprepped DNA with 2 μl 10x buffer appropriate for the enzyme, 1 μl 
enzyme appropriate for the experiment and 13 μl MilliQ water.  Most digests were 
incubated for 2 hours at 37 ˚C.  The digests were then run on a 1 % (v/v) agarose gel 
to look for the presence of the expected bands.  If the plasmid was not fully digested a 
further 1-3 μl enzyme were added and the incubation at 37 ˚C allowed to continue for 
a further 2 hours before checking again for complete digestion.
2.5.3 Oligo Annealing
Oligos to be annealed were diluted to 220 μM with MilliQ water.  4.5µl of each oligo 
were mixed with 1µl Annealing buffer (see Appendix).  This mixture was placed at 
65 °C for 10 minutes and then transferred to a beaker of water at 65 °C and allowed to 
cool slowly to room temperature.  Annealed oligos could then be stored at -20 ˚C for 
later use in ligations.
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2.5.4 Shrimp Alkaline Phosphatase (SAP) Treatment
SAP treatment was used to dephosphorylate DNA ends and prevent vector religation 
where cloning was non-directional.  1 pmol of 5’ ends requires 0.1 units SAP (Promega). 
mol of ends is equal to the weight of DNA in the sample divided by the molecular mass 
of the DNA used, all multiplied by two.  A 50 μl reaction was set up using Promega 
Buffer D and incubated at 37 ˚C for 90 minutes.  The enzyme was heat inactivated at 
65 ˚ C for 15 minutes and the reaction stored in the freezer.  The DNA was then purified 
before use (2.7.1).
2.5.5 Ligations
To subclone inserts, insert and vector were mixed in approximately a 3:1 ratio with 
1 μl T4 ligase (Promega), enough buffer to produce 1x solution and MilliQ water up 
to 10 μl.  The reaction was incubated at 4 ˚C overnight and then used to transform 
E. coli cells. For any particularly difficult cloning steps the ligation was microdialysed 
before transformation using nitrocellulose membranes (Millipore) over MilliQ water 
for 30 minutes.
2.5.6 Transformations
XL1-Blue cells were used for routine cloning and transformations, SCS110 cells were 
used to generate unmethylated DNA (both Stratagene).  0.85 μl beta mercaptoethanol 
(in kit with cells) was added to 50 μl of defrosted cells and the cells incubated on ice 
for 10 minutes.  1 μl plasmid DNA or 2 μl of ligation or all of a ligation that had been 
microdialysed was added to the cells and they were incubated on ice for a further 
30 minutes.  The cells were heatshocked at 42 ˚C for 45 seconds and then incubated on 
ice for 2 minutes.  950 μl preheated LB medium was added to the cells and they were 
incubated, shaking, at 37 ˚C for one hour.  50-250 μl of the transformed cells were 
spread on LB agar plates containing the appropriate antibiotic and were incubated 
overnight at 37 ˚C.
2.6 DNA/RNA Preparation
2.6.1 Genomic DNA Extraction from Fin Clips
Fish were anaesthetised in Tricaine (0.4 % (v/v) pH 7 diluted 4.2 ml in 100 ml of fish 
water).  One half of their caudal fin was removed using scissors and placed in 100 μl 
of Genomic DNA extraction buffer (see Appendix).  The fish were then returned to 
clean water and allowed to recover.  Tail clips were incubated at 55 ˚C for 3 hours with 
occasional vortexing and then at 95 ˚C for 5 minutes to inactivate the Proteinase K. 
The DNA was centrifuged at 14,000 rpm for 20 minutes.  55 μl of the supernatant was 
diluted in 500 μl of MilliQ water of which 1 μl was used in PCR.
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2.6.2 Genomic DNA Extraction from Whole Embryos
Embryos were placed one per PCR tube and washed three times in MilliQ water.  25 μl 
of Embryo genomic DNA extraction buffer was added and tubes incubated at 55 ˚C 
for four hours and then at 95 ˚C for 5 minutes to inactivate the Proteinase K.  75 μl of 
MilliQ water was added and 2 μl of this solution used in PCR.
2.6.3 DNA Extraction from Bacterial Colonies for PCR
Individual bacterial colonies were streaked onto fresh agar plates and grown overnight 
at 37 ˚C.  Part of each streak was picked into 20 μl MilliQ water in PCR tubes and the 
samples boiled for 10 minutes to extract the DNA.
2.6.4 RNA Preparation using mMessage mMachine (Ambion)
To generate sense RNA, plasmids were linearised by cutting at the 3’ end of the insert 
and the DNA was phenol chloroform purified and ethanol precipitated (2.7.1).  The 
transcription reaction was set up using mMessage mMachine kit in the following 
order: Nuclease free water to bring final volume to 20 μl, 10 μl 2x NTP/CAP, 2 μl 10x 
reaction buffer, 1 μg template DNA, 2 μl enzyme mix (SP6).  The reaction mixture 
was mixed and incubated at 37 ˚C for 2 hours.  1 μl TURBO DNase was added, mixed 
and incubated at 37 ˚C for 15 minutes.  RNA was recovered using a MEGAclear kit 
(Ambion, 2.7.3).
2.7 DNA/RNA Purification
2.7.1 Phenol Chloroform Extraction and Ethanol Precipitation
10 μl 3M NaAc and 110 μl phenol/chloroform/isoamylalcohol (25:24:1) per 100 μl of 
solution were added to the dirty DNA and vortexed briefly.  The mixture was centrifuged 
at 14,000 rpm for 15 minutes.  The top layer was collected and two volumes of 100 % 
ethanol added.  This was stored at -20 ˚C overnight.  The tube was centrifuged again at 
14,000 rpm for 15 minutes.  The supernatant was decanted, the pellet rinsed with 70 % 
(v/v) ethanol and left to dry at room temperature.  The pellet was then resuspended 
in 20 μl of nuclease-free water.  4 μl of the resuspended DNA diluted in 96 μl MilliQ 
water was used to determine the concentration of DNA using a spectrophotometer.
2.7.2 Gel Extractions
Where a fragment had been excised from a plasmid for subsequent subcloning the 
whole digest was run on a 1 % (v/v) agarose gel.  The required band was then excised 
from the gel and the DNA purified from this band, using a QIAquick gel extraction kit 
(QIAGEN).  When the band had been excised from the gel, the gel slice was weighed. 
Three volumes of Buffer QG were added to the gel slice in a 2 ml microcentrifuge 
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tube (i.e. 300 μl Buffer for every 100 mg of gel).  This was incubated at 50 ˚C for 
10 minutes until the gel slice had dissolved.  One gel volume of isopropanol was 
then added to the sample and mixed.  A QIAquick spin column was placed in a 2 ml 
microcentrifuge tube and the sample applied to the column.  This was centrifuged for 
1 minute at 14,000 rpm and the flow-through discarded.  Where the volume of the 
sample exceeded 750 μl the column was spun once, then the remainder of the sample 
was added and the column spun again.  The column was washed by applying 750 μl 
Buffer PE to the column, centrifuging for one minute at 14,000 rpm and discarding 
the flow-though.  The column was centrifuged again at 14,000 rpm for one minute to 
remove all residual Buffer PE.  The column was then placed in a clean microcentrifuge 
tube and the DNA eluted by applying 30 μl or 50 μl MilliQ water to the column, 
incubating at room temperature for one minute and centrifuging for one minute at 
14,000 rpm.  Recovery was evaluated on a 1 % (v/v) agarose gel.
2.7.3 RNA Purification using a MEGAclear Kit (Ambion)
An RNA transcription reaction (from 2.3.2 or 2.6.4) was made up to 100 μl with 
Elution buffer.  350 μl Binding solution was added followed by 250 μl 100 % Ethanol. 
The mixture was mixed and applied to the filter in a collection tube.  This was spun 
for one minute at 14,000 rpm.  The collection tube was emptied and the filter washed 
twice with 500 μl Washing Solution.  The filter was spun once more, for one minute, 
empty.  To elute the RNA, 50 μl Elution Buffer preheated to 95 ˚C was applied to the 
filter and, with a clean collection tube, spun for one minute at 14,000 rpm.  This was 
repeated to increase yield.
2.8 PCR
2.8.1 Genotyping PCR Conditions
PCRs were set up using 1 μl of CFP-F and CFP-R primers, the appropriate volume of 
DNA from fin clips or embryos, 10 μl GoTaq Green Master mix (Promega) and MilliQ 
water to a total volume of 20 μl.  The PCR program used was: 94 ˚C 5 minutes, 35 
cycles of 94 ˚C 30 seconds, 58 ˚C 30 seconds, 72 ˚C 1 minute, followed by 5 minutes 
at 72 ˚C and held at 10 ˚C.  Products were run on a 1 % (v/v) agarose gel.  
2.8.2 Colony PCR
Colony PCR was used where cloning the correct insert into a vector was difficult. 
Using the technique large numbers of bacterial colonies from plates were screened in 
order to find the colony that contained the plasmid required.  This avoided the need to 
do large numbers of time consuming and expensive minipreps and diagnostic digests. 
DNA was prepared from each colony as 2.6.3.  PCR reactions were then set up using 
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10 μl DNA preparation, 2 μl primers, 12 μl BioMix or BioMix Red PCR mix (Bioline). 
The PCR program used was: 94 ˚C 3 minutes, 34 cycles of 94 ˚C 15 seconds, 55 ˚C 15 
seconds, 72 ˚C 15 seconds, followed by 3 minutes at 72 ˚C and held at 10 ˚C.  Products 
were run on a 1 % (v/v) agarose gel.  PCRs using primers S21/S22 used the PCR 
program: 94 ˚C 5 minutes, 35 cycles of 94 ˚C 30 seconds, 58 ˚C 30 seconds, 72 ˚C 30 
seconds, followed by 5 minutes at 72 ˚C and held at 10 ˚C.
2.9 Sequencing
DNA was sent to MWG for sequencing (www.mwg-biotech.com).  1 μg DNA was 
air dried using a Speed Vac (Stratech Scientific).  Non-standard primers were sent 
in addition to the sample in some cases, otherwise standard primers were provided 
by MWG.  Sequence data was analysed using the BLAST tool on the NCBI website 
(www.ncbi.nlm.nih.gov) and Clone Manager SN software.
2.10 DNA/RNA Microinjection
Embryos were injected using a Nanoject II (Drummond Scientific Co., Broomall, PA) 
at the one cell stage.  Needles were pulled on a Micropipette puller (Sutter Instrument 
Co., Novat,CA) from 3 ½ ” Drummond glass capillaries (Drummond Scientific Co., 
Broomall, PA).  DNA/RNAs were diluted in MilliQ water with 0.005 % (v/v) phenol 
red.  Embryos to be processed for ISHs were fixed in 4 % (v/v) PFA overnight at 4 °C 
before being dechorionated, refixed at room temperature for approximately one hour 
and dehydrated according to the ISH protocol.
2.11 Promoter Analysis
DNA sequence was submitted to TRANSFAC public version 6.0 using the Pattern 
Search for Transcription Factor Binding Sites (PATCH 1.0) interface.  Parameters 
were set to look for vertebrate transcription factor binding sites of 6 bp or more with 
the maximum number of mismatches being set at zero (Matys et al. 2003).
2.12 Statistical Analysis
Simple statistical analyses were performed in Microsoft Office Excel 2003.  More 





We discussed in 1.5.3 a model that we intend to test, adapted from one proposed by 
Kim et al. (2003), for the role of Sox10 in melanophores (Figure1.04).  One of the 
predictions from our model was that as well as promoting melanophore specification 
by activating expression of mitfa, Sox10 has a role to inhibit or delay melanophore 
differentiation by repressing, either directly or indirectly, the expression of genes 
downstream of Mitfa.  In this Chapter we will test this prediction by exploring the 
zebrafish phenotypes of sox10t3 and mitfaw2 mutants.  If Sox10 does repress expression 
of melanophore marker genes, then they will be derepressed in sox10t3 mutants but 
remain repressed in mitfaw2 mutants (which still express functional Sox10).  This is a 
direct parallel to an experiment which revealed derepression of Phox2a in mouse Sox10 
mutants (Kim et al. 2003).  We will also look at xanthophore marker gene expression 
to test the generality of our model in other neural crest derived pigment cells.
We know that mitfaw2 homozygous embryos do not have any melanised cells (Lister 
et al. 1999) and embryos which are homozygous for the sox10t3 mutation appear to 
lack all pigment cells too.  However, closer observation reveals that sox10t3 mutants 
have what are referred to as residual melanophores (Dutton et al. 2001).  At 3 dpf, the 
residual melanophores appear as small specks of melanin distributed mainly in the 
dorsal stripe region.  It is unclear whether these specks of melanin are melanophores 
whose morphology is abnormal or whether there is another explanation for them. 
Existing data shows that residual pigmented cells are not dependent upon expression of 
mitfa, since they are still present in sox10t3:mitfaw2 double mutant embryos (Elworthy 
et al. 2003).  Also, it has been previously reported that the melanophore marker dct is 
expressed in sox10t3 mutant embryos at 24 hpf and 30 hpf (Kelsh, Schmid and Eisen 
2000).  This unexpected expression is seen in a premigratory neural crest position, just 
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where residual pigmented cells are located.  These data are supportive of the prediction 
from our model that genes downstream of Mitfa will be derepressed in the absence 
of Sox10 and that normally Sox10 has a role to inhibit melanophore differentiation. 
To help explain these unexpected melanised cells in sox10t3 embryos, and to find out 
more about what they teach us about the role of Sox10 in melanophores, we aim to 
examine them more closely.  We will ask how early these residual cells first appear 
as well as observe their morphology and distribution.  We would also like to discover 
how long dct expression persists and will also look for the expression of a wider set of 
melanophore marker genes in sox10t3 and mitfaw2 embryos (where we would not expect 
to see residual expression) to confirm the pattern.
Melanophores are not the only non-skeletogenic cell type which appears to begin 
to differentiate in mutant embryos.  Pigmented xanthophores have been observed in 
sox10 mutant fish before 35-45 hpf but they are not morphologically normal and only 
appear in very low numbers (Dutton et al. 2001).  Some iridophores, termed escapers, 
also appear in low numbers (typically 1-5) in a proportion of mutant fish.  In contrast to 
melanophores and xanthophores, escaper iridophores appear entirely normal (Chapter 
4 and personal communication, J. Müller).  Iridophores, and the effects of sox10 on 
their development, are being studied by others in the lab.  However, we will look 
more closely at the development of xanthophores in sox10t3 embryos by looking for 
expression of early xanthophore markers.  We predict that we may also see derepression 
of xanthophore markers in these embryos which would suggest that the model we are 
testing for the role of Sox10 in melanophores may also be applicable in other neural 
crest derivatives.  
The melanophore markers we have chosen to use are dopachrome tautomerase (dct), 
tyrosinase, silva and tyrosinase-related protein b (tyrp1b).  dct encodes one of the 
enzymes involved in the later stages of the melanin synthesis pathway, and is well 
documented as an early melanophore marker (see Chapter 1).  In zebrafish, it is 
expressed in melanoblasts from 19 hpf through to melanophores at the latest stage 
observed, 8 dpf (Kelsh et al. 2000).  The three other markers we have chosen to use 
are often used in mouse melanocyte studies.  Tyrosinase (Tyr) and Tyrosinase-related-
protein 1 (Tyrp1) are two other tyrosinase family genes known to be involved in the 
melanin synthesis pathway and Silver is a gene encoding a structural melanosome 
protein (see Chapter 1 for details).  In zebrafish, the tyrosinase expression pattern 
was documented by (Camp and Lardelli 2001).  They saw expression of tyrosinase 
in cells in positions characteristic of early melanoblasts which persists until at least 
46 hpf, when the pattern resembles that of melanised cells.  Zebrafish have two copies 
of tyrp1, named tyrp1a and tryp1b (Braasch, Schartl and Volff 2007).  tyrp1a does not 
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have a documented expression pattern but tyrp1b does (Thisse et al. 2001).  Between 
19 hpf and 60 hpf it is expressed in cells in a pattern resembling that of melanoblasts/
melanophores.  Zebrafish also have two copies of the Silver gene, called silva and silvb 
(Schonthaler et al. 2005).  silvb is expressed only in the pigmented retinal epithelium, 
silva is expressed here and also in cells resembling the pattern of melanophores at 
2 dpf.  Thisse et al. (2001) also report silva expression in the ‘neural crest’ between 
16 hpf and 19 hpf and in ‘pigment cells’ between 19 hpf and 48 hpf; these authors did 
not identify the precise pigment cell type.
Xanthophores are a less well studied cell type and markers are therefore more difficult 
to come by.  The two most regularly used markers are gch and xdh.  Gch, GTP-
cyclohydrolase I, and Xdh, xanthine dehydrogenase are both enzymes involved in the 
synthesis of pteridine pigments.  These markers, however, come with a caveat that they 
appear to also mark melanoblasts at early stages (Parichy et al. 2000b).  The product of 
Gch activity, tetrahydrobiopterin, is also important for the conversion of phenylalanine 
to tyrosine (a melanin precursor) and so the overlap seen with gch expression and 
lightly melanised cells (and therefore cells which are developing as melanophores) is 
perhaps not surprising.  xdh expression was seen to overlap with mitfa expression (but 
not melanin).  Parichy et al. (2000b) suggest these double positive cells may represent 
a population of melanophore/xanthophore precursors expressing genes indicative of 
both.  It is of particular importance to bear this caveat in mind with reference to our 
work.  We will not know the differentiation state of any of the cells which may be 
expressing either gch or xdh in sox10t3 mutants.  Even at later stages we may be looking 
not at committed xanthoblasts/xanthophores, but at early stage melanoblasts or partially 
specified but as yet uncommitted xanthophore/melanophore precursors which, due to 
the loss of functional Sox10, have been unable to differentiate further.  To attempt 
to make our results easier to interpret we have also used another, novel, xanthoblast 
marker.  paics was identified as a xanthoblast marker both in a screen for novel pigment 
cell markers carried out in the lab (ERG and J. Müller, unpublished data), and by a 
microarray screen in progress in the lab (A. Boyd, T. Chipperfield, unpublished data). 
paics encodes an enzyme in the purine biosynthetic pathway (Li et al. 2007).  Although 
we know that expression of paics does not overlap with melanin (T. Chipperfield, 
unpublished data), we cannot eliminate that it is not expressed together with mitfa in 
melanoblasts.  A zebrafish paics transgenic insertion mutant exists which has a loss 
of xanthophore pigmentation, but whose neural crest derived melanophores appear 
normal (Amsterdam et al. 2004).  This suggests that paics may never be expressed in 
melanoblasts/melanophores and that if it is, it does not perform an essential function 
in these cells.  Use of paics as a xanthophore marker may provide some insight into 




3.2.1 Observations of Pigmented Cells in sox10t3 Embryos
Residual melanophores in sox10t3 mutants have previously been reported at 3 dpf but 
no mention was made of how much earlier they can be seen.  Initially, we examined 
several embryos between 26 hpf and 72 hpf at low magnification.  In these embryos, 
melanised cells were not seen at or before 31 hpf but were present at 39 hpf.  From this 
timepoint the number of residual cells appeared to increase.  We also had the impression 
that there were changes in the size and melanisation of these cells.  Residual melanised 
cells are easily confused with other pigment cell types at low magnification.  We ruled 
out that we were observing iridophores by also examining the embryos under incident 
light.  We could still have been observing xanthophores, which sometimes take up 
methylene blue and become blue/green rather than yellow.  We looked at another set of 
embryos at higher magnification to be sure we were not observing xanthophores and 
enabling us to document residual melanophores more comprehensively.  We observed 
29 embryos (Table 3.01) and scored the dorsal stripe in the region of each somite 
for whether or not there were melanised cells present.  This can only represent an 
approximation of melanised cell number since more than one was often present in 
each somite.
Tables representing the data collected for each embryo can be seen in the Appendix 
and Table 3.02.  From these tables, we can see that each embryo is unique in when and 
where melanised cells appear in the dorsal stripe.  On no occasion were any melanised 
cells seen in sox10t3 embryos at or before 35 hpf (24 embryos observed).  One embryo 
at 36 hpf had melanised cells and two embryos at 37 hpf had melanised cells.  In some 
embryos, development of residual melanised cells did not occur until even later, if at 
all.  Thus, the time at which we begin to see residual melanised cells is variable between 
embryos but it does not occur before 36 hpf, representing a delay in melanisation of at 
least 12 hours in these mutant embryos compared to wild types. 
Over a time course, the average number of somites per embryo which contain melanised 
cells increases (Table 3.03, Figure 3.01).  When we examine the data tables for each 
embryo, we can see that this represents changes in the timing of the appearance of 
melanised cells within individual embryos rather than differences between embryos 
(Table 3.02).  Although the embryos are highly variable, we can see that initially a 
small number of residual cells tend to be present in the most anterior somites.  At later 
timepoints, as melanised cell number increases, the cells extend into more posterior 
somites.  However, no melanised cells were seen beyond somite 24 and more usually 














































































































































































































































































































































































































































































































































































































































































































We photographed a number of our embryos as we scored them, allowing us to compare 
individual somites every few hours.  These photographs showed that the residual 
melanised cells are dynamic; they seem to change position and melanin distribution 
(Figure 3.02).  One particularly striking example of this is shown in Figure 3.02.  At 
41 hpf we photographed a pigmented cell which was comparatively large and had 
a stellate morphology.  By 43 hpf the cell appeared to have undergone melanin 
redistribution and could now be seen in the same somite, in the same position but it 
was much smaller, darker and rounded.
3.2.2 Melanophore Marker Gene Expression in sox10t3 
Embryos
We considered that the residual melanophores we had observed might represent the 
products of derepression of melanogenic genes.  To investigate this possibility we 
carried out ISHs using melanophore marker genes in sox10t3 mutant embryos.  ISHs 
were carried out on embryos at six hour intervals between 24 hpf and 60 hpf from a 
sox10t3 heterozygous incross.  We used probes for dct, silva, tyrosinase and tyrp1b and 
each experiment was repeated on at least two occasions, with consistent results.  Of the 
embryos in the figures for this section, embryos processed by ISH with probes for dct, 
tyrosinase and silva were all processed at the same time, although silva was allowed to 
develop for longer.  The ISHs for tyrp1b were processed on a separate occasion but were 
carried out under comparable conditions.  All ISHs were checked regularly and allowed 
to develop until no further staining became visible, plus a few hours longer.  These ISHs 
had to be ‘pushed hard’ to allow us to see the expression in mutant embryos.  Combined 
with the fact that we aimed to develop each stage for the same amount of time this 
means that some fish pictured may show more background staining than would be 
ideal.  Where this is the case, it should be noted that on other occasions, when the same 
ISH was not allowed to develop for so long, the same pattern was always apparent but 
staining was weaker and there was no background staining.
As predicted by our model, all of the markers examined were expressed in sox10t3 
embryos.  Mutant embryos were easy to differentiate from wild types by the pattern of 
expression in the neural crest.  We could therefore score how many mutant embryos 
there were in a batch and how many of those displayed residual expression (Table 3.04). 
All of the markers used were expressed in the pigmented retinal epithelium in addition 
to the neural crest.  This provided a useful means of knowing that the protocol had 
worked on individual embryos.  No differences were seen between mutants and wild 
types in PRE expression and since we are interested in the neural crest we concentrate 
on expression in these cells.  Where we state that there was no expression of a marker 
in an embryo, we exclude the expression seen in the PRE.
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Figure 3.02 Melanophore phenotype of sox10t3 mutants
A. Over time, the residual melanophores in mutant fish become more numerous, darker 
and smaller.  At 45 hpf in this example there are only four visible pigmented cells 
(arrows).  These cells are small compared to wild type melanophores but larger than 
similar cells in later stage embryos.  They are light in colour.  By 48 hpf, the same fish 
has more pigmented cells.  Some of the cells appear more punctate than others and 
are darker.  At 56 hpf, there are still more pigmented cells and in addition, more cells 
appear punctate.  Note how the most anterior cell at 45 hpf changes at 48 hpf and 54 
hpf (arrows).  Particularly comparing 48 hpf and 56 hpf, there is also an impression 
that some of the pigmented cells have moved or disappeared and been replaced by 
others.
B. Pigmented cell undergoing melanin redistribution.  Over a timecourse it appeared 
that some residual cells first had a fairly normal morphology but then undergo melanin 
redistribution to form dark spots of pigment.  Here we were able to capture a single 
pigmented cell either side of that event.  At 41 hpf, the cell is large compared to other 
pigmented cells in sox10t3 mutants, though perhaps smaller than wild type equivalents, 
and has an uneven border, almost stellate as normal melanophores are.  By 43 hpf the 









24 hpf 30 hpf 36 hpf 42 hpf 48 hpf 54 hpf 60 hpf
dct 7/7/26 6/6/24 5/6/25 6/6/28 5/5/24 1/3/24 0/4/23
7/7/24 6/6/17 9/9/40 2/2/24 3/11/34 0/8/23 0/8/23
silva 6/6/20 4/4/25 6/6/23 8/8/28 8/8/26 4/8/24 0/6/25
4/4/22 8/8/24 8/8/49 6/6/21 10/12/37 8/8/26 0/5/24
tyrosinase 3/3/23 5/5/24 4/5/25 6/7/23 0/6/23 0/5/24 0/2/23
8/8/24 12/12/23 6/6/19 9/10/24 5/7/44 3/11/25 0/9/24
tyrp1b 7/7/24 8/8/25 5/5/22 7/7/24 2/2/24 0/1/23 0/4/23
5/5/21 2/4/21 0/4/16 0/4/24
24 hpf 27 hpf 30 hpf 33 hpf 36 hpf
dct 0/1/23 1/3/22 2/6/24 3/4/24 0/4/25
0/5/24 0/5/24 3/6/24 0/2/23 0/6/18
silva 2/4/18 5/8/22 1/3/21 3/7/25 0/4/16
0/2/26 0/6/23 4/9/31 2/4/20 0/3/20
tyrosinase 4/4/20 7/7/24 4/4/19 1/2/22 0/3/22
2/2/21 6/6/24 6/6/25 0/3/19 0/5/20
tyrp1b 2/3/18 0/3/22 0/6/24 0/8/22 0/5/25
4/6/22 0/4/16 0/5/28 0/7/25 0/6/18
Table 3.04 Number of embryos with residual expression of 
melanophore markers in sox10t3 mutant embryos
Table 3.05 Number of embryos with residual expression 
of melanophore markers in mitfaw2 mutant embryos
As for Table 3.04 except that mitfaw2 heterozygotes were 
incrossed for this experiment.
sox10t3 heterozygotes were crossed and their progeny analysed by ISH using 
melanophore markers, dct, silva, tyrosinase and tyrp1b probes.  The table shows 
the number of mutant embryos with residual expression followed by the total 
number of mutant embryos followed by the total number of embryos in each 
batch.  If all of the mutant embryos showed residual expression of the markers 
the box is coloured blue, if none showed residual expression it is coloured yellow 
and if there was a mixture it is coloured green.  
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The pattern of expression for each of the markers was broadly similar.  At earlier 
stages the markers were expressed in cells dorsal to the neural tube, the same area that 
the residual melanised cells are located.  Within any given batch of mutant embryos 
there was often variation in the extent/strength of signal.  At later stages there were 
progressively fewer cells expressing the markers, in progressively fewer mutant 
embryos until all mutant embryos showed no residual expression (Figures 3.03-3.06). 
Despite the similarities, there are subtle differences between the patterns of expression 
with different markers.  dct and tyrosinase have very similar patterns of expression 
in the mutant embryos both in terms of levels of expression (within the limitations 
of judging this by ISH) and in terms of spatial and temporal patterning of expression 
(Figure 3.03 and 3.05).  Initially, at 24 hpf, there are low numbers of cells in a fairly 
anterior position in all of the mutant embryos.  By 30 and 36 hpf, expression had 
extended more posteriorly.  By 48 hpf and 54 hpf, the numbers of residual cells had 
noticeably decreased as had the occurrence of embryos with residual staining.  At 
60 hpf neither marker was expressed in mutant embryos.  Loss of residual expression 
seems to be a gradual process which begins after approximately 36 hpf and ends in 
complete loss of marker gene expression at some time between 48 hpf and 60 hpf 
depending upon the embryo.
silva has a much stronger, broader and more persistent level of expression than any 
of the other melanophore markers (Figure 3.04).  At 24 hpf, silva was expressed in a 
premigratory neural crest position but expressing cells were densely packed so that 
from a lateral view they appeared as a continuous line.  Expression extended more 
posteriorly in the mutants than in the wild type embryos (well beyond the yolk sac 
extension) and more ventrally than the other markers in mutants at this stage.  However, 
the trends in silva expression were much like that of dct and tyrosinase.  At 36 hpf the 
area of cells expressing silva is much reduced, although distinct cells are still not easily 
distinguishable.  By 48 hpf expression has reduced again such that individual cells can 
now be seen.  As with the other markers, by this stage there is the occasional embryo 
which lacks any silva expression.  At 54 hpf there are fewer embryos which express 
silva and those that do, do so in only a few cells.  More embryos still have expression 
of silva at this stage when compared to embryos expressing dct at the same stage.  At 
60 hpf no embryos have any detectable silva expression.
The temporal pattern of tyrp1b expression in sox10t3 mutants is similar to that seen for 
dct and tyrosinase (Figure 3.06).  However, where a mutant embryo expresses tyrp1b, 
it does so only weakly and in very few cells; these cells are in a position that would be 
















Figure 3.03 dct expression in sox10t3
Wild type expression of dct correlates with the published expression patterns. Early, 
melanoblasts can be seen dorsal to the neural tube and migrating away along the medial 
and lateral pathways.  Later, more cells can be seen migrating until by 48 hpf dct 
positive cells resemble the final pattern of differentiated melanophores in three stripes. 
In sox10t3 embryos, where no melanophores properly differentiate, some residual dct 
expression is still seen. Cells are in a position dorsal to the neural tube (arrows) but are 
not seen in migratory positions.  Expression is seen at 24 hpf in cells in the anterior 
trunk.  Expression appears to extend more posteriorly at 36 hpf (note position of the 
most posterior arrows, marking the most posterior residual cells, in the figure at these 
timepoints).  At 48 hpf there are fewer cells expressing dct, by 54 hpf and at later 
















Figure 3.04 silva expression in sox10t3
Wild type expression of silva correlates with published data, corresponding with the 
position of melanoblasts and later, melanophores. In sox10t3 embryos, some residual 
silva expression is still seen in cells in a position dorsal to the neural tube but not in 
migratory positions.  Strong expression is seen at 24 hpf in cells in the whole trunk 
and at this stage from a lateral view it appears as a solid streak of expression.  Note 
also, that expression in the mutant embryos extends more posteriorly than in wildtypes 
(arrows), well beyond the yolk sac extention.  At 36 hpf, expression levels are still 
high with expressing cells still forming a solid line dorsal to the neural tube but 
expression is weaker than at 24 hpf, particularly anteriorly.  At 48 hpf there are fewer 
cells expressing silva so that we can now see individual cells, although in those cells 
expressing silva, the signal is still strong.  By 60 hpf there is no residual expression 
















Figure 3.05 tyrosinase expression in sox10t3
Wild type expression of tyrosinase correlates with the published expression patterns. 
In sox10t3 embryos, some residual tyrosinase expression is still seen. Cells are in a 
position dorsal to the neural tube and are not seen in migratory positions.  Expression 
is seen at 24 hpf in cells in the trunk, with a tendency for them to be concentrated more 
anteriorly (arrows).  Expression at 36 hpf is slightly shifted posteriorly (arrowheads) 
and is generally weaker, appearing in fewer cells.  At 48 hpf there are still fewer cells 
expressing tyrosinase with some embryos lacking expression altogether.  By 60 hpf 
















Figure 3.06 tyrp1b expression in sox10t3
Wild type expression of tyrp1b correlates with the published expression pattern.  The 
levels of tyrp1b expression in wild type embryos appears to comparable to that of 
the other markers in wild type embryos.  In sox10t3 embryos, however, where no 
melanophores properly differentiate, residual tyrp1 expression is still seen but only 
very weakly, compared to the other markers, and in a very few cells. Expression is seen 
in some embryros at 24 hpf, 36 hpf and 48 hpf in cells in the area just posterior to the 
ear (arrows).   By 60 hpf there is no residual tyrp1b expression.  Scale bar 100 mm.
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3.2.3 Melanophore Marker Gene Expression in mitfaw2 
Embryos
To determine whether the expression of our melanophore marker genes in sox10t3 
mutants was as a result of derepression by loss of Sox10, we also examined expression 
of our marker genes in embryos from a heterozygous mitfaw2 incross.  Our model 
predicts that there will be no expression of our marker genes in the neural crest of 
these embryos because Sox10 is still present to repress them.  The embryos used in 
the figures in this section were processed and developed at the same time as their 
equivalents in the previous section allowing us to make as direct a comparison as 
possible between the two mutants.  All of the markers are expressed at some time in 
mitfaw2 embryos (Figure 3.07-3.11 and Table 3.05).  Preliminary experiments showed 
that, in contrast to sox10t3 mutants, expression is extremely weak and no expression 
of any marker is seen at, or after, 36 hpf (data not shown).  As a result, we examined 
embryos over a shorter timecourse than for sox10t3 mutants, every three hours between 
24 hpf and 36 hpf.  
Again, the four different markers share some similarities in their expression patterns 
in mitfaw2 mutant embryos.  All are present in cells in the premigratory neural crest 
position.  Generally, expression is weaker and in fewer cells than in sox10t3 mutants and 
at any given timepoint only some of the mutant embryos show any expression at all. 
The expression pattern of tyrosinase is most like that which we see in sox10t3 mutants 
both in terms of positions of positive cells and strength of signal.  The tyrosinase signal 
is generally strongest at 24 hpf and extends more posteriorly than we see at the same 
stage in sox10t3 mutants.  Expression then decreases both in strength and in numbers 
of cells, particularly from anterior positions, until at 36 hpf no tyrosinase expression 
is seen at all.  Expression of dct and silva are slower to appear, being almost entirely 
absent from 24 hpf embryos, and are never seen in all embryos in a batch.  Positive 
cells are located in the trunk and not in more anterior positions as in sox10t3 mutants. 
The expression of tryp1b is essentially absent from mitfaw2 mutants.  Only at 24 hpf did 
any embryos have tyrp1b expression, and then in only one or two weakly expressing 
cells in a very anterior position.  These results support our hypothesis that the residual 
expression of melanophore marker genes in sox10t3 mutants is as a result of loss of 
repression by Sox10.
3.2.4 Expression of Melanophore Marker Genes in 
sox10t3;mitfaw2 Mutants
Embryos which were mutant for both sox10 and mitfa also have residual pigmented 
cells (Elworthy et al. 2003).  This indicates that the residual pigmented cells are not 
















Figure 3.07 dct expression in mitfaw2
Wild type expression of dct correlates with the published pattern In mitfaw2 embryos, 
where no melanophores differentiate, some residual dct expression is still seen, though 
only in a comparatively small proportion of embryos. Cells are in a position dorsal to 
the neural tube but are not seen in migratory positions.  Expression is not seen at 24 
hpf but by 27 hpf one embryo out of eight had a weakly expressing cell (pictured). 
Expression is greater, in terms of signal strength, number of cells and number of 
embryos with expression at 30 hpf.  dct positive cells are located in the trunk of the 
embryo and do not extend as anteriorly as dct positive cells in sox10t3 mutant embryos 
(arrows).  This pattern persists at 33 hpf but expression is lost completely at 36 hpf. 



















Figure 3.08 silva expression in mitfaw2
Wild type expression of silva correlates with published data. In mitfaw2 embryos, some 
residual silva expression is still seen. Cells are in a position dorsal to the neural tube but 
are not seen in migratory positions.  Expression is seen in about one third of the mutant 
embryos at 24 hpf in positions scattered along the trunk (arrows).  Similar expression 
is seen at 27 hpf.  Expression of silva is stronger than that of other markers in mitfaw2 
embryos but much weaker than silva expression in sox10t3 embryos.  Expression 
persists at similar levels in similar positions until 33 hpf but is lost completely by 36 



















Figure 3.09 tyrosinase expression in mitfaw2
Wild type expression of tyrosinase correlates with the published expression pattern. 
In mitfaw2 embryos some residual tyrosinase expression is still seen. Cells are in a 
position dorsal to the neural tube but are not seen in migratory positions.  Expression 
is seen between 24 hpf and 33 hpf.  Note the anterior and posterior limits of expression 
at each stage, the most posterior limit of expression changes little, whereas expression 
is lost in more anterior regions.  By 36 hpf expression of tyrosinase is lost completely. 



















Figure 3.10 tyrp1b expression in mitfaw2
Wild type expression of tyrp1b correlates with the published data. In mitfaw2 embryos, 
there are occassionally a couple of cells expressing tyrp1b at 24 hpf in very anterior 
positions (not shown) but no residual tyrp1b expression is ever seen at any other stage.











Figure 3.11 Comparison of melanophore marker gene expression in wild type, 
sox10t3 and mitfaw2 30 hpf embryos
Images are of the region of the trunk anterior of the end of the yolk sac extension taken 
at a focal plane in the centre of the embryo so that the notocord is in focus.  Expression 
of all markers is stronger in sox10t3 than in mitfaw2.  silva is the marker most strongly 
expressed in sox10t3 and mitfaw2.  tyrp1b expression is not visible in these images, its 
expression is confined to more anterior regions. Scale bar 50µm.
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that they are due to derepression of melanophore differentiation genes.  To further 
examine this hypothesis we generated fish which were homozygous for mitfaw2 and 
heterozygous for sox10t3.    Embryos generated from an incross of these fish were all 
homozygous for the mitfaw2 mutation and one quarter were also homozygous for the 
sox10t3 mutation and could be described as double mutants.  If the additional loss of 
functional Sox10 on a mitfaw2 mutant background has an effect, then one quarter of our 
embryos will have a different expression pattern than the rest.  If not, then our double 
mutants will have the same marker gene expression patterns as mitfaw2 single mutants 
and all of the embryos in these experiments will look identical.  We carried out ISHs 
on embryos at 36 hpf, 48 hpf and 60 hpf for dct, silva, tyrosinase and tyrp1b.  Two 
independent replicates of this experiment were carried out.  
The most informative timepoint is 36 hpf (Figure 3.12 and Table 3.06).  At this stage, 
there is robust residual staining of all of our markers in most sox10t3 single mutants 
but none at all in mitfaw2 single mutants.  In our double mutants we saw approximately 
25 % of the embryos had strong residual staining.  We conclude that these embryos 
are double sox10t3;mitfaw2 mutants.  Ideally we would have liked to have genotyped 
these embryos to confirm which are double mutants but despite many attempts this 
proved impossible.  However, supporting our conclusion, we also see expression 
of dct, silva and tyrp1b at 48 hpf and of dct and silva at 60 hpf in a few embryos, 
these are both stages when no expression at all is seen in mitfaw2 single mutants 
and expression is being lost from sox10t3 single mutants.  This further supports the 
hypothesis that the normal function of Sox10 is to repress the expression of these 
genes, and melanophore differentiation, and that the residual expression we see in 
sox10t3 mutants is mitfa independent.
3.2.5 Xanthophore Marker Gene Expression in sox10t3 
Embryos
We also examined expression of three xanthophore marker genes in sox10t3 mutant 
embryos to see whether loss of Sox10 had similar effects upon different pigment cell 
types.  Probes for gch, xdh and paics were used and each experiment was repeated 
on at least two occasions, with consistent results.  ISHs were carried out on embryos 
from a sox10t3 heterozygous incross.  ISHs were processed and developed on separate 
occasions, but under comparable conditions.  All ISHs were allowed to develop until 
no further staining became visible, plus a few hours longer.  As with the ISHs with the 
melanophore marker genes, these ISHs had to be ‘pushed hard’, particularly at later 


















Figure 3.12 Expression of melanophore marker genes in sox10t3;mitfaw2 double 
mutants
The pattern and strength of expression in the double mutants at 36 hpf is comparable 
to that seen in sox10t3 single mutants.  Scale bar 100 µm.
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Age dct silva tyrosinase tyrp1b
36 hpf 2/24 3/22 5/24 2/19
10/36 6/26 4/25 5/26
48 hpf 0/31 6/26 0/18 0/24
6/17 5/27 6/23 4/25
60 hpf 0/29 0/28 0/25 0/23
3/23 1/24 0/23 0/23
Table 3.06 Marker gene expression
in double mutants
If expressed at all, all marker genes are expressed in approximately 
one quarter of embryos from an incross of fish which are homozygous 
for mitfaw2 and heterozygous for sox10t3.  We suggest that these fish 
are the double mutants in each batch.  Where the marker genes are 
expressed in some embryos the table is coloured pink, where the 




All of the markers examined were expressed in sox10t3 embryos (Figure 3.13-3.16). 
Mutant embryos were usually easy to identify since the pattern of expression in the 
neural crest differed markedly from that in wild type embryos.  Only gch presented 
difficulties at early stages where, due to the strength and broad pattern of expression, 
mutants and wild types were more difficult to differentiate.  However, we were able 
to score how many mutant embryos there were in a batch and how many of those 
displayed residual expression (Table 3.07).  All three xanthophore markers were 
seen to be expressed in premigratory crest positions and later only in cells migrating 
along the lateral pathway, a pattern indicative of xanthophores.  The general pattern 
of expression of these markers in mutant embryos was very similar to that of the 
melanophore markers.  All were expressed in cells in a premigratory neural crest 
position in mutant embryos.  Overall, expression was broader/in more cells at earlier 
stages and later it was seen in fewer cells in fewer embryos until by 48 hpf all of 
the xanthophore markers are essentially absent from mutant embryos.  For all of the 
markers, the ISHs took longer to develop in mutant as compared to wild type embryos 
during the development stage of the protocol, suggesting that expression was weaker 
in mutants as compared to wild types.  
There were however, also differences between the markers.  Particularly notable is 
the expression pattern for xdh.  In accordance with the published pattern, the wild 
type expression of xdh is comparatively weak particularly at later stages although 
this is more pronounced in our figures which may be due to differences between the 
ISH protocol used in Parichy et al. (2000b) and our own.  The timing of loss of xdh 
expression differs from the pattern seen with other markers; no expression is seen at 
stages after 33 hpf.  This is much earlier than the other xanthophore markers which are 
still present at 42 hpf or any of the melanophore markers, which are not completely 
lost until 60 hpf.  This may only reflect our inability to detect a very weak signal by 
ISH since our conditions do not seem to be optimal for this probe.  At 24 hpf and 
30 hpf expression of gch is broad and very strong.  When we could identify mutants we 
did so by their lack of migrating cells.  By 36 hpf, expression had decreased so that we 
could easily see individual cells.  By 45 hpf and 48 hpf not all of the mutant embryos 
express gch and where an embryo does, it is only in very few (45 hpf), or one (48 hpf) 
cell.  paics has an expression pattern that lies somewhere between those of xdh and gch 
and is most like that which we see for the melanophore markers.  At 24 hpf, there are 
a few cells expressing paics in a fairly anterior position and by 30 hpf, expression has 
extended more posteriorly.  By 36 hpf expression has begun to be lost again, being in 
fewer cells and in fewer embryos.  We continue to see a loss of paics expression until 
















Figure 3.13 gch expression in sox10t3
Wild type expression of gch is in stellate cells on the lateral pathway consistent with 
published data and with their being xanthoblasts and xanthophores.  In sox10t3 embryos, 
where xanthophores do not properly differentiate, residual gch expression is still seen. 
Cells are in a position dorsal to the neural tube but are not seen in migratory positions. 
Strong expression is seen in a dense line at 24 hpf and 30 hpf in very similar patterns 
dorsal to the neural tube.  From this time, expression decreases, the number of cells 
expressing gch apparently becomes less so that we can see individual cells.  At 48 hpf 
















Figure 3.14 xdh expression in sox10t3
Wild type expression of xdh is, as published, in cells on the lateral pathway consistent 
with their being xanthoblasts/xanthophores. At 24 hpf, mutants and wild types are 
indistinguishable; cells can be seen dorsal to the neural tube and are more densely 
packed anteriorly.  Later in wild type embryos, migrating cells can be seen.  xdh 
positive cells always appear to have fairly weak expression.  By 36 hpf, the wild type 
expression is very weak and in a decreased number of cells compared to 33 hpf.  In 
sox10t3 embryos, residual xdh expression is still seen. Cells are in a position dorsal to 
the neural tube but are not seen in migratory positions.  Expression patterns at 27 hpf, 
30 hpf and 33 hpf are very similar but by 33 hpf not all of the embryos are expressing 



















Figure 3.15 paics expression in sox10t3
Wild type expression of paics is in cells on the lateral pathway and not on the medial 
pathway, indicating that they are xanthoblasts/xanthophores.  In sox10t3 embryos, some 
residual paics expression is still seen. Cells are in a position dorsal to the neural tube 
but are not seen in migratory positions.  Expression is seen at 24 hpf in cells in the 
anterior trunk.  Expression appears to extend more posteriorly at 30 hpf (note antero-
posterior postiton of the arrows).  By 36 hpf there are fewer cells expressing paics and 










Figure 3.16 Comparison of xanthophore marker gene expression in wild type 
and sox10t3 30 hpf embryos
Images are of the region of the trunk anterior of the end of the yolk sac extension taken 
at a focal plane in the centre of the embryo so that the notocord is in focus.  Notice that 
gch expression in sox10t3 embryos is strong and xdh expression is particularly weak. 


















































































































































































































































































































































































































3.3.1 Sox10 Represses Melanophore Differentiation Genes
sox10t3 embryos have severe defects in a subset of neural crest cells including a 
dramatic reduction of all pigment cells, although residual melanised cells and escaper 
iridophores exist at 3 dpf in mutant fish and xanthophore-like cells are still seen before 
approximately 35 hpf.  In Chapter 1 we proposed a model for the role of Sox10 in 
melanophores.  One of the predictions from that model was that Sox10 promotes 
melanophore differentiation by activating expression of mitfa.  Previous work by 
Elworthy et al. (2003) concluded that this was indeed the case.  However, further 
to Elworthy et al. (2003) our model predicts that Sox10 also inhibits melanophore 
differentiation by repressing expression of melanophore differentiation genes.  If this 
is the case then we would expect to see derepression of genes downstream of Mitfa in 
sox10t3 mutants.  Such derepression could explain the presence of residual melanised 
cells in sox10t3 mutant embryos.  We sought to look more closely at the phenotype 
of sox10t3 mutants to test our prediction.  dct has been previously described as being 
absent in sox10 mutants at 21 hpf (when it is expressed in wild types) but present at 
24 hpf and 30 hpf in cells dorsal to the neural tube (Kelsh et al. 2000).  We wanted to 
find out if and when dct expression is lost from mutant embryos and to ask whether 
three other melanophore markers, silva, tyrosinase and tyrp1b are also expressed in 
sox10t3 mutants.  We found that all of our melanophore marker genes are expressed 
in sox10t3 mutants from 24 hpf until approximately 54 hpf.  We also looked for 
expression of the same genes in mitfaw2 mutant embryos.  If the expression of marker 
genes is reduced in those embryos which have functional Sox10 but lack Mitfa (mitfaw2 
embryos), as compared to those which lack both Sox10 and Mitfa (sox10t3 embryos), 
this will support the hypothesis that Sox10 has a repressive effect upon the expression 
of melanophore marker genes.  We found that expression of tyrp1b is almost entirely 
absent from mitfaw2 embryos and that expression of the other marker genes occurs 
over a shorter time period, is much weaker and in fewer cells than in sox10t3 embryos. 
We were also able to show that the strong residual expression seen in sox10t3 mutants 
was not as a result of undetectable mitfa expression in these embryos since it is also 
observed in sox10t3;mitfaw2 double mutants.  Together, these data provide support for 
our hypothesis that Sox10 is able to inhibit melanophore differentiation by repressing 
expression of melanophore differentiation genes.
These data contrast with data about melanocyte marker gene expression in Sox10 
mutant mice.  Of the four markers we have used in our work only Dct has been properly 
examined in mouse.  It has been shown, both in vivo and in neural tube culture, that 
Dct is not expressed in the neural crest of Sox10 deficient mice (Britsch et al. 2001, 
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Potterf et al. 2001, Southard-Smith, Kos and Pavan 1998).  However, it may be that 
Dct is expressed below the threshold at which it can be detected by ISH, we know that 
expression in zebrafish sox10 mutants is very weak.  The same authors also failed to 
observe pigmented cells in their experiments which may be an artefact of decreased 
sensitivity in detecting melanin in mouse as compared to zebrafish.  Alternatively, it 
may suggest that there is no residual expression or that that which does exist is too 
little to generate melanin.  It would be of interest to look at expression of Tyrosinase 
and Tyrp1 in mouse Sox10 mutants to confirm that these genes are not expressed 
either.  If it was found that no melanophore specific genes are derepressed in Sox10 
mouse mutants it would suggest that there are significant interspecies differences 
between mouse and zebrafish in the way that melanophore development is regulated 
by Sox10 in each.  Similar differences have been suggested before, by Hou et al. 
(2006), who demonstrated a late requirement for Sox10 to activate expression of 
Tyrosinase.  There is no evidence for a late role for Sox10 in zebrafish melanophore 
development (Elworthy et al. 2003).  Elworthy et al. (2003) showed that Sox10 directly 
activates expression of mitfa and conclude that subsequent expression of genes such 
as dct are not in direct response to Sox10 expression but that they respond via Mitfa. 
They excluded the possibility of a late requirement for Sox10 in melanophore gene 
expression in a series of overexpression experiments which demonstrated that Mitfa 
is able to rescue morphologically normal melanophores equally well in the presence 
or absence of functional Sox10.  Further to this, and in contrast to data from Hou et al 
(2006) suggesting a positive late role for Sox10 in melanocyte development, our data 
suggest that Sox10 actually functions to repress expression of melanophore marker 
genes thus having a negative late role in melanophore development.  These apparent 
interspecies differences will be discussed and explored further in later chapters.
3.3.2 Precocious Xanthophore Development in sox10t3 
Embryos
We also looked for residual xanthophore marker expression in sox10t3 mutants to 
attempt to explain the residual xanthophores observed in sox10t3 mutant embryos 
(Dutton et al. 2001, Kelsh and Eisen 2000) and to begin test the generality of our 
model in different pigment cell types.  We found that our xanthophore markers were 
indeed expressed in similar spatial and temporal patterns as the melanophore marker 
genes in sox10t3 mutants.  sox10t3 mutants display another phenotype reminiscent of 
the derepression phenotypes described for melanophore markers.  When examined for 
fluorescence, sox10t3 mutants can be reliably sorted from wild types at 24 hpf by the 
presence of cells which fluoresce in crest positions in the head and anterior trunk (55 
out of 57 sorted embryos were mutant).  The fluorescence persists at 27 hpf and 30 hpf. 
We know that our xanthophore markers are lost at later stages and that many neural 
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crest cells die between 35 hpf and 45 hpf (Dutton et al. 2001) so, as predicted, we 
found that by 54 hpf the fluorescence is gone.  Xanthophores are autofluorescent and 
we suggest that what we were seeing was xanthophore autofluorescence some 11 hours 
prior to when it would normally be seen in wild type embryos.  To confirm this we 
would need to photograph fluorescence in live embryos and process them by ISH for 
gch, xdh or paics for direct comparison.  The precocious development of pigment in 
xanthophores is in contrast to the delayed development of pigment in melanophores 
and is probably due to the speed at which the necessary levels of enzymes required 
for pigment to form can be achieved in the different cell types.  These data suggest 
that there is derepression of xanthophore marker genes in sox10t3 mutants and that our 
model may be more generally applicable in other neural crest derivatives.  However, 
far less is known about xanthophore development than melanophore development. 
For example, we have no equivalent for mitfa in xanthophores, no master regulator of 
xanthophore differentiation.  Without a xanthophore equivalent for the mitfaw2 mutant 
it is difficult to confirm that the residual xanthophore marker gene expression we see 
in sox10t3 mutants represents derepression of those genes.  Similarly, it is currently 
impossible to generate a genetic network to describe xanthophore development or a 
testable model for the role of Sox10 within that network.   
3.3.3 Melanophore Development, Beyond Testing the Model
There are further implications for our understanding of melanophore development 
arising from the data presented here.  A great deal of work in mouse and human has 
accumulated showing that Sox10 and Mitf can activate expression from the promoters 
of Dct, Tyrp1 and Tyrosinase (Britsch et al. 2001, Potterf et al. 2001, Murisier and 
Beermann 2006, Murisier, Guichard and Beermann 2006, Murisier, Guichard and 
Beermann 2007, Bertolotto et al. 1998, Bentley, Eisen and Goding 1994).  Both 
Sox10 and Mitfa are not functional/present in our mutants and yet some marker gene 
expression remains.  However, we found that although expression of the markers 
appeared readily in wild type embryos, to see staining in the mutants we had to ‘push’ 
the ISHs hard at the developing stage.  This indicates that gene expression in mutant 
cells is at comparatively lower levels than in wild type embryos.  We also observed that 
residual expression of melanophore markers could be rather variable between mutant 
embryos in a single batch.  Our results showing dct expression at 24 hpf and 30 hpf, 
recapitulated those in (Kelsh et al. 2000) and we also saw an anterior to posterior 
progression of dct positive cells similar to that which would occur in wild type embryos. 
The pattern for the other markers was comparable in this respect and counts of residual 
melanised cells also revealed an increase in their number over time together with an 
anterior to posterior progression.  Whilst these pieces of evidence demonstrate the 
importance of Sox10 and Mitfa in the regulation of our melanophore marker genes, 
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either by direct or indirect regulation, it also indicates that there may be an additional 
mechanism by which these genes are activated.  An attractive and plausible hypothesis 
is that the mechanism employed to achieve expression of melanophore marker genes 
in sox10t3 embryos is part of the mechanism by which those genes are activated in wild 
type embryos but which is less efficient in the absence of Sox10 and Mitfa.  Genes 
of the Tyrosinase-related protein family from various organisms have binding sites in 
their promoters for Pax3 (Murisier and Beermann 2006) and Pax3 has been shown to 
regulate expression from the Tyrp1 promoter in mouse (Galibert et al. 1999).   One 
possibility is that Pax3 in a wild type embryo will act in conjunction with Mitfa to 
regulate expression of the tyrosinase-related family genes and that even in the absence 
of Mitfa it is still able to do this.  Without Mitfa however, gene activation is inefficient 
which leads to variability in expression between embryos and explains why normal 
levels of expression are never achieved.  This would be in contrast to data from adult 
mouse melanocyte stem cells where Pax3 has been shown to inhibit the expression of 
Dct (Lang et al. 2005).
This inefficiency of marker gene activation in the absence of Sox10 and Mitfa may 
also explain some of the observations we have made of residual melanised cells.  We 
looked carefully at individual sox10t3 mutant embryos and did not observe any residual 
melanised cells, at or before 35 hpf but did find them from 36 hpf onwards.  In wild 
type embryos melanisation begins at approximately 24 hpf so in sox10t3 mutants there 
is a delay in melanisation of at least 12 hours. There was also a great deal of variation 
in the time at which embryos gained melanised cells with some embryos failing to 
develop pigment at all.  Activation of melanogenic enzymes appears to be inefficient in 
the absence of Sox10 and Mitfa so whether or not the genes are activated in particular 
cells is variable and it will take longer for the necessary components to accumulate 
resulting in the variability and delay in pigmentation that we see in sox10t3 mutants.
Expression of our melanophore marker genes in sox10t3 embryos is apparent from 
24 hpf and progresses posteriorly until approximately 36 hpf.  From this time, the 
number of positive cells decreases so that expression is lost entirely from some embryos 
as early as 48 hpf and from all by 60 hpf.  This is consistent with data from Dutton et 
al. (2001) which showed that there is increased cell death in neural crest cells in sox10t3 
mutants between 35 hpf and 45 hpf.  They suggest that as a result of loss of Sox10, 
neural crest cells fail to specify and die by apoptosis.  It is therefore likely that late loss 
of marker gene expression is as a result of apoptosis of expressing cells rather than 
loss of expression from cells which remain alive.  However, we still see some embryos 
with some cells expressing our markers after 45 hpf, although there is great variability 
within each batch of embryos.  Dutton et al. (2001) refer to ‘a notable concentration of 
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apoptotic cells’ which they see between 35 hpf and 45 hpf but they do not detail what 
happens to the TUNEL staining after 45 hpf.  From our results we would only expect 
a small number of cells to be dying after this timepoint and increased death of a small 
number of cells would have been difficult to detect by TUNEL staining.  The data 
we have discussed so far enables us to conclude that melanophore development can 
continue to some degree even in the absence of Sox10 and Mitfa but that these cells 
are not able to develop normally and probably eventually die by apoptosis.  Apoptosis 
is also the accepted fate of cells which fail to specify in mouse Sox10 mutants (Britsch 
et al. 2001, Paratore et al. 2001, Sonnenberg-Riethmacher et al. 2001, Kapur 1999, 
Honoré, Aybar and Mayor 2003).
Most of the melanised cells that we observed in sox10t3 mutants were very small, round 
and darkly pigmented.  We have considered whether these are the remains of melanised 
cells which have undergone apoptosis.  We know that apoptosis is characterised by 
cell shrinkage followed by blebbing and the formation of apoptotic bodies (Lodish 
et al. 2001).  We were able to capture images of a cell which appears to shrink and 
undergo melanin redistribution.  At 41 hpf the cell in question was relatively large and 
of stellate morphology.  At 43 hpf the same cell (judged by position and fortuitous lack 
of any other cells in the vicinity) was now much smaller, darker and round.  Looking 
closely it also appears that there are other, unpigmented, bodies close by.  We were 
only able to document this event once.  This suggests that melanisation of neural crest 
cells in sox10t3 mutants is a rare event, because of inefficient gene activation, but that 
it does sometimes occur before apoptosis.  By 3 dpf most of the residual cells observed 
are of similar apoptotic morphology, rounded, compact and darkly pigmented.  To test 
whether residual melanised cells are apoptotic, we would need to carry out TUNEL 
staining on embryos between 36 hpf and 3 dpf and look for labelled, melanised cells.
Our observations of residual melanised cells in sox10t3 embryos illustrate again the 
failure of melanophores to form normally in these embryos.  The residual melanised 
cells are fewer in number than melanophores in wild type embryos, are only seen in 
premigratory positions and do not look like wild type melanophores.  This reiterates 
to us the importance of Sox10 and Mitfa for development of proper melanophores 
but begs the question why exactly do these cells not survive?  Our observations so far 
have all been based upon melanin production; we have either looked at genes required 
for melanin/melanosome production or at melanin itself.  Therefore, our results only 
indicate that Sox10 is not essential in directly or indirectly regulating genes involved 
in melanin synthesis.  However, Sox10 or Mitfa may be an absolute requirement in the 
regulation of other genes needed for proper melanophore differentiation and survival. 
For example, a zebrafish c-Kit homologue, kita, is a transmembrane receptor present in 
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melanophores which is not important for melanophores to differentiate (kita mutants 
only have a reduced number of melanophores) but is important for their survival and 
migration (Parichy et al. 1999).  It is known that kita is undetectable by ISH in sox10t3 
mutant embryos (Dutton et al. 2001) and so it is likely that this gene requires either 
Sox10 or Mitfa to be expressed.  kita is just one example of a melanophore survival 
gene that is completely absent from sox10t3 mutants and it is likely there are more, as 
yet undiscovered.  For example, in mouse, Bcl2 has been shown to be a melanocyte 
survival factor regulated by Mitf (McGill et al. 2002).  This gene has been identified 
in zebrafish (Kratz et al. 2006) but little is known about its expression and function 
although we might expect similarities with mouse.  We would predict that Bcl2 will 
be expressed in zebrafish melanophores and that it will be regulated by Mitfa.  Thus it 
may be another important survival factor missing from sox10t3 embryos.
Up until this point we have discussed the expression patterns of the melanophore 
markers in terms of their similarities and the general conclusions we can draw from 
those similarities.  However, there are some points to note which are specific to each 
gene which might shed light upon more specific details of melanophore development. 
We described in the results section how similar, with respect to spatial and temporal 
patterning, the expression patterns of dct and tyrosinase are in sox10t3 mutants.  These 
similarities suggest that perhaps the factors which regulate the expression of these 
two genes, beyond the requirement for Mitfa, are also similar.  This might include 
regulation by Pax3 as discussed above but could also include regulation by other 
factors.  tyrp1b positive cells are much lower in number and have weaker staining than 
any of the other markers.  This implies that tyrp1b expression may not be repressed by 
Sox10 as much as the other genes.  Alternatively, tyrp1b expression might be repressed 
by genes other than Sox10, expression of which are not affected by loss of functional 
Sox10, resulting in reduced residual expression.  Another possibility is that expression 
of tyrp1b may be more dependent upon genes downstream of Sox10, i.e. Mitfa, than 
the other markers.  Some of these concepts are illustrated in Figure 3.17.  In contrast, 
whilst expression of silva follows the same temporal pattern of expression as either 
dct, tyrosinase or tyrp1b, spatially its expression is slightly different.  silva is clearly 
expressed more broadly and in more cells than the other markers.  This suggests that 
regulation of silva may be slightly different again from the other marker we have used. 
It may be that repression of silva expression by Sox10 is more important than for the 
other genes so that when functional Sox10 is lost, more cells are able to express silva 
than the other markers.  Alternatively, it may be that there are factors which allow 
more efficient activation of silva in the absence of Sox10 and Mitfa compared to the 






















Figure 3.17 Differential regulation of melanophore marker genes
Repressor transcription factors are represented by hexagons and activator transcription 
factors by ellipses.  TF Z and TF Y represent unknown, hypothetical transcription 
factors also involved in the regulation of melanophore marker gene expression.  The 
size of each transcription factor represents its predicted importance for gene expression. 
From our results, the regulation of dct and tyrosinase appear to be similar.  There is 
also no evidence that any one transcription factor is important over and above the rest. 
However, from our data it appears that Sox10 may particularly important for silva 
repression.  Alternatively, or perhaps in addition, TF Y may be more important than 
Mitfa for silva expression.  Sox10 seems to be less important for regulation of tyrp1b 
suggesting that Mitfa might be a key activating factor for this gene or that TF Z may 
be more significant for regulation of this gene than the others.
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It would be interesting to know how far the expression of silva overlaps with that of 
the other marker genes.  Which combinations of genes does a cell need to become 
melanised?  Work from mice suggests that all of the genes we have examined will be 
required for melanin synthesis, since loss of any one results in changes in coat colour. 
Mouse Tyrosinase mutants have white coats, (Beermann, Orlow and Lamoreux 2004) 
and the zebrafish tyrosinase mutant (sandy) has unpigmented melanophores, reflecting 
the key role of tyrosinase at the top of the melanin synthesis pathway (Haffter et al. 
1996, Kelsh et al. 1996, Page-McCaw et al. 2004).  Mice which are mutated at the Dct 
and Tyrp1 loci have a weaker phenotype with reduced pigment and are dark grey and 
brown respectively (Bennett et al. 1990).  This reflects the importance of these genes in 
eumelanin synthesis and in maintaining the balance of melanin components (Jackson 
et al. 1992, Zdarsky, Favor and Jackson 1990).  However, whilst candidates have been 
suggested, we do not currently know the zebrafish phenotype for mutants in these 
genes and so we do not know the effect on pigmentation in cells which do not express 
dct or tyrp1b.  Close examination of the correlation between dct, silva, tyrosinase and 
tyrp1b positive cells with each other and with melanin in mutant embryos (by carrying 
out double and potentially triple ISHs with different combinations of markers) would 
help to resolve which combinations are conducive to melanin synthesis.  Alternatively, 
for example, it would be interesting to know how numbers of tyrp1b positive cells 
correlate with numbers of melanised cells.
We had also carried out some experiments using xanthophore markers and found that 
all three of the markers we used, gch, xdh and paics, were expressed in sox10t3 mutants 
in a pattern very similar to that seen for the melanophore markers.  In wild type embryos 
there is some overlap between gch and melanin and with xdh and mitfa expression 
(Parichy et al. 2000b).  Assuming these cells do not also express neural markers, this is 
suggestive of the concept of progressive fate restriction of neural crest cells and thus of 
partially restricted precursors such as a pigment cell precursor (reviewed in Le Douarin 
and Dupin (2003)).  These partially restricted precursors might be expected to express 
genes characteristic of all the differentiated cell types.  In the process of becoming 
specified it could be imagined that in wild type embryos cells might exist transiently 
which express genes characteristic of multiple cell types before markers of all but one 
cell type are lost and the cell can be described as, for example, a melanoblast.  Perhaps 
when Sox10 function is lost, as in our mutants, we might catch cells in this partially 
specified state, giving us a window into normal wild type development.  To test this 
idea further double ISHs in wild types and mutants could be used to look for cells with 
combinations of cell type markers, for example silva and xdh.  Since silva and gch are 
so widely expressed in sox10t3 mutants it would be difficult to imagine that they do not 
overlap.  It is also pertinent to note here some relevant data about iridophores in sox10t3 
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mutants.  The expression pattern of an iridophore marker, ltk, in sox10t3 mutants is also 
very similar to, and might be expected to overlap with, that of the markers we have used 
here for melanophores and xanthophores (Lopes et al. 2008).  ltk expressing cells can 
be seen in a premigratory position in sox10t3 mutants and are increased in number and 
in strength of expression in mutants as compared to wild types.  This differs slightly 
from the expression of our melanophore differentiation markers, probably because ltk 
appears to have a much earlier role in iridophore development than differentiation, 
but contributes to the concept of partially restricted precursors caught in this state in 
sox10t3 mutants.  Indeed, the authors suggest that these ltk expressing cells actually 
represent multipotent pigment cell precursors.
3.3.4 Summary
In this Chapter we have provided evidence in support of our model for the role of 
Sox10 in melanophores which predicted that melanophore marker genes will be 
derepressed in sox10t3 mutants.  We were also able to make a number of other interesting 
observations from our data about the regulation of our melanophore marker genes and 
the regulation of melanophore development.  We found that xanthophore markers may 
also be derepressed in sox10t3 mutant embryos suggesting the possibility that our model 
may be generally applicable to other neural crest derived pigment cells.  If Sox10 
does have a role to inhibit differentiation of melanophores by repressing melanophore 
differentiation genes then our model predicts that it will have to be downregulated to 





Our data in Chapter 3 clearly indicated a derepression of multiple melanophore 
marker genes in sox10 mutants (Figures 3.03-3.12).  This was strongly reminiscent 
of an observation made in sympathetic neurons in mouse Sox10 mutants where a 
neurogenic gene, Phox2a, was seen to be derepressed (Kim et al. 2003).  The data 
supports one of the predictions from our model (Figure 1.04), that whilst Sox10 
initiates melanophore specification by inducing expression of mitfa it also prevents 
those cells from differentiating by inhibiting expression of genes further downstream of 
Mitfa.  Another of the predictions from our model is that Sox10, due to this repressive 
function, would need to be downregulated to allow melanophore differentiation to 
proceed.  Loss of sox10 mRNA from melanophores has been briefly reported by Dutton 
et al. (2001).  They commented that most cells on the lateral pathway at 24 hpf were 
negative for sox10 but that at 36 hpf, some melanised cells in the dorsal stripe were 
still expressing sox10.  Previous work using a transgenic line has also suggested that 
there is a downregulation of expression from the Sox10 promoter in differentiating 
melanophores (Carney 2003).  The transgenic line used expressed GFP under the 
control of a 4.9 kb section of the zebrafish sox10 promoter, Tg(-4.9sox10:GFP).  Loss 
of GFP from differentiating melanophores was observed from approximately 30 hpf. 
By approximately 90 hpf only a few melanophores still expressed GFP.  Of course, 
due to GFP perdurance, this may not reflect the true timecourse of loss of Sox10 from 
differentiating melanophores.  In our experiments we sought to test the prediction that 
Sox10 is downregulated in differentiating melanophores more thoroughly.  We looked 
directly at both Sox10 protein, using immunofluorescence (anti-Sox10 antibody 
kind gift of Dr. B. Appel), and at sox10 mRNA by ISH, over a timecourse, aiming to 




In addition to testing our model, if we can establish that Sox10 is downregulated in 
melanophores and provide details of this phenomenon it will provide a solid foundation 
for comparisons with mouse melanocyte development.  As we discussed in Chapter 
1, it has been suggested that mouse and zebrafish may differ significantly in the way 
that they regulate melanocyte development (Hou, Arnheiter and Pavan 2006).  Sox10 
appears to be lost from differentiating zebrafish melanophores but it remains to be 
definitively tested whether Sox10 is downregulated in differentiating melanophores 
or not.  Data that exists from mouse is contradictory, with some reports suggesting 
that Sox10 is lost from differentiating melanocytes and others that it is not (Chapter 
1).  Often the work has been carried out in vitro and in melanoma cell lines so the 
relevance of the work in vivo is also questionable.  We hope that by helping fill this 
gap in our knowledge with respect to zebrafish melanophores we can enable more 
meaningful comparisons to be made of melanocyte development in both organisms.  
Our model predicts that downregulation will be necessary to allow zebrafish 
melanophores to become fully differentiated.  Assuming we could establish that 
Sox10 is downregulated in melanophores as they differentiate we planned to test this 
second hypothesis by making a transgenic zebrafish line to drive sox10 expression in 
melanophores past the timepoint where it is normally switched off.  We would predict 
that this would either prevent or delay melanophore differentiation.  To achieve this 
overexpression of Sox10 we intended to make two DNA constructs; a control construct 
containing an appropriate melanophore specific promoter with a reporter gene and an 
experimental construct with these elements plus the sox10 gene fused in frame to the 
reporter gene.  These constructs would then be used to generate both transient and 
germline transgenics which themselves could be used/analysed to determine whether 
Sox10 downregulation is necessary for melanophore differentiation.
Generating zebrafish transgenics using conventional techniques of simply injecting 
plasmid DNA into one cell stage embryos, growing these fish and screening them for 
founders which pass the transgene through their germline, can be very time consuming 
and laborious and has a low frequency of generating transgenic lines; between about 
5 % and 9 % (Stuart et al. 1990, Amsterdam, Lin and Hopkins 1995).  Retroviruses have 
been used to increase the efficiency of gene transfer (Lin et al. 1994) but only increase 
efficiency to 10 % and have the additional technical difficulties attached to handling 
retroviruses in the lab (Linney et al. 1999).  I-SceI meganuclease has been used to more 
dramatic effect, increasing efficiency to 30.5 % (Thermes et al. 2002).  More recently 
however, several transposon systems have been developed and used in zebrafish.  These 
include Tc3, Sleeping Beauty and Tol2 (Kawakami 2004, Raz et al. 1998, Davidson et 
al. 2003).  Of these systems it is the Tol2 system (Kawakami 2004) that appears most 
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promising.  The system utilises a medaka transposable element (Tol2) into which the 
transgene is inserted (Kawakami, Shima and Kawakami 2000).  This construct is then 
co-injected with transposase mRNA (made in vitro) into one cell stage embryos.  The 
transposase RNA is translated into protein in the early embryo.  The transposase enzyme 
cuts the transgene out of the injected construct and allows it to be incorporated into the 
zebrafish genome.  The procedure for generating transgenic lines from this point is the 
same as for conventional transgenesis except that efficiency is increased many fold 
(50 % in Kawakami et al. (2004)).  For this reason we decided to use this technique 
for making our transgenics.  We were able to obtain, by kind gift of Koichi Kawakami, 
plasmids containing both the Tol2 element (pT2KXIG, Kawakami et al. (2004)) and the 
gene encoding a suitable transposase (pCS-TP) and designed our cloning strategy to 
incorporate our transgene into pT2KXIG.  pT2KXIG contained a number of components 
(Xenopus EF1 α enhancer/ promoter, rabbit β-globin intron, EGFP gene and SV40 
polyA signal).  Of these, only the SV40 polyA signal was appropriate for our purposes 
so we planned to remove most of the DNA between the Tol2 elements and replace it 
with a linker.  Linkers are short stretches of DNA which can be designed to contain 
specific restriction enzyme recognition sites.  They are obtained as single stranded DNA, 
annealed to one another and ligated into a plasmid vector using conventional cloning 
techniques.  The Linker we designed contained all of the restriction sites required for us 
to be able to insert the different components of our constructs.
There were a number of components to be sourced to generate our constructs.  We 
first needed an appropriate promoter to drive expression in melanophores at all stages 
of development.  An ideal promoter for this purpose would have been the zebrafish 
dct promoter since dct is expressed in melanophores from early in their development 
(19 hpf) to the latest stage observed at 8 dpf (Kelsh et al. 1996).  Unfortunately, at 
the time of commencing the project, the zebrafish genome was not sufficiently well 
sequenced for us to be able to locate a dct promoter region.  The dct coding region 
was in fact at the 5’ end of a contig with no overlapping stretches of sequenced DNA 
available that might be expected to contain the dct promoter.  Instead, we chose to 
investigate the possibility of using a Dct promoter from mouse.  We obtained the 
previously identified mouse Dct promoter as a kind gift from Ian Jackson in plasmid 
pPB2 with a LacZ reporter gene (Budd and Jackson 1995, Mackenzie et al. 1997). 
In mouse, this 3.6 kb promoter had been shown to be active in all areas where Dct is 
normally expressed in the mouse, the early PRE, the telencephalon and in neural crest-
derived melanoblasts and melanocytes (Mackenzie et al. 1997).  In these transgenic 
lines, the promoter was also shown to be active in two ectopic sites, the optic nerve 
and neural crest-derived neuronal cells (DRGs and caudal spinal nerves).  We were 
able to test pPB2 in transient transgenic zebrafish and satisfy ourselves that the mouse 
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Dct promoter was also active in zebrafish and that it recapitulated endogenous dct 
expression.  We therefore decided to use this promoter in our constructs.
We used the sox10 coding region from a plasmid called p7.2GFPsox10 made by James 
Dutton.  To allow us to observe cells expressing ectopic sox10 and to aid screening of 
transgenic founders, we proposed to tag our ectopically expressed Sox10 with ECFP 
by placing ECFP (pECFP-C1, Clontech) in frame, upstream of the sox10 sequence. 
Previous experiments using a GFP-Sox10 fusion demonstrated that a fusion protein, 
with the GFP at the N-terminus of the Sox10 protein, was capable of rescuing pigment 
cells in sox10 mutants and, therefore, that the Sox10 protein can retain its function 
even when fused to GFP in this way (J. Dutton, personal communication).  We 
would generate a fusion protein with the ECFP at the N-terminus as opposed to the 
C-terminus of the Sox10 protein as we were reassured that our CFP-Sox10 fusion was 
also likely to be functional.  A second line expressing only ECFP under the control 
of the Dct promoter would be useful as a control for our experiment but could also 
become a useful tool in its own right.  By choosing to use ECFP, this line could be 
crossed with available lines expressing GFP in the neural crest for use in any number 
of experiments where labelling neural crest and early melanoblasts in distinct colours 
would be required.  
4.2 Results
4.2.1 Sox10 is Downregulated in Differentiating Melanophores
We performed sox10 in situ hybridisation and Sox10 antibody staining (antibody 
kind gift from Dr. B. Appel) on embryos that had not been treated with PTU so that 
melanophores were identifiable by their pigment.  For the ISHs, we used embryos at 
30 hpf and at three hour intervals after that until 48 hpf.  For the antibody staining we 
used embryos at 30 hpf and at two hour intervals until 48 hpf, plus 54 hpf and 72 hpf. 
In both experiments, the embryos were scored blind so that we did not know the exact 
age of the embryos at the time of scoring.  At each stage, 20 pigmented melanophores 
in the region of the trunk between the edge of the yolk and the end of the yolk sac 
extension (Figure 4.01) were scored in each of five embryos for whether or not they 
were expressing Sox10/sox10.  We attempted to score melanophores from different 
dorso-ventral and antero-posterior positions.  Both experiments were repeated twice; 
visual inspection of the data showed that each set was consistent with the other and so 
data were pooled.
We showed that the loss of Sox10 protein from pigmented melanophores occurs between 













































































































































































































































































































































































































































































































































until 36 hpf, when it accelerates.  The time at which half of the melanophores were 
Sox10 positive and half were negative was at approximately 44 hpf.  In contrast, rate 
of loss of sox10 transcript from melanophores was constant and more rapid.  The time 
at which half of the melanophores scored were sox10 positive and half were negative 
was 38 hpf, six hours earlier than for Sox10 protein.  We have shown that Sox10 and 
sox10 are downregulated in melanophores as they differentiate, both confirming and 
extending previous work.
4.2.2 Is Sox10 Downregulation Necessary for Melanophore 
Differentiation?
We now wanted to test whether downregulation of Sox10 is necessary for melanophores 
to differentiate by generating a transgenic line which expresses Sox10 in melanophores 
past the timepoint where it would normally be downregulated.  We aimed to generate 
two constructs in a Tol2 vector backbone; an experimental plasmid containing the 
3.6 kb mouse Dct promoter with an ECFP-sox10 fusion downstream of the promoter, 
and a control plasmid with only ECFP downstream of the promoter.  These plasmids 
could then be used to generate stable transgenic lines which could be used to address 
our hypothesis.  Information on all plasmids used can be found in Figures 4.02 and 
4.03.
4.2.2i Mouse Dct Promoter Activity in Zebrafish Embryos
To determine whether the mouse Dct promoter might be suitable for our proposed 
use in zebrafish we had to test whether the promoter was active in zebrafish and if so, 
whether it gave expression in melanophores.  The plasmid pPB2 contains 3.6 kb of the 
mouse Dct promoter with a LacZ reporter gene downstream of it.  We injected 9.2 nl 
of this plasmid at a concentration of 40 ng/µl into zebrafish eggs at the one cell stage, 
grew them to approximately 27 hpf, fixed them lightly and detected β-galactosidase 
activity using XGal.  For the perdurance of the β-galactosidase, any cells in which the 
mouse Dct promoter had been active would then be labelled with a blue precipitate. 
These cells could be observed and scored by position and morphology to determine the 
cell types in which the promoter had been active.
We obtained compatible results from three separate sets of injections and so data 
have been combined here. Approximately 1420 eggs were injected over the three 
experiments, although only 648 (46 %) of the injected embryos survived to 27 hpf. 
This high death rate was expected due to the high concentration of DNA which we 
had used to maximise the concentration of DNA in individual cells and integration 
of the DNA into the genome to maximise our chances of observing LacZ positive 






Figure 4.02 Plasmids from which components were taken for creation of 
pTol2DctCFPsox10
A. pPB2 from which the mouse Dct promoter was removed as a SalI fragment.
B. pECFP-C1 from which ECFP was removed as an AgeI/BspEI fragment (diagram 
taken from plasmid data sheet, Clontech).
C. p7.2GFPsox10 was made with a pCS2 backbone.  We were able to remove the 
sox10 coding region as an XhoI/SfoI fragment using the XhoI site present at the 5’ end 
of the sox10 (created during the original cloning) and the SfoI(KasI) site in the multi-
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Figure 4.03 Tol2 system plasmids
A. pT2KXIG contains the Tol2 elements and is the vector from which pTol2DctCFP 
and pTol2DctCFPsox10 were built.  Sequence between the Tol2 elements and sites 
ApaI (3070) and ClaI (5004) was removed.
B. pCS-TP contains the gene for the transposase which is used in conjuction with the 
pT2KXIG plasmid to aid integration of our construct into the genome.  pCS-TP is cut 
with NotI and used with SP6 RNA polymerase to make transposase RNA which is co-
injected with our constructs into one cell stage eggs.








that survived to 27 hpf had LacZ positive cells.  Fish had between one and 16 cells 
positive for LacZ.  The location and cell type of each of 144 LacZ positive cells from 
54 embryos at 27 hpf were noted (Table 4.01).  Most of the cells observed in this 
way (57.8 %) could either be positively identified as melanophores (43.2 %, either 
neural crest derived or in the pigmented retinal epithelium) or, by morphology and 
location, could be identified as neural crest derived cells (14.6 %, Table 4.01, Figure 
4.04).  13.2 % of the cells observed were muscle cells, clearly identifiable by their 
characteristic shape and exact size of one somite in length.  Many transgenes generate 
ectopic expression and often, as in this case, this ectopic expression is in the muscle 
of transient transgenics (Thummel, Burket and Hyde 2006, Carney 2003, Udvadia and 
Linney 2003) so this observation did not concern us.  4.9 % of cells were in the CNS. 
These cells were in different areas of the CNS, from the forebrain/telencphalon to the 
spinal cord.  Dct is expressed in the mouse telencephalon but not at all in the zebrafish 
brain and it would be reasonable to assume that there are differences between the control 
elements present in the respective promoters which orchestrate this.  Perhaps these 
differences mean that when in zebrafish, the mouse Dct promoter can drive expression 
of a reporter in the telencephalon or even other areas of the CNS.  Alternatively, the 
expression may be a result of the transgene location; maybe close to a CNS enhancer. 
True ectopic expression was seen in 4.6 % of cells in the otic epithelium or the olfactory 
epithelium.  However, this was a small percentage of cells and was not deemed likely 
to cause a problem in our experiments.  The remaining 20.1 % of cells were either 
unidentifiable or were apoptotic (apoptotic cells were identified by their characteristic 
‘blebbed’ appearance).
From these experiments we concluded that the mouse Dct promoter had the correct 
spatiotemporal properties and would be a suitable promoter for us to use in our 
construct.
4.2.2ii Preparing the Backbone
The scheme we designed for the building of our two constructs is detailed in Figure 
4.05.  First, approximately 5 μg pT2KXIG was cut using ApaI and ClaI enzymes in a 
Multicore buffer (Promega).  The whole digest was run on a 1 % agarose gel and the 
6 kb band, corresponding to the ‘empty’ pT2KXIG vector, was excised from the gel 
and gel purified (Figure 4.05 A).
In order to be able to build our construct into this empty pT2KXIG vector we designed a 
linker.  We designed our linkers to contain SalI, AgeI, BspEI, XhoI and KasI restriction 
sites which we would use later to construct our full construct.  To aid ligation into the 
empty pT2KXIG vector the linkers were also designed to have ApaI and ClaI sticky 
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Pigmented melanocyte 9 6.3
Probable melanocyte 42 29.2





Subtotal expected 83 57.8
Ectopic expression
Ear 3 2.1





Subtotal ectopic 61 42.4
Total 144 100
Table 4.01 LacZ expression in transient transgenics
The plasmid pPB2 was injected into one cell zebrafish 
embryos.  Fish were evaluated for LacZ expression at 
27hpf.  Most of the LacZ expression was specific to cells 
which endogenously express dct.  Note: percentages do 







Figure 4.04  Mouse Dct promoter recapitulates endogenous dct expression
The plasmid pPB2 was injected into one cell zebrafish embryos.  Fish were evaluated for 
LacZ expression at 27hpf.  Panels A-E compare the wild type dct in situ hybridisation 
pattern (A, B and D) with examples of LacZ expressing cells in fish injected with pPB2 
(C and E) Scale bar is the same for A and for B - E, 50µm.
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Figure 4.05 Schematic of cloning strategy
Each component has and retains its own colour throughout.  A. Preparing the vector. 
B. Inserting mouse Dct promoter.  C. Inserting CFP sequence.  D. Inserting a spacer 
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ends when annealed to one another (Figure 4.06).  Linkers 1 and 2 were ordered from 
Invitrogen as a 200 nmol synthesis of custom primers and were PAGE purified prior to 
being sent to us (see Appendix for sequences).
Linkers 1 and 2 were annealed to each other (Chapter 2).  A ligation was then set up 
using 3 μl annealed Linkers and 1 μl empty pT2KXIG vector.  The ligation was used to 
transform competent cells, two of the resulting colonies were picked and miniprepped. 
Digests were set up to check for the presence of SalI, AgeI, BspEI, XhoI and KasI 
restriction sites.  All except BspEI were present (Figure 4.07).  We hypothesized that 
the BspEI digest failed because the activity of BspEI is blocked by overlapping dam 
methylation.  Since the cells into which the plasmid had been transformed were dam 
positive, if we had inadvertently created a methylation site in our linker it would be 
methylated and BspEI would be unable to cut the DNA despite the presence of a 
BspEI restriction site.  MspI is an enzyme which recognises the same restriction site as 
BspEI but is not methylation sensitive.  We therefore digested our plasmid with MspI 
to test for the presence of the BspEI site.  MspI was able to cut the plasmid in several 
places.  If our BspEI site is present in the linker among other band sizes there will be 
bands of 769 bp and 966 bp.  If the site is not present, these bands will not be present 
but a 3696 bp band will be.  The band pattern we saw after MspI digestion included 
bands of the expected sizes as well as bands of 769 bp and 966 bp but not of 3696 bp 
(Figure 4.07).  From this, we were able to determine that MspI was cutting within 
our linker and that the BspEI site was therefore present in our linker.  We were now 
confident that our complete linker was present within the pT2KXIG backbone and the 
plasmid was named pTol2+linker.  To confirm that methylation was preventing BspEI 
cutting our plasmid, and to find a way to remove that methylation so that we could 
use the BspEI site for our cloning, we transformed pTol2+linker into SCS100 cells 
(Stratagene).  These cells are dam negative and thus will generate unmethylated DNA. 
It was possible to cut pTol2+linker purified from these cells with BspEI, confirming 
that the BspEI site was present and that it had not cut before due to methylation.  This 
showed that we would be able to use the BspEI site in later cloning steps if the plasmid 
had been prepared from dam negative cells.
4.2.2iii Inserting the Mouse Dct Promoter
The mouse Dct promoter fragment was isolated from pPB2 as a SalI fragment by 
digesting approximately 5 μg pPB2 with SalI, running the whole digest on a 1 % 
agarose gel, removing the 3.6 kb band corresponding to the mouse Dct promoter and 
gel purifying the DNA (Figure 4.05 B).  5 μg pTol2+linker (methylated) was linearised 
using SalI, run on a 1% agarose gel and gel purified.  A ligation was set up using 2 μl 
































































Figure 4.07 Successful insertion of Linker into pT2KXIG
A. Digests were run against undigested plasmid as a marker.  pTol2+linker can be 
digested with SalI, AgeI, ClaI, XhoI and KasI. The plasmid appears to linearise 
producing single bands for most of these enzymes (left arrow). DNA digested with 
ClaI and XhoI appear to be incompetely digested, but a band equivalent in size to that 
produced from the other digests is present as well as one larger, undigested band (top 
right arrow). The DNA appears undigested with BspEI.
B. BspEI is methylation sensitive. MspI cuts at the same recognition site but is not 
methylation sensitive. If the BspEI site is not present, cutting with MspI will give a 
band at approximately 3.7 kb; if it is, bands will be seen at 769 bp and 966 bp instead. 
No band is present at 3.7 kb but bands are present at 769 bp and 966 bp. Therefore the 
BspEI site is present in our linker.
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cells (dam positive, Stratagene).  17 colonies were miniprepped and digested with SalI 
to ascertain whether the promoter had successfully inserted.  The expectation was to 
see two bands, one being the 6 kb pTol2+linker and one the 3.6 kb mouse Dct promoter. 
However, only the 6 kb pTol2+linker band was present and we concluded that under 
the conditions used the plasmid had simply re-annealed to itself without incorporating 
the mouse Dct promoter.  To prevent this, we treated the linearised pTol2+linker with 
Shrimp Alkaline Phosphatase (SAP) to remove the phosphates from the 5’ ends of 
the DNA.  This would prevent the ends from annealing to one another but still allow 
them to anneal to untreated DNA ends.  In 40 µl of plasmid, we had 0.3 pmol of ends 
and needed at least 0.03 units SAP (0.2 units were actually used as less was too little 
to measure accurately).  Following SAP treatment a second ligation was set up, this 
time using 1µl linearised and SAP treated pTol2+linker and 3 μl mouse Dct promoter 
with SalI ends.  However, even after a number of attempts no colonies were produced 
using this method.  The reasons for this are unclear and it could have been a result of a 
combination of a number of factors including the difficulty of inserting a comparatively 
large fragment into the vector (3.6 kb into 6 kb).
We reverted to using colonies generated from ligations between linearised pTol2+linker 
that had not been treated with SAP and the mouse Dct promoter.  To search these 
colonies in larger numbers than could otherwise be done for the few that might contain 
the insert we used Colony PCR.  We prepared DNA from colonies and carried out a 
PCR using primers BS1 and TYR1 (Kawakami 2004) which bind to the Tol2 elements 
within the plasmid, one either side of our insert.  We predicted that we would see a 
product if the insert was not present but would not if it was since the interval between 
the primers would then be too large to amplify.  This method would generate a small 
number of false positives if DNA preparation was not efficient and PCR failed on these 
samples (we could control for poor PCR results by using undigested pTol2+linker as a 
positive control) but it would at least reduce the number of colonies which would need 
to be miniprepped and digested to identify the required plasmid.  After screening 144 
colonies in this way and miniprepping 30 of these, we identified one colony which, 
when digested with SalI gave three bands corresponding to linear plasmid plus insert 
(~10 kb, present as a result of incomplete digestion of the plasmid), pTol2+linker 
backbone (6 kb) and mouse Dct promoter (3.6 kb).  We performed a second digest to 
determine the orientation of the promoter within the vector as the cloning was non-
directional and only one orientation would be useful.  When digested with KpnI, if 
the insert was in the correct orientation we would see bands of 4.7 kb and 5 kb, in the 
incorrect orientation the digested plasmid would produce bands of 6.2 kb and 3.4 kb, 
which is unfortunately what we saw.  This meant that the promoter was inserted in the 
incorrect orientation but we now knew that the promoter definitely could insert into 
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the vector (presumably its large size made the event less likely).  So we continued 
with our Colony PCR strategy.  After doing Colony PCR on a further 201 colonies, 
12 more minipreps yielded a further two colonies in which the promoter was inserted 
in the incorrect orientation, but it also yielded one colony in which the promoter was 
in the correct orientation (colony number 194, Figure 4.08).  This plasmid was now 
named pTol2Dct.
4.2.2iv Inserting the ECFP Gene
ECFP was excised from approximately 5 μg of the pECFP plasmid using AgeI and 
BspEI enzymes (Figure 4.05 C).  These two enzymes do not work in the same buffer so 
the plasmid was digested with AgeI first and cleaned by Phenol Chloroform extraction 
before being digested with BspEI.  The digest was run on a 1 % agarose gel and 
the desired 800 bp band containing ECFP was removed from the gel and the DNA 
extracted from it.  pTol2Dct was transformed into SCS110 dam negative bacteria to 
produce unmethylated DNA so that the plasmid could then be linearised with AgeI and 
BspEI.  Since the sequence of pECFP close to the BspEI recognition site (methylation 
sensitive) was such that it would not be methylated, the BspEI enzyme was able to cut 
pECFP without the need to ensure the DNA was unmethylated.  5 μg unmethylated 
pTol2Dct was first digested with BspEI.  After cleaning the DNA with a Phenol 
Chloroform extraction it was digested with AgeI.  The DNA was again cleaned using a 
Phenol Chloroform extraction (the small fragment of linker that was removed by AgeI/
BspEI digestion was lost during Phenol Chloroform extraction).
Both BspEI and AgeI give CCGG overhangs so it was more likely that the pTol2Dct 
backbone would re-ligate to itself rather than incorporate the ECFP fragment.  To 
prevent this approximately 0.5 μg linearised pTol2Dct was SAP treated using 0.2 units 
of SAP and a ligation was set up using 1 μl of this DNA and 10 μl ECFP fragment. 
This ligation was microdialysed and the whole quantity used to transform competent 
cells.  18 colonies were picked and miniprepped.  Of course, since AgeI and BspEI 
ends are compatible with each other, the ECFP fragment may be inserted in either 
direction, only one of which was the one we wanted.  To determine which samples 
contained the ECFP insert in the correct orientation each was digested with AgeI. 
Plasmids containing the ECFP fragment in the correct orientation would be linearised 
by AgeI because in this case the restriction site is remade.  If however, the plasmid has 
annealed to itself and does not contain the ECFP fragment or if the ECFP fragment 
has inserted in the incorrect orientation, it will not linearise, since when AgeI and 
BspEI ends ligate to one another they do not remake the AgeI restriction site.  Of the 
18 colonies picked, 14 could be digested by AgeI and appeared to be larger than 10 kb 
(we expect a 10.4 kb plasmid at this stage) confirming that these colonies contain the 
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Figure 4.08 Cloning of the mouse Dct promoter into pTol2+linker
A. Colony PCRs using BS1 and TYR1 primers on colonies 185, 186, 190-196, 198 and 
199.  All colonies except 193 and 194 give products using this PCR.  This indicates that 
the colonies from which these samples came do not contain the mouse Dct promoter as 
this product would be too large to be made.  That 193 and 194 do not produce a PCR 
product indicates that they may have incorporated the mouse Dct promoter.
B. Digests to confirm that the mouse Dct promoter has inserted into the plasmids and 
to determine the orientation of the insert.  SalI digests confirm the presence of the 
promoter.  In both colonies 193 and 194 the enzyme digests out the promoter giving 
a 6 kb pTol2+linker band and a 3.6 kb promoter band.  Digests with KpnI determine 
the orientation of the promoter in the plasmid.  193 gives two bands of 6.2 kb and 
3.4 kb, the expected sizes if the insert is in the incorrect orientation.  194 gives one 
band at approximately 4.7-4.9 kb, the size expected if the promoter is inserted in the 
correct orientation.  Note that this band is brighter than the others since it consist of 























































































































































































































































































































































































































































































ECFP insert in the pTol2Dct plasmid (Figure 4.09).  Sample 2 was chosen and named 
pTolDctCFP.
4.2.2v Inserting the sox10 Gene
The sox10 gene was isolated from the p7.2GFPsox10 plasmid using KasI and XhoI in 
separate digests (since their buffers were incompatible).  p7.2GFPsox10 was first cut 
with KasI, cleaned and then digested with XhoI (Figure 4.05 D).  The digest was run on 
a 1 % agarose gel, the appropriate band excised and the DNA cleaned by gel extraction. 
5 μg pTol2DctCFP was linearised first with KasI, cleaned by Phenol Chloroform 
extraction and then cut with XhoI before being cleaned again by Phenol Chloroform 
extraction.  113 colonies were tested using Colony PCR and S21/S22 primers (see 
Appendix) which bind to the sox10 gene.  However, none gave products and it was 
concluded that no colonies had the sox10 gene in the pTol2DctCFP plasmid.
When pTol2DctCFP has been cut with KasI there is only 1 bp between the XhoI site 
and the end of the DNA strand.  Whilst this should not greatly affect the ability of the 
enzyme to cut the DNA (Moreira and Noren 1995) it is possible that a low frequency 
of XhoI cutting the pTol2DctCFP plasmid would explain why we did not find any 
plasmids containing our sox10 insert.  If XhoI is not cutting efficiently, then any 
colonies we obtain will just contain pTol2DctCFP which has been cut with KasI and 
has re-ligated to itself.  To solve this problem we decided to insert a spacer into the 
plasmid between the KasI site and the XhoI site.  We designed two oligos such that, 
if pTol2DctCFP is cut with SfoI (SfoI has the same recognition site as KasI but cuts 
to give blunt ends) and the annealed oligos, now called the Spacer, inserted into it 
then the KasI/SfoI site is remade only at the end furthest away from the XhoI site (see 
Appendix).  The Spacer also contained unique ClaI and EcoRV sites to enable us to 
check for its presence.  A primer (spacerprimer, see Appendix) was designed over the 
Spacer and adjacent sequence which, in conjunction with the BS1 primer, would also 
allow us to check the orientation of the Spacer.  The oligos to make the Spacer were 
ordered as for the Linker.
Thus, approximately 5 μg pTol2DctCFP was cut with SfoI and cleaned by Phenol 
Choloform extraction.  The spacer oligos were diluted to 220 µM and annealed to 
one another as described in Chapter 2 for the Linkers.  Then, 7 μl of Spacer and 1 μl 
SfoI linearised pTol2DctCFP were used in a ligation.  11 of the resulting colonies 
were picked, 10 of which could be digested with EcoRV and ClaI and so contained 
the Spacer.  Three of these colonies also produced products using the Spacer and BS1 
primers in a PCR and so must contain the Spacer in the correct orientation (Figure 
4.10).  One of these was chosen and the plasmid named pTol2DctCFP+spacer.
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Figure 4.10 Correct insertion of spacer
A. EcoRV and ClaI will only cut in the spacer, thus linearising the plasmid.  To 
determine whether any contained the spacer, 11 colonies were miniprepped and 
digested with these enzymes.  Samples 1, 2 and 9 are shown here as examples.  All 
samples except sample 9 were linearised with both EcoRV and ClaI showing that all 
except 9 contained the spacer.
B. To determine the orientation of the spacer a PCR was carried out on diluted 
miniprepped DNA from samples 1-8, 10 and 11 using spacerprimer and BS1.  Samples 
2, 4 and 10 gave products (*) indicating that they have the spacer inserted in the correct 





























































pTol2DctCFP+spacer was linearised with KasI, Phenol Chloroform extracted and cut 
again with XhoI (Figure 4.05 E).  The cut plasmid was cleaned by Phenol Chloroform 
extraction and a ligation set up with 2 μl pTol2DctCFP+spacer and 6 μl sox10 insert.  Of 
57 colonies analysed by PCR using S21/S22 primers for the sox10 insert (see Appendix 
for sequences) none gave a band of the correct size but four generated a product of the 
incorrect size.  MluI and NdeI would both be expected to linearise the plasmid if the 
sox10 gene is present correctly in the construct.  DNA from the four colonies which 
gave incorrect products from the PCR with S21/S22 primers did not cut as expected 
with MluI and NdeI.    Two samples were cut by neither enzyme and the other two 
cut with only one enzyme.  So we suspected that there may be contamination of our 
sox10 fragment with other fragments of DNA which appeared to be incorporating into 
our construct instead of the sox10 DNA.  Further, careful analysis of p7.2GFPsox10 
digested with KasI in larger quantities than had been examined before revealed faint 
bands of unexpected sizes which had not been noticed before (data not shown).  This 
confirmed our idea that contamination of the sox10 insert had occurred.  These bands 
were not seen when the plasmid was digested with SfoI.  It is likely that this is because 
SfoI is methylation sensitive and the sites where KasI cuts unexpectedly to give 
unexpected bands are methylated so that SfoI does not cut there but only at the site at 
the 3’ end of the sox10 gene.  We decided to isolate more sox10 DNA using SfoI and 
XhoI instead of KasI and XhoI.  A small quantity of the insert was used in a PCR with 
S21/S22 primers to confirm that sox10 was definitely present.  A ligation was set up 
using this DNA and pTol2DctCFP+spacer that had also been cut with SfoI and XhoI. 
Of 12 colonies picked and miniprepped, one gave a band of expected size when used in 
a PCR with S21/S22 primers for the sox10 gene (Figure 4.11).  Subsequent restriction 
digest analysis was performed to confirm that this plasmid contained the sox10 insert 
(data not shown).  Digestion with XhoI and SfoI removed the sox10 fragment again. 
NheI linearised the plasmid, as expected since sox10 contains an NheI recognition site 
but no other components of the construct did.  SalI and AgeI digests also produced bands 
of expected sizes consistent with the idea that we had incorporated the sox10 gene into 
our construct.  Primers BS1, S22, S19 and seqCFP were used as sequencing primers to 
verify the whole sequence between the beginning of the CFP sequence and the end of 
the sox10 sequence (Figure 4.12).  We named the plasmid pTol2DctCFPsox10 (Figure 
4.13).  The same sequencing data enabled us to confirm that the junctions of the sox10 
sequence with the other cloned components were correct.  Particularly important was 
that the sox10 sequence was in frame with the CFP sequence to produce a single fused 




6 7 8 9 10 11 12
Figure 4.11 Correct insertion of sox10 into pTol2DctCFP to create 
pTol2DctCFPsox10
DNA from colony number 6 generates a band of expected size (compare to 
p7.2GFPsox10 plasmid marker/control) when used in a PCR with primers S21 and 
S22 suggesting sox10 has inserted to the plasmid in this colony.  Later data using 
restriction enzyme digestion supports this (data not shown). 
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             M  V  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G  D  V  N  
ccggtcgccaccatggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaac
 G  H  K  F  S  V  S  G  E  G  E  G  D  A  T  Y  G  K  L  T  L  K  F  I  C  T  T  G  
ggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggc
 K  L  P  V  P  W  P  T  L  V  T  T  L  T  W  G  V  Q  C  F  S  R  Y  P  D  H  M  K  
aagctgcccgtgccctggcccaccctcgtgaccaccctgacctggggcgtgcagtgcttcagccgctaccccgaccacatgaag
 Q  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  F  F  K  D  D  G  N  Y  K  
cagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaag
 T  R  A  E  V  K  F  E  G  D  T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  
acccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaac
 I  L  G  H  K  L  E  Y  N  Y  I  S  H  N  V  Y  I  T  A  D  K  Q  K  N  G  I  K  A
atcctggggcacaagctggagtacaactacatcagccacaacgtctatatcaccgccgacaagcagaagaacggcatcaaggcc
 N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  
aacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggc
 P  V  L  L  P  D  N  H  Y  L  S  T  Q  S  A  L  S  K  D  P  N  E  K  R  D  H  M  V  
cccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtc
 L  L  E  F  V  T  A  A  G  I  T  L  G  M  D  E  L  Y  K  S  G  L  E  M  S  A  E  E  
ctgctggagttcgtgaccgccgccgggatcactctcggcatggacgagctgtacaagtccggactcgagatgtcggcggaggag
 H  S  M  S  E  V  E  M  S  P  G  V  S  D  D  G  H  S  M  S  P  G  H  S  S  G  A  P  
cacagcatgtcggaggtggaaatgagtcccggggtgtcggacgatgggcactccatgtcccctggtcactcgtcgggcgctccc
 G  G  A  D  S  P  L  P  G  Q  Q  S  Q  M  S  G  I  G  D  D  G  A  G  V  S  G  G  V  
ggtggcgcggactcccctctgcccggtcagcagtctcagatgtccgggatcggggatgatggagccggtgtctccggcggggtc
 S  V  K  S  D  E  E  D  D  R  F  P  I  G  I  R  E  A  V  S  Q  V  L  N  G  Y  D  W  
tcggtgaagtccgacgaggaagatgaccggttccccatcggcatccgcgaggcggtcagtcaggtgctgaacgggtacgactgg
 T  L  V  P  M  P  V  R  V  N  S  G  S  K  S  K  P  H  V  K  R  P  M  N  A  F  M  V  
acgctcgtgcccatgcccgtgcgcgtgaactcgggcagcaagagcaaaccgcacgtcaagcggccgatgaacgcgttcatggtg
 W  A  Q  A  A  R  R  K  L  A  D  Q  Y  P  H  L  H  N  A  E  L  S  K  T  L  G  K  L  
tgggcgcaggccgcgcgcaggaaactggcggatcaatatccgcacctgcacaacgccgagctcagcaaaacactggggaagctg
 W  R  L  L  N  E  T  D  K  R  P  F  I  E  E  A  E  R  L  R  K  Q  H  K  K  D  Y  P  
tggagactgctgaacgagacggataagcggccgtttatcgaggaggccgagcgcttgaggaagcagcataagaaagattatccc
 E  Y  K  Y  Q  P  R  R  R  K  N  G  K  P  G  S  S  S  E  A  D  A  H  S  E  G  E  V  
gagtacaagtaccagccacgtcgacgcaagaacggcaaaccgggttccagctcagaggccgacgcccactctgagggtgaggtc
 S  H  S  Q  S  H  Y  K  S  L  H  L  E  V  A  H  G  G  A  A  G  S  P  L  G  D  G  H  
agccacagccaatcgcattacaagagcctgcacctggaggtggcgcacggcggggctgcagggtcaccattgggtgatggacac
 H  P  H  A  T  G  Q  S  H  S  P  P  T  P  P  T  T  P  K  T  E  L  Q  G  G  K  S  G  
caccctcacgctacaggtcagagtcacagccctccaacgccccctaccacccccaagacggaactgcagggaggaaaatcaggc
 E  G  K  R  E  G  G  A  S  R  S  G  L  G  V  G  A  D  G  S  S  A  S  S  S  A  S  G  
gagggcaagcgtgagggcggagcctctcggagtggactgggggtgggagcagatggaagctccgcctcatcgtctgccagcggg
 K  P  H  I  D  F  G  N  V  D  I  G  E  I  S  H  D  V  M  A  N  M  E  P  F  D  V  N  
aaaccgcacatcgacttcggtaacgtggacattggcgaaatcagccatgacgtgatggccaacatggagccgttcgacgtgaac
 E  F  D  Q  Y  L  P  P  N  G  H  P  Q  A  S  A  T  A  S  A  G  S  A  A  P  S  Y  T  
gagttcgaccagtatctcccacccaatggccacccgcaggcgtccgccactgccagcgcaggatctgcagcgccatcgtataca
 Y  G  I  S  S  A  L  A  A  A  S  G  H  S  T  A  W  L  S  K  Q  Q  L  P  S  Q  Q  H  
tacggcatctccagcgcgctagcggccgctagtggccactccaccgcatggctgtccaagcagcaactgccgtcccagcagcat
 L  G  A  D  G  G  K  T  Q  I  K  S  E  T  H  F  P  G  D  T  A  A  S  G  S  H  V  T  
ttgggcgcagatggcgggaaaacgcagataaagagtgaaacacacttccctggggatacagcggcgagcggttcacacgtcaca
 Y  T  P  L  T  L  P  H  Y  S  S  A  F  P  S  L  A  S  R  A  Q  F  A  E  Y  A  E  H  
tacacgccgctaacactgccgcactacagctccgccttcccctcgctggcgtcccgcgcacaattcgccgaatacgccgagcac
 Q  A  S  G  S  Y  Y  A  H  S  S  Q  T  S  G  L  Y  S  A  F  S  Y  M  G  P  S  Q  R  
caggcctcgggatcctactacgcccactccagccagacctcaggcctctactccgccttctcctacatgggcccctcacagcgg
 P  L  Y  T  A  I  P  D  P  G  S  V  P  Q  S  H  S  P  T  H  W  E  Q  P  V  Y  T  T  
cccctgtacaccgccattccggatccgggatccgtgccgcagtcacacagccctacgcattgggagcagcccgtatacaccaca





Figure 4.12 Correct insertion of sox10 into pTol2DctCFP to create 
pTol2DctCFPsox10
Complete sequence, with translation above, between the start of the CFP sequence and 
the end of the sox10 fragment.  Junctions between sox10 and the other components of 
the plasmid have been sequenced and verified using primers S22, BS1, seqCFP and 
S19.  Purple - ECFP fragment from ECFP plasmid, AgeI-BspEI, Bright blue - ECFP-
sox10 ATG, Green - BspEI site used to clone ECFP into, Red - XhoI site used to clone 
sox10 into, Orange - Sox10 ATG, Dark blue - Sox10 coding sequence, Green - ECFP-
sox10 STOP codon, Black - CS2 sequence from end of sox10 to SfoI.
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Figure 4.13 pTol2DctCFP and pTol2DctCFPsox10
A. Diagram of final pTol2DctCFP plasmid.  Indicated are the restriction sites used for 
cloning.
B. Diagram of final pTol2DctCFPsox10 plasmid.  Indicated are the restriction sites 
uesd for cloning and the primer binding sites for the primers used either during cloning 
or sequencing of the the final plasmid.  TYR1 is at 5437, seqCFP at 10080, S19 at 














































4.2.3i Testing Functionality of CFP-sox10
Prior to generating germline transgenics we had to test whether the Sox10 protein 
would still function when fused to CFP.  We did not anticipate that the CFP would have 
any effect upon the functionality of Sox10 since previous transgenics in the lab had 
placed GFP upstream of sox10 whilst retaining Sox10 function (J. Dutton, personal 
communication).  However, it was still necessary to test our construct to confirm 
this.  Previously, pigment cells in a sox10 mutant have been rescued by injection of 
a plasmid containing sox10 into one cell stage embryos (Dutton et al. 2001).  In this 
case sox10 was under the control of a heatshock promoter which was used to drive 
Sox10 expression at 10-12 hpf and 22-24 hpf to rescue melanophores.  To test our 
constructs we performed a modified version of this experiment.  We injected either 
pTol2DctCFPsox10 or pTol2DctCFP (as a control) at concentrations of 25ng/µl, 
together with transposase RNA at 25ng/µl, into one cell stage embryos from an incross 
of adults heterozygous for sox10t3 and looked for rescue of pigment cells.
Embryos were injected and grown to 27 hpf.  To confirm that the constructs were 
working successfully we checked that at least some embryos from each batch were 
expressing CFP at this stage.  However, we grew and scored all fish, whether positive 
for CFP or not.  This ensured that we did not miss embryos which might still go 
on to have rescued cells but which might be expressing CFP at lower levels or at 
a later stage than we screened them.  All the embryos were grown to 72 hpf when 
the mutants could easily be selected by their severe reduction in pigment cells.  Any 
escaper/rescued pigment cells were then scored.  We expected that we might see rescue 
of any or all pigment cells so we looked for xanthophore and iridophore rescue as well 
as melanophore rescue.
sox10t3 embryos lack properly formed neural crest-derived melanophores altogether 
and have only small, punctuate residual melanised cells by 72 hpf.  We therefore knew 
that any melanophores we saw at this stage that were not small and punctuate could be 
described as rescued cells.  Out of 221 mutant fish injected with the control plasmid 
pTol2DctCFP no fish showed any melanophores or melanophore-like cells.  Out of 
273 mutant fish injected with pTol2DctCFPsox10 three fish had a single melanophore 
and one had two (Figure 4.14).  As we demonstrated in Chapter 3, dct is expressed 
in the neural crest of these mutants, but only in a limited number of cells and at very 
low levels.  Since our construct uses a Dct promoter to drive expression of CFP-
sox10 we expected that only very few cells will express CFP-Sox10 and so only a 
few cells will be rescued.  This is in contrast to the experiments from Dutton et al. 






















































































































































































































































and so the potential to rescue cells is greater.  We considered the melanophores seen in 
fish injected with pTol2DctCFPsox10 to be cells rescued as a result of expression of 
CFP-Sox10 in these cells.
Xanthophores are not present in 72 hpf sox10t3 fish.  Some xanthophores do form 
earlier in development but they have abnormal morphology and by 35-45 hpf they 
have died (Dutton et al. 2001).  Since xanthophores also stain blue with methylene blue 
(Le Guyader and Jesuthasan 2002), we looked for blue/green cells of an appropriate 
morphology and location to be xanthophores.  Again, out of 221 mutant fish injected 
with pTol2DctCFP none had any visible xanthophores.  Out of 273 mutant fish injected 
with pTol2DctCFPsox10, one had a single fully developed xanthophore (Figure 4.14). 
We also saw xanthophores in two other embryos (one and two cells respectively) during 
our preliminary experiments.  Again, despite the small sample size, in the absence of 
any xanthophores in the control embryos and due to the limitations of the experiment 
discussed above we consider these to be rescued cells.
The case for iridophores is more complex.  Even untreated sox10t3 fish have some 
escaper iridophores (Kelsh and Eisen 2000) so instead of looking for any rescued cells 
at all we were in fact looking for an increase in iridophores over and above the normal 
escaper cells.  Iridophores were counted in each fish, whether they were injected with 
pTol2DctCFP or pTol2DctCFPsox10.  The data did not show a normal distribution so 
they were analysed using a Mann Witney U test to compare the medians of the two sets 
of data.  This test showed that the medians of the two data sets differed significantly 
with p<0.0001.  Returning to look at the actual data, it is possible to see that there is a 
decreased proportion of fish in the experimental group that have no iridophores at all. 
There is an increased number of fish in experimental group as compared to the control 
group which have one, two or three or more iridophores (Table 4.02).  We interpret this 
as showing that our experimental plasmid has the effect of altering the median number 
of iridophores compared to the control plasmid and that this is as a result of increasing 
the number of escaper iridophores in sox10t3 embryos; in short, that pTol2DctCFsox10 
can rescue iridophores in sox10t3 embryos.
Therefore, we were satisfied that we had shown rescue of all pigment cell types in 
sox10t3 fish by injecting them with pTol2DctCFPsox10.  This indicated to us that our 
CFP-Sox10 fusion would be likely to function in our germline transgenics.
4.2.3ii Generating Tg(Dct;CFP) and Tg(Dct;CFP-sox10)
Having established that our pTol2DctCFPsox10 plasmid produced a CFP-Sox10 fusion 


















































































































































































































































































































































plasmid caused cells to make functional CFP protein) we continued to generate germline 
transgenics.  For a schematic of how this was achieved see Figure 4.15.  To generate 
transgenic lines each plasmid was injected into eggs at the one cell stage together 
with transposase RNA at 25ng/µl. pTol2DctCFP was injected at a concentration of 
50ng/µl, pTol2DctCFPsox10 at 25ng/µl.  These fish were screened at approximately 
27 hpf for expression of CFP.  Those showing CFP expression were selected and 
grown to adulthood; we reasoned that embryos expressing CFP at levels high enough 
to observe may be more likely to have incorporated the transgene into their genome 
and may be more likely to show germline transmission than those that did not show 
CFP expression.  Similarly, it should be noted that to maximise the likelihood of the 
transgene integrating into the genome it is desirable to ensure that there is a high death 
rate among injected embryos, since if DNA is injected at the maximum concentration 
that the embryos can tolerate it maximises the chances of transgene incorporation 
into the genome.  Amongst approximately 4500 fish injected with pTol2DctCFP, 
we observed a death rate of 65.2 %.  Of the fish that survived, 21 % showed CFP 
expression and were grown to adulthood.  93 fish, named Tg(Dct;CFP), survived to 
adulthood.  Amongst approximately 3500 fish injected with pTol2DctCFPsox10, we 
observed a death rate of 37.7 %.  12.8 % of surviving fish showed CFP expression 
and were grown to adulthood.   Approximately 45 fish, named Tg(Dct;CFP-sox10), 
survived to adulthood.  These potential founder fish were then screened to determine 
whether or not they were able to transmit the transgene through their germline.  Fish 
were incrossed initially to quickly screen as many fish as possible.  At least 50 embryos 
from each of these initial crosses were observed at approximately 27 hpf.  It has been 
found that when using the Tol2 system 27 – 100 % of F1 embryos are positive for the 
transgene in question (Kawakami et al. 2004).  If this is the case in our experiment then 
a founder should not transmit at such a low rate that we will miss it in our screening.  If 
none of the F1 embryos scored had any CFP expression the parents were deemed not to 
be transmitting through their germline and were euthanised.  If, however, some of the 
embryos did display CFP expression we knew that either or both of the parents were 
able to transmit the transgene through their germline.  These fish were then outcrossed 
to wild type fish to find which parent was transmitting the transgene.  Again, any fish 
that didn’t transmit the transgene were euthanised.  Once a fish had been identified 
as transmitting through the germline it was placed in a separate tank and given an 
ID, a name beginning with ‘C’ for Tg(Dct;CFP) founders and a name beginning with 
‘S’ for Tg(Dct;CFP-sox10) founders, e.g. ‘Charlie’ or ‘Sam’.  In this way, all of the 
Tg(Dct;CFP) fish and approximately 32 of the Tg(Dct;CFP-sox10) fish were screened. 
14 Tg(Dct;CFP) founder fish and 14 Tg(Dct;CFP-sox10) founder fish were identified. 
We aimed to collect 100 CFP positive progeny from each founder fish (outcrossed to 




at one cell stage
Sort at 27 hpf
CFP negative - euthenise
CFP positive- grow to adulthood
All progeny CFP negative - euthenise parentsSome progeny CFP positive - cross to 
wildtype to identify which is the founder
All progeny CFP negative - 
not a founder so euthenise
Some progeny CFP positive - give 
founder ID and collect CFP positive 
progeny to form F1 generation
F1 generation - all heterozygous for transgene
Cross F1 sh to generate embryos 
to use to characterise phenotype
Founder? Founder?Wild type Wild type
Figure 4.15 Generating transgenics
Embryos are first injected at the one cell stage with our constructs, together with 
transposase RNA.  The embryos and their progeny then undergo a series of selection 
procedures to find those that are CFP positive and then those that are able to transmit 




11 Tg(Dct;CFP-sox10) lines).  These fish should all be heterozygous for the transgene 
and were grown to adulthood for use in further experiments.
4.2.4 Characterisation of Tg(Dct;CFP)
Prior to choosing which lines to maintain and use for further experiments we performed 
a quick screen for CFP expression in each line.  Embryos were scored at 27 hpf and 
48 hpf under a Nikon Eclipse 300.  This allowed us to ensure that the expression 
patterns were as we expected and to note any ectopic expression.  For these initial 
observations F1 lines were incrossed and their embryos observed at 27 hpf and 48 hpf. 
This also checks for any recessive effects of the transgene.  We did not notice any 
recessive effects of our transgene, for example death rates and rates of malformation 
did not appear increased.
Although the levels of CFP expression were variable between lines, Tg(Dct;CFP) 
lines generally had fairly weak CFP expression.  It was useful that we had performed 
incrosses of probable heterozygotes and therefore noticeably brighter individuals were 
present, which we assumed to be homozygous carriers of the transgene, that were 
easier to observe.  It did however, mean that where we were forced to outcross the 
F1 fish (due to unfavourable sex ratios in particular lines) expression was invariably 
even weaker.  These lines were more difficult to analyse.  Of four lines which were 
outcrossed no CFP expression was seen at any stage in two, and only at 27 hpf in the 
remaining two.  It may be that this apparent loss of transgene expression was in fact due 
to human error in the process of sorting these embryos.  Alternatively it may represent 
a real lack of expression at one or both stages in these lines or that it is too weak and 
we simply cannot detect it (since we are only observing heterozygotes).  Of the lines 
which we were able to incross all had broadly the same expression pattern.  A summary 
of the expression patterns seen is in Table 4.03.  At 27 hpf, expression was seen in the 
PRE of the eye, in cells in a premigratory neural crest position and in neural crest cells 
migrating on the medial and lateral pathways, as well as in pigmented melanophores. 
However, some pigmented melanophores at this stage did not express CFP (Figure 
4.16).  It was also noted that several lines appear to have stronger CFP expression more 
posteriorly, i.e. in younger crest cells and less CFP expression in migrating/older crest. 
These observations suggest that expression from the promoter is strongest at earlier 
stages and that it may be downregulated at later stages.  Some ectopic expression was 
also seen at this stage.  Two lines had CFP expression in the CNS together with cells 
expressing CFP in a melanoblasts/melanophore pattern (Cuthbert and Clint).  One 
line, Chris, did not have CFP expression in melanophores but instead had expression 
in xanthophores as identified by their characteristic spindly shape and by their location 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.17 Examples of ectopic CFP expression seen in Tg(Dct;CFP) lines
A and B. CFP expression in cells on the lateral migration pathway of F2 Chris 
embryos at 27 hpf and 48 hpf respectively.  CFP expression was only seen in cells in 
a premigratory postion and on the lateral pathway (not on the medial pathway). This, 
along with the charcteristic spindly morphology of the cells, suggests that they are 
xanthophores.
C. CFP expression in dorsal cells of the spinal cord of an F2 Clint embryo at 27 hpf. 
Cells are present through the whole spinal cord from left to right.  Anterior to left, 
posterior to right, dorsal top, ventral bottom.  Dorsal edge of embryo can just be seen 




When examined at 48 hpf embryos were treated with PTU from 24 hpf to prevent 
melanin from blocking the fluorescence.  Most of the Tg(Dct;CFP) lines had CFP 
expression in cells of a position and morphology consistent with their being 
melanophores.  The exceptions were the two outcrossed lines which had had expression 
of CFP at 27 hpf but no longer had visible CFP at 48 hpf.  Expression at 48 hpf was 
generally even weaker than at 27 hpf supporting the suggestion that our transgene may 
be being turned off by this stage.  Cells could be seen in the eye, dorsal and ventral 
stripes and more importantly in the lateral stripe.  This latter fact, together with the 
morphology of the cells, was particularly important to differentiate the cells from auto-
fluorescent iridophores, which are not present in the lateral stripe.  There were cells 
observed in all of the stripes which were only fluorescent using the CFP filter and not 
any of the other filters (i.e. the cells were not auto-fluorescent and so not iridophores/
xanthophores).  In addition, the cells did not photobleach after prolonged UV exposure 
(as autofluorescence from xanthophores would).  The ectopic expression seen in some 
of the lines at 27 hpf persisted to 48 hpf with the addition of heart expression in some 
Clive embryos.  This heart expression was not always present in embryos which had 
CFP expression in melanophores.
CFP expression was also observed in all of the Tg(Dct;CFP) lines at earlier stages; 
20 hpf and 24 hpf.  At 20 hpf CFP was present in the developing eye only.  By 24 hpf 
it was also seen in neural crest-like cells in the anterior trunk.  Their position and 
morphology was characteristic of early migrating neural crest cells as can be identified 
by ISH for dct.  Whilst this pattern of expression mimics that of dct when it is first 
switched on, the timing is delayed by approximately 5 hours (Kelsh, Schmid and 
Eisen 2000).
By judging the lines for brightness of CFP expression, how faithfully the dct expression 
pattern was recapitulated and the number of fish in the F1 generation, we selected three 
Tg(Dct;CFP) lines to continue to work with – Charlie, Cuthbert and Cameron.
4.2.5 Characterisation of Tg(Dct;CFP-sox10)
No obvious melanophore phenotype had been noted in any of the Tg(Dct;CFP-sox10) 
lines examined, i.e. there was no dramatic loss of melanophores or striking delay 
in their differentiation.  In addition, a brief exploration of melanophore number at 
30 hpf and at 46 hpf revealed no significant difference between the mean number 
of melanophores in three Tg(Dct;CFP) lines and three Tg(Dct;CFP-sox10) lines at 
these stages (data not shown).  We examined F2 embryos from eight out of eleven 
Tg(Dct;CFP-sox10) lines and found that none of those examined showed any CFP 
expression at all at any stage.  We did not examine the three remaining lines due 
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to difficulties in obtaining F2 embryos from them.  We hypothesised that a lack of 
functional CFP-Sox10 fusion protein would explain a lack of melanophore phenotype 
in these embryos.  Since we could not find any CFP expression in our Tg(Dct;CFP-
sox10) lines we needed to investigate by other means the functionality of the Dct;CFP-
sox10 transgene.  The first possibility to test was that the transgene was not being 
transcribed and so could not be translated into protein.  We generated an ISH probe for 
CFP which we used on F2 embryos from Tg(Dct;CFP-sox10) and Tg(Dct;CFP) lines 
at different stages to look for transgene transcript. The second possibility was that the 
transgene had been removed from the genome or that the sequence had been disrupted. 
We looked to confirm that our F1 generation fish were carriers of the transgene by 
genotyping F1 fish from the Sam, Sebastian and Simon lines and to confirm that the 
transgene persisted in the F2 generation by also genotyping F2 embryos.
4.2.5i Detection of CFP RNA by In Situ Hybridisation
We generated a plasmid containing ECFP to make a CFP ISH probe.  This allowed us 
to look at CFP expression at the RNA level.  Comparing the pattern of CFP expression 
to that of dct in Tg(Dct;CFP) embryos, we can see that this pattern is generally 
consistent with CFP being expressed, as expected, in cells which express dct in this 
line (Figure 4.18).  However, CFP appears to be expressed in younger, more posterior, 
cells than dct at 24 hpf.  The expression patterns observed in different embryos varied 
but CFP did seem to be expressed more weakly than dct, particularly in older cells at 
33 hpf suggesting that it is being switched off at this time.  This is consistent with our 
observations of CFP protein in live embryos.
We looked for CFP expression in our Tg(Dct;CFP-sox10) lines.  Charlie was used as 
a control line to compare against Sam, Sebastian and Simon.  F2 embryos from each 
of these lines were fixed at 24 hpf, 48 hpf and 72 hpf with an additional timepoint 
at 34 hpf for the Tg(Dct;CFP-sox10) lines.  CFP expression was seen at 24 hpf and 
48 hpf in F2 Charlie embryos in a pattern resembling that seen for CFP protein in 
this line.  At 24 hpf CFP positive cells could be seen both in a premigratory position 
and in migrating cells on the medial and lateral pathways.  At 48 hpf CFP could be 
seen in a pattern resembling that of melanophores at this stage, in dorsal, lateral and 
ventral stripes (Figure 4.19).  At both stages CFP expression could also be seen in 
the eye (data not shown).  By 72 hpf CFP expression was no longer detectable in 
Tg(Dct;CFP) embryos.  However, no detectable expression of CFP was seen at any 
stage in any of the Tg(Dct;CFP-sox10) lines (Figure 4.19).  We concluded that our 
transgene transcript is not transcribed or maintained at levels detectable by in situ 
hybridisation in Tg(Dct;CFP-sox10) F2 embryos.  It is likely that this explains the lack 



























































































































































































































































































































































































































































































































































































4.2.5ii Genotyping of F1 Parents and F2 Progeny
Another hypothesis to explain the lack of transgene transcript is that our transgene 
was lost from or disrupted in the genome of F1 fish.  We now tested whether our F1 
Tg(Dct;CFP-sox10) fish had our transgene incorporated into their genomes.  Primers 
were designed that would amplify a 142 bp fragment of CFP (see Appendix for 
sequences).  Fin clips were taken from each of the fish of the F1 generation of Sam, 
Sebastian and Simon plus five fish from the F1 generation of Charlie as a positive control. 
Genomic DNA was extracted from these samples and used in PCR.  Initial experiments 
looking at the first five fish from each line revealed that our primers produced three 
different sized bands (including a 140 bp band) in different fish and some fish showed 
no amplification at all (see Figure 4.20 A).  We cloned each of these bands to identify 
what we had amplified.  The 142 bp band proved to be the CFP sequence that we were 
expecting.  The two larger bands contained sequence from the pT2KXIG Tol2 plasmid 
into which our original construct had been built which had been amplified due to weak 
sequence similarities with our primers.  Why plasmid sequence was incorporated into 
the genome instead of or as well as our transgene is unclear.
At least one fish from the Sebastian line had the appropriate 142 bp CFP band (Figure 
4.20 A).  We wanted to identify this fish and determine whether it was able to transmit 
the transgene to the F2 generation.  If it was not able to do this then this would explain 
why we do not see detectable transgene expression in the F2 generation.  We went 
back to the F1 Sebastian generation and reclipped each fish, this time keeping each fish 
separately.  We genotyped these samples and found that again there was the same variety 
of PCR product sizes (Figure 4.20 B).  Some fish did not produce any product, either 
because they were not transgenic or because the PCR did not work on these samples. 
As is visible in Figure 4.20, two of the three wild type negative controls had very faint 
bands which we believe to be contamination of the DNA from repeated use.  Our water 
control was negative however so we selected the eight fish with the strongest bands in 
the 142 bp position for further experiments.  We incrossed one female with two males 
and outcrossed the remaining fish with wild types.  Of the four clutches produced 
(including one from the incross) no embryos had visible CFP expression between 
24 hpf and 30 hpf.  We genotyped 24 embryos from three clutches (not including 
the incross) and found that many of the embryos did contain our transgene as well as 
bands representing vector insertions (Figure 4.20 C and D).  Interestingly, the ratios for 
each mating did not appear to conform to Mendelian ratios expected from a mating of 
heterozygous fish and the banding patterns were often variable within a clutch.
Thus, we have established that our F1 generation transgenics are transgenic and that the 
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Figure 4.20 F1 and F2 Tg(Dct;CFP-sox10) fish have the transgene
A. Five F1 fish from Sam, Simon and Sebastian were genotyped using primers for CFP. 
Four from Sam and Sebastian are shown here.  One fish has a band in the appropriate 
place for the CFP product, 142 bp.  Others had additional bands which were cloned 
for analysis.
B. All 19 F1 Sebastians were genotyped.  Several had the correct band whilst others 
also had one or two larger bands one of which is similar to that in A (*).
C. F2 embryos from an incross of fish 1, 5 and 6 from B.  All but two (*) out of 24 had 
the 142 bp band.
D. F2 embryos from an outcross of fish 19 from B.  2-8 negative, 1, 9-11, 14, 17, 19 and 




is not detectable in these fish.  This explains the lack of any obvious melanophore 
phenotype in our Tg(Dct;CFP-sox10) lines and makes it unlikely that there will be a 
more subtle phenotype.
4.3 Discussion
4.3.1 Sox10 is Downregulated in Differentiating Melanophores
In Chapter 3 we demonstrated that in the absence of functional Sox10, melanophore 
differentiation genes are derepressed.  This implies that in normal development Sox10 
acts to inhibit melanophore differentiation by repressing these same genes.  If this is the 
case then Sox10 would eventually have to be downregulated in melanophores to allow 
them to differentiate.  Thus, we looked at the expression both of Sox10 protein and 
sox10 mRNA in melanophores as they pigment.  If Sox10 is able to inhibit melanophore 
differentiation as we predict then it should not be expressed in differentiating cells.  We 
found that Sox10 and sox10 are both expressed in pigmenting cells but that they are 
downregulated over time.  This provides further data in support of our model for the 
role of Sox10 in melanophore development.
It is interesting to note that Sox10 and sox10 are still expressed in some pigmented 
cells; if Sox10 strictly inhibits differentiation then it might not be expected to be present 
in differentiating cells.  However, Kim et al. (2003) report that levels of Sox10 are 
important in its various roles in sympathetic neuron differentiation so that whilst only 
comparatively low levels of Sox10 expression are sufficient for activation of Mash1 
and Phox2b (these genes are still expressed in heterozygous Sox10 mutants), much 
higher levels are required to inhibit expression of Phox2a (expression of this gene 
is derepressed even in heterozygous Sox10 mutants).  Similarly, it may be the case 
in melanophores that only low levels of Sox10 are required for mitfa expression but 
higher levels are required to inhibit expression of melanophore differentiation genes. 
Thus, Sox10 could still be expressed in pigmenting cells but at levels not high enough 
to inhibit differentiation.
Our results demonstrating downregulation of sox10 show a gradual loss of the mRNA 
from pigmented melanophores after 30 hpf.  There is a possibility that the loss of 
Sox10 and sox10 expression that we observe over time is due to the increasing amounts 
of melanin obscuring any signal that is present.  We feel that this is unlikely as we 
observed two cells within one embryo which were pigmented to the same extent, one 
of which was Sox10 positive and one Sox10 negative thus confirming the presence of 
Sox10 negative melanophores (Figure 4.01).  In addition, our results were consistent 
with previous work by Dutton et al. (2001) and Carney (2003).  Dutton et al. (2001) 
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comment that at 36 hpf they are still able to see pigmented cells in the dorsal stripe 
expressing sox10 whilst melanophores on the yolk are sox10 negative.  Dutton et al. 
(2001) also report a loss of sox10 positive cells from the lateral pathway at 24 hpf 
and 30 hpf, timepoints where we have identified no sox10 negative melanophores. 
However, they refer only to cells on the lateral pathway, whereas we have looked 
at premigratory cells and cells on the medial and lateral pathways.  This suggests 
that there may be differences between different migratory populations that we would 
not have picked up.  There may also be differences between our technique and that 
used in Dutton et al. (2001) which could explain the different results by, for example, 
giving increased sensitivity in our experiments so that we could identify cells that 
were expressing sox10 even very weakly.  It might be of interest in further experiments 
to score each melanophore according to its position as well as whether or not it is 
expressing Sox10 or sox10 to enable us to make more detailed comments about 
different migratory populations of melanophores and the timing of loss of Sox10 or 
sox10 from these cells.
Our data also support and extend previous work by Carney (2003) where a loss of 
GFP from pigmenting cells was observed in a transgenic line expressing GFP under 
the control of 4.9 kb of the sox10 promoter.  A rapid loss of GFP from melanophores is 
reported in these embryos but Carney (2003) reports that GFP is still present in a few 
melanophores at 4 dfp when we now know from our own work that Sox10 expression 
is lost by 54 hpf.  We know that GFP shows good perdurance (Carney 2003) which may 
partly explain these differences.  The dynamics of loss of Sox10 and GFP also differ in 
that our Sox10 graph follows a sigmoid curve but the GFP data followed an exponential 
decay curve.  The difference between these data probably represents differences in the 
way that GFP and Sox10 proteins are turned over in the cell.  Exponential decay, as for 
GFP, is consistent with loss of protein by simple degradation over time (Carney 2003). 
A sigmoid curve, as for Sox10, might suggest a more controlled degradation of the 
protein.  We know that Sox10 can be SUMOylated (Girard and Goossens 2006) and 
we know that SUMOylation protects a protein from being ubiquitinated and marked 
for degradation (Hay 2005).  This might be one means by which the stability of Sox10 
and its rate of degradation could be controlled in the cell.  The rate of loss of sox10 
mRNA is different again, the relationship between proportion of sox10 positive cells 
and time being a linear one.  This may reflect differences between turnover of mRNA 
and protein.  It appears that in this case sox10 mRNA is turned over more rapidly than 
the protein and protein levels only start to decrease once mRNA levels have dropped. 
We know that Sox10 protein in mouse cell culture can be shuttled between the nucleus 
and the cytoplasm (Rehberg et al. 2002).  This could be a mechanism to allow for a 
slower initial rate of degradation of Sox10 compared to sox10 since the protein does not 
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need to be degraded to be rendered non-functional.  However, we found no evidence 
for cytoplasmic localisation of Sox10 in our own studies where, at the scale we could 
observe, localisation appeared to be nuclear.
In mouse, Sox10 expression is not downregulated but persists in neural crest cells as they 
migrate away from the neural tube and home to the skin (Osawa et al. 2005). There are 
several subsets of melanoblasts in mouse skin/hair follicles and these behave differently 
with respect to their expression of Sox10.  Sox10 is expressed in all melanoblasts at 
embryonic stages.  However, from postnatal day 2 Sox10 expression begins to be lost 
from melanoblasts as they become melanocyte stem cells.  This seems to be important 
for the cells to maintain a stem cell fate.  Other melanoblast/melanocyte populations 
maintain Sox10 expression at the same stage (Osawa et al. 2005).  It is not clear what 
happens to Sox10 expression in these cells at later stages and late differentiation of 
mouse melanocytes as compared to zebrafish could mean that these later stages are 
more comparable to our studies.  Results from Osawa et al. (2005) were obtained 
using a combination of in situ hybridisation, immunohistochemistry and single cell 
PCR from skin sections to describe the gene expression profiles of melanoblasts. 
However, the work is not exhaustive and it is particularly important to note that mice 
were not scored for Sox10 expression between E18.5 and P2 which leaves a gap in the 
data set of approximately five days.  Other evidence from mouse melanoma cell lines 
also suggests that differentiated melanocytes still express Sox10, although of course 
these cells are by no means comparable to ‘normal’ melanocytes in vivo (Southard-
Smith, Kos and Pavan 1998).  Thus, in mouse it seems that Sox10 may be required in 
melanocytes as they differentiate and needs to be turned off in melanocyte stem cells. 
By contrast, we see Sox10 downregulation in cells as they differentiate and we have 
evidence that Sox10 promotes a stem cell-like state by inhibiting differentiation in 
zebrafish melanoblasts.  This highlights the apparent differences between mouse and 
zebrafish, as discussed by Hou, Arnheiter and Pavan (2006), in the role of Sox10 in 
melanoblasts, melanocytes and melanophores.  However, there is further evidence from 
cultured human melanocytes showing that, as in zebrafish, Sox10 is downregulated in 
these cells as they differentiate (Cook et al. 2005).  Further careful and directed study 
in mouse and on human skin samples without culture with the aim of providing in vivo 
expression data for comparisons between organisms would be valuable.
4.3.2 Mixed Results from Generating Transgenics
As we demonstrated in Chapter 3, Sox10 is able to inhibit expression of melanophore 
differentiation genes and we now know it is downregulated in differentiating 
melanophores.  These two facts led us to hypothesise that it may be necessary for Sox10 
to be downregulated to allow melanophores to differentiate.  To test this hypothesis we 
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sought to generate two transgenic lines.  One line would express CFP under the control 
of the mouse Dct promoter and act as a control for further experiments.  The second 
line would express a CFP-Sox10 fusion under the control of the same promoter.  In this 
way we would express Sox10 in melanophores at times later in development than it 
would normally be expressed.  If our hypothesis, that Sox10 can inhibit melanophore 
differentiation and its downregulation is necessary for melanophore differentiation, is 
true then we would expect to see a cessation or delay in melanophore development in 
the latter transgenic line.
Generation of constructs for use in making each transgenic was successful; the 
plasmids were named pTol2DctCFP and pTol2DctCFPsox10.  We were also able to 
successfully generate multiple lines (named Tg(Dct;CFP)) using the pTol2DctCFP 
plasmid.  When examined in the F2 generation, many of these lines expressed CFP 
in their melanoblasts and melanophores as expected.  However, there was some 
indication that expression of CFP was turned off at later stages.  This is not comparable 
to the endogenous expression of dct, expression of which persists until at least 8 dpf 
(Kelsh et al. 2000).  Nevertheless, these lines would provide a valuable control for our 
experimental transgenics and are also a useful tool in their own right.  They could be 
used in any number of experiments where there is a need for melanoblasts to be marked 
separately from other neural crest derivatives.  We know of another zebrafish line 
which expresses GFP in melanophores under the control of the Fugu tyrp1 promoter 
(Zou et al. 2006).  Our lines have an advantage over this line since they express CFP 
rather than GFP, this means they can be used in conjunction with other transgenic lines 
such as Tg(-7.2sox10:GFP) which mark all neural crest cells with GFP.  This would 
enable researchers to study melanoblasts in isolation and also with respect to other 
neural crest derivatives.
A small proportion of the Tg(Dct;CFP) lines generated also displayed ectopic expression 
of CFP.  In some cases we had seen the same ectopic expression in our initial trials with 
the mouse Dct promoter, for example CNS expression, and so they were expected.  We 
know that Dct is expressed in mouse telecephalon so it is conceivable that the mouse 
Dct promoter, when used in zebrafish, could drive reporter gene expression in the 
CNS.  Other patterns were unexpected, and might best be explained by the suggestion 
that the site of integration of the transgene can effect the expression pattern; this 
might also explain the slight variation in strength of CFP signal between the different 
lines (Kawakami 2004).  Indeed, the Tol2 system has been used to take advantage 
of insertional effects in a gene trap approach whereby endogenous promoters drive 
expression of Tol2 inserted GFP (Kawakami et al. 2004).  One of our lines which 
produced an ectopic expression pattern could be very useful; Chris has CFP-labelled 
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xanthophores.  As we noted in Chapter 3, this cell type currently only has two published 
markers and these have limitations since they also appear to mark early melanoblasts 
(Parichy et al. 2000b).  Of course a more thorough characterisation of the line would 
be required but it could prove valuable.  
Another of the ectopic expression patterns we observed in the Tg(Dct;CFP) lines was 
seen in the Clive line.  F2 embryos from the Clive line occasionally had expression in 
the heart as well as in melanoblasts/melanophores.  That this pattern was only seen in a 
small number of embryos in a batch from any given pair of fish suggests that there may 
be multiple insertion sites of our transgene resulting in multiple expression patterns 
from the same founder.  Whilst the Tol2 system ensures that only a single copy of the 
transgene is inserted at any one site, it may be inserted multiple times at different sites 
within the genome.  More than 25 insertion sites have been transmitted by a single 
founder but with an average of 5.6 insertions per founder, much lower numbers are 
more usual (Kawakami 2004).  The overall weakness of expression in our transgenics 
as compared to other lines available in the lab might also be explained by the fact that 
the Tol2 system ensures single copy insertion.  Other lines, such as Tg(-4.9sox10GFP) 
have been generated by injecting linearised plasmid.  This method has been shown 
to lead to concatemerisation of the DNA before integration which leads to increased 
reporter expression in the embryo (Stuart et al. 1988).  
We successfully generated a pTol2DctCFPsox10 plasmid and we were able to show 
that the CFP-Sox10 fusion is functional as transient expression of it in sox10t3 mutants 
rescues pigment cells.  It is interesting that by expressing sox10 in cells which are 
already expressing dct we were able to rescue xanthophores and iridophores as well as 
melanophores.  This suggests that cells which are expressing dct in sox10t3 mutants are 
not yet committed to a melanophore fate.  It may simply be that a lack of endogenous 
sox10 in these cells means that they have not developed normally at all and so they are 
not able to commit to the melanophore lineage.  However, it is also suggestive of the 
concept of a pigment cell precursor not yet fully described in wild type embryos which 
is expected, for a short time, to express differentiation genes indicative of multiple cell 
types (Lopes et al. 2008).  Perhaps in a sox10 mutant these cells get caught at this stage 
of differentiation?  This is also reminiscent of our observations of the expression of 
other pigment marker genes in sox10t3 mutants in Chapter 3.  The expression pattern 
of the melanophore marker silva for example was so extensive it seemed unlikely that 
it did not overlap with the xanthophore maker xdh.  We suggested some experiments 
in Chapter 3 looking for overlap of melanophore and xanthophore marker gene 
expression in sox10t3 mutants to test this possibility.  In testing our CFP-Sox10 fusion 
we did not observe any rescued non-pigment neural crest derived cells but it would 
131
Chapter 4
be interesting to look for rescue of such cells, for example enteric neurons.  If rescued 
neurons were found it might indicate that even once cells begin to express genes 
indicative of a melanophore they retain flexibility in terms of their final fate beyond 
the pigment cell lineages.
Having established the functionality of our CFP-Sox10 fusion we went on to begin 
to generate transgenic Tg(Dct;CFP-sox10) lines.  We were able to select a number of 
founders based initially on their CFP expression 27 hours after being injected with 
pTol2DctCFPsox10 and later by selecting those that generated CFP positive F1 progeny 
(which we grew and used to establish each line).  However, in the F2 generation we 
could see no CFP expression either as protein or transcript between 24 hpf and 72 hpf. 
This was true for progeny from all of the eight different founders we examined and is 
surprising because reports suggest that generation of transgenics by the Tol2 system 
can allow transgene expression as far as F5 (Kawakami 2005).  Of course, the CFP-
sox10 fusion may be expressed at levels below the detection threshold for in situ 
hybridisation and we have not tested whether any such expression could be detected 
by RT-PCR.  Nevertheless, the lack of detectable CFP expression, by fluorescence 
microscopy or by ISH, meant that the CFP-Sox10 fusion was not expressed in our F2 
embryos at levels that would enable us to test the hypothesis that overexpression of 
Sox10 in melanophores would halt or delay their development.  An alternative approach 
might be to generate transient transgenics with which to test our hypothesis.  However, 
we found that less than 1 % of embryos injected had any CFP-expressing cells.  In 
addition, there were usually only 1-3 CFP-expressing cells within those embryos some 
of which were not melanoblasts/melanophores.  Therefore, for practical reasons it was 
unfeasible to generate enough transient transgenics with enough CFP positive cells to 
be able address the hypothesis in this way.
It might be possible to try the same experiment again, perhaps using the Fugu tyrp1 
promoter which was reported in Zou et al. (2006) as being melanophore specific at 
least until 3 dfp.  Of course, if silencing occurs because of the incorporation of a 
CFP-sox10 fusion into the genome rather than due to effects of the promoter, then 
silencing may occur again.  Use of a heatshock promoter (Pyati, Webb and Kimelman 
2005) or GAL4/UAS system (Halpern et al. 2008) with our CFP-sox10 fusion would 
allow control over the timing of transgene expression and may prevent silencing.  A 
complimentary approach might include overexpression of Sox10 in melanophores in 
culture.  Zebrafish melanophore culture is not well documented so care would have 
to be taken here to carefully control culture conditions and to fully understand how 
normal melanophore development in vitro proceeds before attempting to disrupt it 
by overexpression of sox10.  Alternatively, if Sox10 must be downregulated to allow 
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melanophore differentiation we would predict that there would be Sox10 binding sites 
within the promoters of melanophore differentiation genes which would allow Sox10 
to repress their expression.  This could be tested by utilising in vitro promoter analysis 
(Antonellis et al. 2006) to determine whether there are Sox10 binding sites within, for 
example, the zebrafish tyrosinase promoter and whether expression from the tyrosinase 
promoter can be directly inhibited by high levels of Sox10.  
Another interesting observation from our PCR analysis of F1 and F2 fish is that there 
are several different products which can be amplified using our primers.  Unexpectedly, 
we found that we were amplifying sequence from the vector backbone as well as the 
expected CFP sequence.  Integration of Tol2 vector has been reported previously 
but only when the transgene has also been inserted (Kawakami 2004).  Here we see 
examples where only the vector becomes incorporated into the genome (Figure 4.19 
B, sample 7).  This could represent bias in the PCR to generate only one of two or 
more possible products.  However, we do see all combinations of PCR products in 
different PCRs carried out under the same conditions.  Further to the observation 
of multiple PCR products, progeny from F1 fish 19 segregate according to whether 
they have the smaller, larger or both of the two PCR bands produced when fish 19 is 
genotyped (Figure 4.19 D).  This suggests that the transgene and vector sequence have 
been inserted separately at different integration sites in one founder fish.  Multiple 
insertion sites have been reported previously (Kawakami 2004) but again, not in this 
combination of transgene and vector sequences.  Whether or not it matters that vector 
sequence can be integrated in this way requires investigation.  In our study, it could be 
that this has disrupted our transgene in some way or somehow triggered silencing of the 
promoter.  It might be interesting to explore these possibilities by finding out, within 
individual fish, which sequences are incorporated from our construct, how many times 
and in what combinations.  Incorporation of vector sequence independent of transgene 
sequence could cause a problem when making any transgenic but particularly in those 
used in insertional mutagenesis screens.  Depending upon the insertion site, vector 
sequence could disrupt expression of endogenous transcripts and cause a phenotype 
whilst remaining undetected.  That phenotype may then be incorrectly attributed to the 
disruption at the site of the intended transgene insertion.  This may not occur often, 
and would usually be seen as segregation of phenotypes, but it may be an important 
possibility to consider when using transgenics in this way.
4.3.3 Summary
We have shown in this Chapter that Sox10 protein and mRNA are downregulated in 
melanophores as they develop.  We were also able to successfully generate two kinds 
of transgenic lines to test the prediction that Sox10 must be downregulated to allow 
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melanophores to differentiate.  One type of transgenic expresses CFP under the control 
of the mouse Dct promoter, in many cases faithfully recapitulating the endogenous 
dct expression pattern.  We also generated other lines which incorporate the same 
promoter along with CFP sequence fused to sox10.  However, we were unable to 
detect any expression of CFP in the F2 generation of any of our Tg(Dct;CFP-sox10) 
lines and it is unlikely that any of our lines were overexpressing Sox10 as we had 
intended.  Certainly no obvious melanophore phenotype was visible.  As such, our 
prediction that Sox10 must be downregulated to allow melanophores to differentiate 





As we discussed in Chapter 1, there is a lot of information from different organisms 
about the different genes that Sox10 may be able to regulate in different cell types. 
Our model for melanophores predicts only indirect regulation of melanophore marker 
genes by Sox10 because here Sox10 works via activation of mitfa which then directly 
regulates melanophore differentiation genes (Figure 1.04).  In zebrafish, this transient 
role for Sox10 is supported by data showing that overexpression of mitfa in the neural 
crest of either Sox10 or Mitfa deficient embryos can rescue melanophores to the same 
degree in each (Elworthy et al. 2003).  However, in mouse it seems that Sox10 has 
an additional role beyond activation of Mitf, to assist in the activation of Tyrosinase 
expression (Hou, Arnheiter and Pavan 2006).  This leads to the conclusion that in 
mice Mitf alone is not sufficient for melanocyte differentiation.  This conclusion is 
contrary to work from other groups which have shown the overexpression of Mitf 
in mouse fibroblasts, quail neuroretina cells and in both zebrafish and medaka, to be 
sufficient for expression of all of the Tyrosinase family genes and for pigmentation 
(Tachibana et al. 1996, Planque et al. 1999, Béjar, Hong and Schartl 2003, Lister et al. 
1999).  There are other contradictory data about the possibility of later roles for Sox10 
in melanocyte development.  In cell culture, Sox10 can activate expression from the 
Dct promoter (Britsch et al. 2001, Potterf et al. 2001, Jiao et al. 2004) suggesting 
Sox10 may play a later role in regulating Dct.  However, Sox10 is not necessary for 
expression of Dct in neural tube culture if Mitf is present (Hou et al. 2006) and dct 
can be induced by ectopic expression of only mitfa in zebrafish (Lister et al. 1999) 
which suggests that a late role for Sox10 may not exist or at least is not vital for 
Dct expression.  Hou et al. (2006) conclude that their work demonstrates contrasting 
roles for Sox10 in melanocyte development in zebrafish and mouse.  They explain the 
disparity between current findings as representing actual differences between the two 
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species.  We feel that due to the contradictions in the literature outlined above, further 
experimentation is required before this proposal can be confirmed.  Ideally, the mouse 
data needs to be tested in vivo to validate in vitro findings.  A study in zebrafish to 
explore exactly which genes are regulated by Sox10 and Mitfa in this model organism 
would be complimentary to current data in zebrafish.  It would also aid comparison 
with data from the available mouse studies since it would provide a closer parallel to 
these studies.
Previously, injection of sox10 RNA into one cell stage zebrafish embryos has been 
shown to induce expression of mitfa by 6 hpf as assayed by ISH (Elworthy et al. 2003). 
Similar injection of mitfa RNA will induce expression of dct (Lister et al. 1999).  We 
will utilise this method, which treats the zebrafish embryo almost as a ‘living test 
tube’, to look at which of our melanophore marker genes (dct, tyrosinase, tyrp1b and 
silva) can be induced by Sox10 or Mitfa, both alone and in combination.  From our 
original model, we would predict that overexpression of mitfa in this way will lead to 
expression of all of our marker genes and that overexpression of sox10 will not directly 
induce expression of our marker genes.  If sox10 is overexpressed in addition to mitfa 
however, the model predicts that it will repress any expression of melanophore marker 
genes induced by mitfa.  On the other hand, if data from Hou et al. (2006) can also be 
applied to zebrafish we will see expression of dct, silva and tyrp1b after overexpression 
of mitfa but we will not see expression of tyrosinase unless we additionally overexpress 
sox10.  Thus, we have a set of clear predictions to test in this chapter.
5.2 Results
We generated sense mRNA for sox10, sox10L142Q (which we will refer to as L142Q), 
mitfa and mitfaw2 (which we will refer to as w2).  Sox10, L142Q and w2 RNA were 
diluted to a concentration of 25 ng/µl.  We found this dose of mitfa RNA to be lethal so 
it was diluted to a concentration of 6.25 ng/µl.  We injected embryos with 4.6 nl RNA 
and grew them for six or 10.5 hours (i.e. prior to the onset of endogenous expression of 
sox10 or mitfa).  Embryos were then processed for in situ hybridisation to see whether 
expression of our genes of interest had been induced.  All of the experiments in this 
section were repeated on at least two separate occasions.  Whenever we injected wild 
type sox10 or mitfa RNA we also injected a set of embryos with L142Q or w2 mutant 
RNA respectively as negative controls.
5.2.1 Sox10 Indirectly Induces Expression of tyrp1b
We first injected sox10 RNA into wild type embryos and looked for expression of 
mitfa.  As expected (Elworthy et al. 2003), six hours after injection we saw expression 
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of mitfa in 55 % of embryos (Table 5.01).  This validated our method and technique.  In 
the same experiment we also looked for expression of dct, silva, tyrosinase and tyrp1b. 
We did not see expression of any of these marker genes in either our experimental 
embryos or our negative controls at 6 hpf (Figure 5.01 A).  We next addressed whether 
allowing embryos to grow to 10.5 hpf altered the result (Figure 5.01, B).  Now, we 
found that although a similar proportion of embryos were positive for mitfa (50 %) 
and none were positive for dct, silva or tyrosinase, we did see expression of tyrp1b in 
46 % of embryos (Table 5.01).  Again, there was no expression of any of these genes 
after injection with L142Q RNA.  We know that mitfa is directly activated by Sox10 
and since tyrp1b expression did not appear until four and a half hours later, it seemed 
likely that this was as a result of indirect activation by Sox10 via Mitfa.  To test this, 
we injected sox10 RNA into embryos from an mitfaw2 homozygous mutant incross 
and looked for expression of tyrp1b after 10.5 hours.  We saw no tyrp1b expression in 
160 embryos.  This supports the hypothesis that the tyrp1b expression we see in wild 
type embryos injected with sox10 RNA is mitfa dependent and strongly supports the 
hypothesis that tyrp1b is not directly regulated by Sox10 under these conditions.
5.2.2 Mitfa Can Induce Expression of dct, silva, tyrosinase, 
tyrp1b and sox10
We would have predicted that if expression of tyrp1b is mitfa dependent, then mitfa 
should also be able to activate expression of the other melanophore marker genes. 
Indeed, based on our model we would predict that injection of mitfa RNA will induce 
expression of our marker genes.  However, from Hou et al. (2006) we would predict 
that this will not be sufficient for expression of tyrosinase.  We now tried injecting 
mitfa RNA into wild type embryos and asked which genes might be turned on by this 
high level of mitfa RNA in the absence of sox10.  We found that all of our melanophore 
marker genes were expressed in 6 hpf embryos after injection with mitfa RNA (Figure 
5.02).  The pattern and quantity of expressing cells in each embryo was highly variable 
but expression was seen in most embryos injected with wild type RNA (Table 5.02) but 
not at all in embryos injected with control w2 RNA.  We also tested some of the same 
embryos to confirm that there was no expression of sox10.  Unexpectedly however, we 
did see expression of sox10 induced by injection of mitfa RNA in 89 % of embryos. 
This was completely unexpected since regulation of sox10 by Mitfa has never been 
reported previously, although a lack of regulation has not been reported either.  The 
result is also in direct contradiction to the prediction from our model that Mitfa will 
have a repressive effect upon sox10 expression.
This unexpected result also raised the issue of whether the expression of our melanophore 
markers after injection with mitfa RNA was dependent upon the induced expression 
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mitfa dct silva tyrosinase tyrp1b
6 hpf
sox10 34/62 0/64 0/63 0/63 0/63
55 % 0 % 0 % 0 % 0 %
L142Q 0/58 0/61 0/61 0/61 0/62
0 % 0 % 0 % 0 % 0 %
10.5 hpf
sox10 40/51 0/81 0/71 0/82 39/84
78 % 0 % 0 % 0 % 0 %
L142Q 0/71 0/73 0/73 0/73 0/70
0 % 0 % 0 % 0 % 0 %
Table 5.01 Expression of marker genes after 





















































































































































































































































































































































































































































































































RNA sox10 dct silva tyrosinase tyrp1b
mitfa 55/62 46/54 40/45 39/46 39/44
89 % 85 % 89 % 85% 89 %
w2 0/44 0/63 0/64 0/61 0/63
0 % 0 % 0 % 0 % 0 %
Table 5.02  mitfa injection into wild type embryos
Between 85 % and 89 % of embryos were positive for 




of sox10.  To test this we repeated the experiment above on embryos from crosses 
between sox10t3 heterozygous fish.  These experiments were repeated on at least three 
occasions.  100 embryos from each set of experiments were left uninjected and scored 
at 3 dpf to ensure that we had 25 % mutant embryos.  We would predict that if Sox10 
is not required for the expression of any of our marker genes then all of the embryos 
will express dct, silva, tyrosinase and tyrp1b after mitfa injection.  If Sox10 is required 
for any one gene to be expressed, then the embryos which are sox10t3 mutants (25 %) 
will not express that gene.  The analysis of the results of this experiment is complicated 
by the fact that even in wild type embryos, after injection with mitfa RNA, only 85 % 
- 89 % express the markers.  So in fact, if Sox10 is necessary for expression of our 
marker genes we expect the proportion of embryos not expressing each gene to be at 
least 25 % of the total number of injected embryos.
Embryos from a sox10t3 heterozygous incross injected with mitfa RNA expressed dct, 
silva and tyrp1b in 86 %, 91 % and 94 % of embryos respectively.  The proportion of 
embryos which did not express each gene differed significantly from the minimum 
25 % that we would expect if Sox10 is necessary for their expression (Two tailed Chi 
squared test, df = 1, p<0.001).  We conclude that the expression of dct, silva and tyrp1b 
are independent of sox10 but dependent upon mitfa expression.
In the same experiment, we saw tyrosinase expression in 73 % of embryos.  This does 
not differ significantly from 75 % (Two tailed Chi squared test, df=1, p>0.05) and 
suggests that sox10 may be required, together with mitfa, for tyrosinase expression. 
However, even in wild types there is not complete penetrance (only 85 % of wild type 
embryos showed tyrosinase induction) so we would actually expect much less than 
73 % of embryos to express tyrosinase if its expression is dependent upon both Sox10 
and Mitfa.  Whilst we cannot rule out that sox10 is required for tyrosinase expression 
we feel that the data presented here suggests it is not.
5.2.3 Mitfa Can Induce Expression of GFP from 7.2 kb of the 
sox10 Promoter
That Mitfa can induce expression of sox10 is surprising and is contradictory to our 
model which suggests that Mitfa will actually repress expression of sox10.  We utilised 
a transgenic line available in the lab, Tg(-7.2sox10:GFP), which expresses GFP under 
the control of 7.2 kb of the zebrafish sox10 promoter to ask whether Mitfa can induce 
expression from that region of promoter.  We injected mitfa RNA into one cell stage 
embryos from an outcross of heterozygous transgenic fish.  If, as we predict, Mitfa is 
able to bind within the 7.2 kb of sox10 promoter present in the line, it will activate 
expression of GFP.  This is what we saw in 94 out of 257 embryos (37 %), six hours after 
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injection (Figure 5.03 and Table 5.03).  At 10.5 hpf the proportion of GFP expressing 
embryos had increased slightly to 45 %.  Both of these figures are lower than the 86 % 
of embryos which express sox10 RNA after mitfa injection.  However, since only 50 % 
of embryos will be transgenic and if the effect of activation of the endogenous and the 
transgenic promoters are equivalent we only expect approximately 45 % of embryos 
to be GFP positive.  No GFP expression was seen in any control embryos injected with 
w2 RNA.  We have shown that mitfa can activate expression of sox10 and that 7.2 kb 
upstream of the sox10 ATG is sufficient for this to occur thus localising likely Mitfa 
response elements.
We also injected sox10 RNA into Tg(-7.2sox10:GFP) transgenic embryos.  Six hours 
after injection we saw only 6 % of embryos had GFP expression but that by 10.5 hours 
after injection, 49 % of embryos had GFP expression (Figure 5.03 and Table 5.03). 
Again, injection of L142Q RNA had no effect.
We analysed the 7.2 kb sox10 promoter for existence of potential Mitf binding 
sites.  This revealed six potential Mitf binding sites at -997 bp, -1143 bp, -3482 bp, 
-4992 bp, -5152 bp and -6703 bp upstream of the translation start site (Figure 5.04). 
The latter three of these would be absent from the promoter sequence used in the 
Tg(-4.9sox10:GFP) line. 
5.2.4 Sox10 Inhibits Activation of Marker Genes by Mitfa
Our original model (modified based on earlier results) predicts that sox10 will have an 
inhibitory effect upon the activation of our marker genes (except tyrp1b) by mitfa but 
we hypothesised that this would only occur if the timing of sox10 and mitfa expression 
is appropriate.  Thus, when mitfa RNA is injected into embryos we see expression of 
all of our marker genes at 6 hpf.  This may be because the delayed expression of sox10 
that we also see in these embryos is not present early enough or in sufficient quantities 
to inhibit the action of mitfa.  When sox10 RNA is injected into embryos it is present 
well before mitfa and so can inhibit expression of our marker genes by mitfa so that 
we only see expression of tyrp1b.  tyrp1b expression does not appear until 10.5 hpf 
because it is mitfa dependent and requires time for Mitfa to build up.  These ideas are 
also presented in Figure 5.05.
To test this hypothesis, we injected embryos with a mixture of sox10 and mitfa RNA. 
We predicted that the presence of high levels of sox10 from the start of the experiment 
would inhibit the expression of our marker genes that we would have seen if only mitfa 
RNA was injected.  We used the same concentration of each RNA as had previously 

















Figure 5.03  Inection of mitfa and sox10 RNA into Tg(-7.2sox10:GFP) embryos
A. Brightfield, fluorescent and merged images of 6 hpf embryos.  Left, these embryos 
had been injected with mitfa RNA.  GFP expression can clearly be seen on the righthand 
side of the embryo.  Right, these embryos had been injected with w2 RNA.  Apart from 
autofluorescence from the yolk, no GFP expression is seen.
B. Brightfield, fluorescent and merged images of 6 hpf embryos.  Left, these embryos 
had been injected with sox10 RNA.  GFP expression can clearly be seen in the top of 
the embryo (arrow).  Right, these embryos had been injected with L142Q RNA.  Apart 
from autofluorescence from the yolk, no GFP expression is seen.
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RNA 6 hpf 10.5 hpf
mitfa 94/257 37 % 68/152 45 %
w2 0/118 0 % 0/78 0 %
sox10 20/319 6 % 95/193 49 %
L142Q 0/120 0 % 0/80 0 %
Table 5.03 Expression of GFP after mitfa or
sox10 RNA injection after 6 or 10.5 hours
Numbers are reduced compared to sox10 as 
measured by ISH (Table 5.01) since only half of 
these embryos are transgenic.  Note the increase 
in GFP positive embryos between 6 hpf and 10.5 







































































































































































































Figure 5.05 Timing of sox10 and mitfa expression are important
Injection of mitfa RNA induces expression of sox10 as well as all of our other markers 
at 6 hpf (first column).  If we inject sox10 RNA, we only see expression of mitfa at 6 
hpf but by 10.5 hpf we also see expression of tyrp1b (third column).  We hypothesised 
that sox10 is able to repress expression of dct, silva and tyrosinase but only when it is 
present in the embryo early enough and at high enough levels compared to mitfa.  This 
would explain why we see different expression profiles seen when we injected mitfa or 
sox10 RNA alone despite the eventual expression of both genes in both experiments. 
We predicted that injection of mitfa and sox10 RNA together, so that both RNAs are 
present from the beginning of the experiment and at high levels, will result in the 
same profile of gene expression at 6 hpf as  if we injected mitfa, except that due to the 
high levels of sox10 present from an early stage, dct, silva and tyrosinase will not be 
expressed (second column).




to affect the embryos.  We found that six hours after injection, tyrp1b was expressed 
but none of the other markers were (Figure 5.06 and Table 5.04).  This is the same 
result as if we had only injected sox10 RNA, except that we see mitfa dependent 
expression of tyrp1b 4.5 hours earlier due to the presence of mitfa RNA from the 
beginning of the experiment on this occasion.  This result supports the hypothesis that 
sox10 can have an inhibitory effect upon dct, silva and tyrosinase expression but not 
tyrp1b expression.
5.2.5 Levels of Sox10 Alter the Functions it Performs
To explore further the inhibitory role of Sox10, we carried out another experiment.  We 
wanted to know whether, when mixed with mitfa RNA, lower concentrations of sox10 
RNA than we used previously would allow some expression of dct, silva or tyrosinase. 
Kim et al. (2003) were able to show that low levels of Sox10 are sufficient to induce 
expression of Mash1 and Phox2b in sympathetic neurons but much higher levels are 
required to inhibit neuron differentiation.  Perhaps in our model system Sox10 might 
also be required at high levels in order to inhibit expression of our melanophore marker 
genes.  We made five different mixtures of sox10 and mitfa RNA which we injected 
into wild type embryos.  The first was the same as we used in previous experiments, 
25 ng/µl sox10 plus 6.25 ng/µl mitfa.  The four remaining mixtures contained 6.25 ng/
µl mitfa plus either 12.5 ng/µl, 6.25 ng/µl or 3.125 ng/µl or 0 ng/µl of sox10 RNA with 
the remainder of the total amount of RNA being made up with L142Q (Figure 5.07, 
A).  For any one RNA mixture, all of the embryos required for the experiment were 
injected in succession and grown together.  Embryos were only divided into separate 
tubes to be processed for ISH with different markers immediately prior to beginning 
the ISH protocol.  The experiment was repeated three times.  On the first two occasions 
each mixture was made up individually.  On the third occasion, a serial dilution of the 
sox10 RNA was performed in an attempt to increase accuracy of the dilutions.
The data we obtained from these experiments was noisy but the general trend observed 
was that as the concentration of sox10 RNA that was injected decreased, a higher 
percentage of embryos expressed each marker gene (Figure 5.07).  For dct as well as 
tyrosinase (Figure 5.07, B and D) both of the end points are consistent with previous 
experiments (most embryos express the markers when L142Q is injected at 25 ng/
µl with mitfa RNA at 6.25 ng/µl and none or very few do when sox10 is injected at 
25 ng/µl with mitfa RNA at 6.25 ng/µl).  The averaged data for dct shows a smooth 
curve with no points which seem anomalous (light blue) and the experimental data 
follows this trend, although there are anomalous data points.  The averaged tyrosinase 
curve appears to begin more steeply and flatten sooner than that for dct and all three 









Figure 5.06 Marker gene expression 6 hours after injection of sox10 and mitfa 
RNA
As predicted, only tyrp1b is expressed when embryos are injected with a mixture of 




dct silva tyrosinase tyrp1b
sox10 + mitfa 0/85 0/116 0/119 65/100
0 % 0 % 0 % 65 %
L142Q + w2 0/52 0/73 0/79 0/67
0 % 0 % 0 % 0 %
Table 5.04 Expression of marker genes after 
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anomalous point.  There does not seem to be any consistency between markers as to 
where anomalous points occur that makes them easy to explain.
The results for silva are only consistent with previous data where the RNA mixture 
contained no sox10 RNA.  Except for on one occasion, we see greater numbers of 
embryos expressing silva at the maximum sox10 dose than we had previously seen 
and there is little change in the numbers of embryos expressing silva as we decrease 
the concentration of sox10 (Figure 5.07, C).  The results for tyrp1b also differ from 
what we would have expected.  In contrast to the other markers, we would expect 
to see between 50 % and 75 % of embryos expressing tyrp1b when the sox10 RNA 
concentration is highest and little change as we decrease sox10 concentration.  Instead 
we see a curve very similar to that for the other markers, although there does appear to 
be more variation at each point.
These data do not contradict the hypothesis that sox10 is only able to inhibit expression 
of our marker genes when present at high enough levels since we see increased 
expression of our marker genes as sox10 concentration decreases.  However, it is 
difficult to make more specific comments about similarities and differences between 
the genes due to the noise in these experiments.
5.3 Discussion
We have tested a model, adapted from one proposed by Kim et al. (2003) for the 
role of Sox10 in mouse sympathetic neurons, to explain the role of Sox10 in 
melanophores (Figure 1.04).  Our model predicted that whilst Sox10 is required to 
initiate expression of mitfa and begin the process of differentiation, it is also able to 
repress the expression of differentiation genes downstream of Mitfa.  This model also 
predicts that Sox10 must be downregulated to allow differentiation to proceed and 
that this downregulation will occur as part of a feedback loop involving Mitfa.  Some 
work in mouse melanocytes contradicts this model and suggests that Sox10 is not only 
required to initiate expression of Mitf but that it also has a later role, to assist in the 
induction of Tyrosinase expression (Hou et al. 2006).  To explore in more detail our 
original model and enable us to make more direct comparisons between zebrafish and 
the work presented in Hou, Arnheiter and Pavan (2006), we undertook a set of RNA 
injection experiments designed to investigate which genes Sox10 and Mitfa may be 
able to regulate in melanophores.  In this chapter we have documented our results from 
these experiments (summarised in Table 5.05).
With respect to all of our results, it is important to consider that they were obtained 
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sox10 RNA injected into wild type embryos can induce expression of mitfa at 6 hpf 
and mitfa and tyrp1b by 10.5 hpf.  This tyrp1b expression is mitfa dependent since we 
do not see expression of tyrp1b after sox10 injection into mitfaw2 mutant embryos.
mitfa RNA injected into wild type embryos can induce expression of all of our marker 
genes, including sox10.  However, the expression of these genes is not dependent upon 
sox10 expression since we see no significant effect upon marker gene expression when 
mitfa is injected into sox10t3 mutant embryos.
When mitfa and sox10 RNA are injected into wild type embryos together we only 
see expression of tyrp1b.  This supports the hypothesis that sox10, if present early 
enough and at high levels, represses expression of dct, silva and tyrosinase.







by working in early embryos and the complement of transcription factors here will 
deviate from that in the developing neural crest.  This means that binding partners 
necessary for normal Sox10 and Mitfa function in the neural crest may not be present, 
altering the way these proteins function.  Equally, there may be additional factors 
present which are absent from the neural crest and which might also alter the functions 
of Sox10 and Mitfa.  We also worked with fairly arbitrary concentrations of RNA 
which are not necessarily physiologically relevant so care will need to be taken to 
assess the physiological relevance of the results obtained.
5.3.1 Mitfa Induces Melanophore Marker Gene Expression 
Our model clearly predicts that expression of Mitfa is sufficient to induce expression of 
melanophore marker genes.  We found that in wild type embryos that had been injected 
with mitfa RNA and allowed to grow to 6 hpf sox10, dct, silva, tyrosinase and tyrp1b 
are all expressed.  By repeating the experiment in sox10t3 mutants, we went on to show 
that the expression of dct, silva, and tyrp1b are not Sox10 dependent and that tyrosinase 
expression is unlikely to be Sox10 dependent.  This result supports the hypothesis that 
sox10 is not required for the expression of dct, silva, tyrosinase and tyrp1b, consistent 
with the idea that Sox10 is only required to induce expression of mitfa after which it 
is not needed for melanophore development (Elworthy et al. 2003).  It also supports 
work in other organisms which shows that Mitfa is able to induce expression of Dct, 
Tyrosinase and Tyrp1 (Murisier and Beermann 2006, Hou et al. 2006, Baxter and 
Pavan 2003, Goding 2000, Lowings, Yavuzer and Goding 1992).  The lack of a late 
role for Sox10 in melanophore development suggested by this work is in contrast to 
mouse data which suggests that Sox10 is required, in addition to Mitfa, for tyrosinase 
to be expressed and for melanophore differentiation to proceed (Hou et al. 2006).  It 
adds weight to the proposal put forward by Hou et al. (2006) that zebrafish and mouse 
appear to be inherently different in the roles that Sox10 performs in melanocytes.  Also 
in agreement with this paper, but contrary to others which demonstrate a positive role 
for Sox10 in Dct expression in mouse (Britsch et al. 2001, Potterf et al. 2001, Jiao et 
al. 2004), we have found no evidence to suggest a role for Sox10 in induction of dct in 
vivo in zebrafish.  Further work in vivo in mouse would provide interesting evidence 
to help resolve these contradictions.
Ideally we would have confirmed our results by genotyping the sox10t3 embryos and 
scoring the mutants for whether or not they expressed our markers.  We were unable to 
optimise our PCR genotyping procedure to carry this out.  The major hurdles were the 
small quantities of DNA (from 6 hpf embryos) combined with the fact that the embryos 
had been through an ISH protocol.  The sox10t3 genotyping PCR is also difficult since 
it requires amplification of both a small (423 bp, wild type) band and a large (1.8 kb, 
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mutant) band.  In addition, the difference in size between these two bands is due to a 
transposon insertion which has repetitive elements for much of its length precluding 
the design of primers within that region (Carney 2003).  Another way to test the result 
would be to conduct double ISHs on mitfa RNA injected embryos to look for co-
expression of sox10 and tyrosinase or, as predicted from our original model, tyrosinase 
positive embryos which are not sox10 positive.
5.3.2 Mitfa Can Activate Expression from the sox10 Promoter
We demonstrated that Mitfa is able to activate the sox10 promoter both by looking for 
sox10 RNA in embryos after they have been injected with mitfa RNA and by looking 
for GFP in embryos from the Tg(-7.2sox10:GFP) line after they have been injected with 
mitfa RNA.  This latter experiment showed that Mitfa binds within the 7.2 kb sox10 
promoter that was used to generate the Tg(-7.2sox10:GFP) line.  We also identified 
multiple potential Mitf binding sites, in silico, within the promoter (Matys et al. 2003). 
However, we have neither found published evidence to suggest that Mitfa is able to 
activate expression of Sox10, either in zebrafish or other organisms, nor evidence that 
it is not able to regulate expression of Sox10.  This has an interesting implication for 
our original model which predicted that Mitfa would repress expression of sox10.  We 
now have evidence that Mitfa may be able to bind to the sox10 promoter, perhaps in 
vivo this would repress sox10 expression.  A lack of specific transcription factors, or an 
excess of the wrong ones, in the early embryo could mean that binding of Mitfa to the 
sox10 promoter will have the opposite effect in our RNA injection experiments than 
it would in vivo. For example, CBP/p300 is expressed in mouse melanocytes and is 
known to interact with Mitf, the suggestion being that recruitment of CBP/p300 assists 
gene activation by Mitf (Sato et al. 1997).  However, zebrafish equivalents of CBP/p300 
have not been described and without further understanding of these genes in zebrafish 
we cannot say if they may be important in regulating Mitfa activity in our experiments. 
Lef is another factor known to have a positive effect upon activation of genes by Mitf 
(Steingrímsson, Copeland and Jenkins 2004).  It too is expressed in zebrafish neural 
crest at least at 16 hpf and is also expressed in the early embryo (Ishitani et al. 2005, 
Lee et al. 2006), though again it is difficult to predict the effect this might have on 
Mitfa target gene expression in our experiments.  A third example of an Mitf co-factor 
is Pias3.  It is known to repress activation of genes by Mitf (Sonnenblick, Levy and 
Razin 2004).  Pias3 and other genes, such as Tfeb and Tfec, have not been described 
yet in zebrafish demonstrating the considerable gaps in our understanding of gene 
regulation by Mitfa in zebrafish and the many possible explanations for our results.
Half of the six Mitfa binding sites identified are not present in the 4.9 kb section of the 
sox10 promoter used to generate another transgenic line, Tg(-4.9sox10:GFP) (Carney 
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2003).  Repeating the experiments described here with this line, may shed light on 
which potential binding sites are likely to be functional.  This could be followed 
up with in vitro promoter analysis (Antonellis et al. 2006) and for example, ChIP 
assays (Yokoyama, Takeda and Shibahara 2006), which could provide more evidence 
for whether the binding of Mitfa to the sox10 promoter has a positive or negative 
regulatory effect in vivo.
We also found that injection of sox10 RNA will induce expression of GFP in 
Tg(-7.2sox10:GFP) embryos.  At 6 hpf, the number of embryos expressing GFP is 
very low, we suggest that this is because Sox10 has no effect on its own promoter.  At 
10.5 hpf there is an increased number of embryos expressing GFP.  Sox10 can induce 
expression of mitfa and we suggest that the extra 4.5 hours between sampling times 
allows Mitfa to accumulate and activate expression of GFP via the transgenic sox10 
promoter.  This could be tested more thoroughly by creating embryos which are both 
transgenic and mutant at the mitfa locus and repeating the experiment where we would 
predict that no GFP expression would now be seen.
5.3.3 Sox10 Can Repress Activation of Genes by Mitfa
We reproduced an experiment from Elworthy et al. (2003) where sox10 RNA was 
injected into one cell stage embryos and expression of mitfa was found to be induced 
after six hours.  We found that none of our other marker genes, dct, silva, tyrosinase 
or tyrp1b, were induced in this way suggesting that Sox10 alone is not sufficient for 
expression of these genes.  However, mitfa dependent expression of tyrp1b was seen 
if embryos were allowed to develop to 10.5 hpf.  This suggests that Sox10 does not 
directly activate expression of tyrp1b but that it induces expression of mitfa, which 
in turn activates the other marker genes.  This was corroborated by the lack of tyrp1b 
expression when the experiment was repeated in embryos which lack functional Mitfa 
and fits with evidence for the regulation of Tyrp1 by Mitf in other organisms (Murisier 
and Beermann 2006).
Our model predicts that Sox10 is able to inhibit expression of genes downstream of 
Mitfa.  We found that Mitfa is only able to induce expression of most of our marker 
genes in the initial absence of Sox10 and not when Sox10 is present in the embryo 
before Mitfa (i.e. after injection of mitfa and not sox10 RNA).  This supports our 
prediction and  fits with data we discussed in Chapter 3 illustrating a repressive role for 
Sox10.  We confirmed this result by injecting both sox10 and mitfa RNA together into 
wild type embryos thus inhibiting the expression of our melanophore marker genes 
that would have occurred in these embryos if mitfa RNA had been injected alone.
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However, there was an exception to this rule; again, as above, tyrp1b was not repressed 
by overexpression of Sox10.  In Chapter 3 we reported that tyrp1b is derepressed to 
a lesser extent than the other marker genes in sox10t3 embryos.  We suggested that 
this could be explained if Sox10 is less important in the repression of tyrp1b than 
in the repression of dct, silva or tyrosinase, or if activation of tyrp1b by Mitfa is 
less dispensable for its expression than for the expression of the other markers.  The 
evidence presented in this Chapter supports the observation that the role of Sox10 
may be less important for inhibition of tyrp1b expression than for regulating the other 
marker genes.  It also suggests that factors which act either alone or in conjunction 
with Sox10 to inhibit tyrp1b expression during normal development are not present in 
the early embryo.
These results highlight one potential difference between our model for Sox10 function 
in melanophores and the model proposed by Kim et al. (2003) for its role in sympathetic 
neurons.  In sympathetic neurons Sox10 represses expression of Phox2a, a transcription 
factor downstream of Phox2b and Mash1.  In our model, Phox2a is represented as 
transcription factor X.  We have no candidate for this gene and have been using our 
melanophore markers as downstream readouts of the transcriptional activity of X. 
However, our marker genes appear to behave differently from one another in these 
experiments and have different expression patterns in sox10t3 mutants (Chapter 3). 
This suggests that if transcription factor X has a role in their regulation there are also 
other important factors involved that differ for each gene.  Alternatively, there may be 
no transcription factor X and dct, silva, tyrosinase and tyrp1b are regulated directly by 
Sox10 and independently of each other.
5.3.4 Levels of Sox10 are Important for its Functions
Kim et al. (2003) suggest the idea that levels of Sox10 may be important in how it 
regulates different genes.  High levels of Sox10 are required for inhibition of Phox2a 
but comparatively lower levels will suffice to induce expression of Mash1 and Phox2b. 
We also know that haploinsufficiency for pigment phenotypes is seen in mouse Sox10 
mutants because heterozygous Sox10 mutant mice have a pigment phenotype (Herbarth 
et al. 1998).  This suggests that levels of Sox10 may also be important in pigment 
cell development.  We have demonstrated that sox10 is downregulated in developing 
melanophores but that it is still expressed in these cells (Chapter 4).  If sox10 always 
represses expression of melanophore differentiation genes then it we would not expect to 
see Sox10 protein in melanised cells at all.  But, if high levels of Sox10 are needed for it 
to inhibit gene expression, only small reductions in Sox10 levels may allow expression 
of our marker genes and melanin synthesis.  We investigated the importance of levels 
of Sox10 in melanophore development using our ‘living test tube’ methodology.
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If we inject mitfa alone, levels of mitfa are high and all of our marker genes are 
expressed.  Since in this case sox10 expression is induced by Mitfa, there is a delay 
in the expression of Sox10 and hence Mitfa-dependent transcription of our marker 
genes occurs.  If we inject sox10 RNA alone levels of sox10 are high and mitfa is not 
expressed immediately or at high levels.  This allows Sox10 to inhibit the induction by 
Mitfa of dct, silva and tyrosinase.  We found that if we injected mitfa and sox10 RNA 
together into embryos, resulting in high levels of sox10 and mitfa from the beginning 
of the experiment, then Mitfa induced expression of all our marker genes but tyrp1b 
was inhibited.  This shows that Sox10 is able to repress expression of dct, silva and 
tyrosinase if present early and at high levels, even in the presence of high levels 
of mitfa.  To test whether the levels of sox10 are important for it to inhibit marker 
gene expression, we carried out a titration experiment.  Embryos were injected with 
mixtures of RNA containing constant amounts of mitfa RNA but decreasing amounts 
of sox10 RNA.  Generally, as levels of sox10 decreased a higher proportion of embryos 
expressed each marker gene.  This supports our hypothesis that high levels of sox10 
are required to inhibit marker gene expression.  Since levels of sox10 do seem to affect 
the function of Sox10 it would be interesting to know how the levels we have used 
compare to those present in vivo.  The lack of a melanophore phenotype in zebrafish 
sox10 heterozygotes would suggest that half of the endogenous concentration of 
sox10 is sufficient for normal melanophore development, or that the cells are able to 
effectively compensate for loss of one gene copy.
The data generated from this titration experiment was rather noisy.  In previous 
experiments we have seen how variable the proportion of embryos expressing different 
markers can be.  However, we have never seen expression of dct, silva or tyrosinase at 
the maximum sox10 dose (Figure 5.05).  In these titration experiments we do see a few 
embryos, sometimes many embryos, expressing our marker genes at this dose (Figure 
5.07).  The RNA used in the titration experiments was made on a different occasion 
to that used in any of the other experiments so there may have been differences in 
measuring RNA concentration resulting in variation in the concentrations of sox10 
RNA in each set of experiments.  It may suggest that even our maximum dose of sox10 
RNA is on the borderline between being enough to repress marker gene expression and 
not being enough.  silva appears to be switched on much more than the other markers 
even at the maximum sox10 dose, suggesting that it may require greater concentrations 
of sox10 than the other markers in order to be repressed.  There were also a number of 
anomalous points in our graphs.  There is lots of opportunity during the protocol for 
inconsistencies to occur, for example through pipetting inaccuracies, despite careful 
work and reasonable sample sizes.  A separate needle was used for each RNA mixture 
to avoid contamination but this may have introduced differences in the quantities of 
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each mixture that were injected.  Since levels of sox10 seem to be important, even very 
subtle differences between the different mixtures or between the concentrations of 
DNA received by individual embryos, will introduce variability into the results.
The noise in the titration data precludes detailed observations of some of the subtle 
differences that appear to exist between the regulation of our different markers by 
Sox10.  For example, tyrosinase expression is never seen in as high a proportion of 
embryos as the other markers, even at the minimum concentration of sox10.  Given the 
variability in the data it is difficult to know whether this represents a real difference 
between tyrosinase and for example dct expression or whether it just represents 
experimental variability.  Further to these experiments it would be interesting to 
inject different quantities of sox10 alone into wild type embryos to find the lowest 
and highest concentrations at which Sox10 is able to repress expression of dct, silva 
or tyrosinase without affecting embryo development.  Observations of marker gene 
expression in embryos injected with amounts of sox10 between these two extremes 
together with mitfa RNA may give cleaner results.  We could also find the lowest 
concentration of sox10 required to induce expression of mitfa, which we would predict 
to be considerably lower than the lowest concentration for inhibiting marker gene 
expression.  Similarly, the lowest concentration of mitfa RNA required to induce 
expression of our marker genes could be found.  It would then be interesting to inject 
the lowest concentration of sox10 needed to repress expression of our marker genes, 
combined with the lowest concentration of mitfa required to induce expression of our 
marker genes and explore further how the relative levels of sox10 and mitfa affect the 
activity of each other.  A second potentially useful approach that could be used would 
be in vitro promoter analysis.  The activity of the different melanophore marker gene 
promoters could be measured with different quantities of Sox10 and Mitfa present 
in the reaction (Antonellis et al. 2006).  This would have the advantage that the 
concentrations of Sox10 and Mitfa in each reaction could be strictly controlled but the 
disadvantage that other conditions would not mimic those in vivo as closely as RNA 
injection experiments might be expected to.
5.3.5 Summary
In this chapter we have shown that mitfa alone is able to induce expression of dct, 
silva, tyrosinase and tyrp1b supporting the hypothesis that in vivo, Sox10 is only 
necessary for expression of mitfa after which melanophores do not require Sox10 
for their development.  Mitfa was also able to induce expression of sox10.  We found 
that Mitfa is able to bind within the 7.2 kb sox10 promoter and that whilst in these 
experiments this induces expression of GFP/sox10, further work is needed to see 
whether endogenously it actually has a repressive role.  This suggestion is plausible 
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since the way a transcription factor behaves in the early embryo may differ from 
the way it behaves later in the neural crest due to the differences in those cellular 
environments.  A repressive role for Mitfa would be consistent with our original model 
which predicted that Mitfa would repress expression of sox10.  We went on to show 
that whilst sox10 is present in embryos injected with mitfa RNA, it is not required 
for the expression of our marker genes and is not able to induce expression of any 
of our marker genes alone (even after an extended incubation of 10.5 hours, we only 
see mitfa dependent expression of tyrp1b).  We showed that sox10 also is able to 
inhibit mitfa induced expression of dct, silva and tyrosinase and that levels of sox10 
are important in this role.
These results provide further evidence in support of our model for the role of Sox10 in 
melanophore development.  The model predicts that Sox10 is only required transiently 
in melanophores for the expression of Mitfa, the expression of which is sufficient for 
them to develop normally.  This is supported by other data in zebrafish as well as data 
from chick, quail and medaka (Planque et al. 1999, Béjar et al. 2003, Lister et al. 1999) 
but is in contrast to recent data from mouse which shows a later requirement for Sox10 
in melanocytes for the expression of tyrosinase and for melanocyte differentiation (Hou 
et al. 2006).  Our results therefore support the conclusion from Hou et al. (2006) that 
zebrafish and mouse are likely to differ in the role that Sox10 plays in melanophores 
and melanocytes.  Further work in vivo in mouse and in zebrafish as well as in other 






Many different genes function to regulate the development and differentiation of the 
neural crest and its derivatives.  One such gene, which is of particular interest to us, 
is Sox10.  The precise role of Sox10 in the neural crest is not completely understood, 
though there seem to be four main areas where it has a role.  In Xenopus at least, 
Sox10 appears to play a role in neural crest induction, though this is not supported by 
work in other organisms (Honoré, Aybar and Mayor 2003, Aoki et al. 2003, Cheung 
and Briscoe 2003).  In several neural crest derived cell types Sox10 has been shown 
to be important for regulating specification via activation of key genes such as Mitf in 
melanocytes and Phox2b and ngn1 in neurons (Elworthy et al. 2005, Elworthy et al. 
2003, Carney et al. 2006, Kim et al. 2003).  Other evidence demonstrates that Sox10 
can also function in sympathetic neurons to inhibit their differentiation and maintain 
cells in a stem cell-like state (Kim et al. 2003).  Finally, continued expression of Sox10 
is known to be important in differentiated glia for expression of genes such as Krox20, 
MPZ and Connexin32 (Ghislain and Charnay 2006, Peirano et al. 2000, Bondurand 
et al. 2001).  So, Sox10 has different functions in many different cell types, often 
performing different roles in each and even multiple roles within one cell type.  This 
variety of expression and function make Sox10 an interesting and important gene to 
study.  In this thesis, we have sought to further investigate the function of Sox10 in 
pigment cells, specifically zebrafish melanophores.
The role of Sox10 in melanocytes has been partially explored but current evidence 
has generated some controversy.  In mouse, human and zebrafish Sox10 is able to 
initiate expression of Mitf, the master regulator of melanocyte differentiation.  Mitf is 
able to activate expression of a wide range of melanophore specific genes including 
c-Kit, Dct, Tyrosinase and Tryp1 and initiate melanocyte differentiation (reviewed in 
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Goding (2000), Steingrímsson, Copeland and Jenkins (2004)).  In zebrafish, work to 
date suggests that the only role for Sox10 is to activate expression of Mitfa and that 
Sox10 is not required in melanophore development for any other purpose (Elworthy 
et al. 2003).  Recent work in mouse has provided evidence to suggest that the contrary 
is true in this model organism; that Sox10 in mouse has an additional, later, role in 
melanocyte development.  They found that Mitf alone is sufficient to activate expression 
of Dct, Silver and Tyrp1 in mouse neural tube culture but that it is insufficient to 
activate expression of Tyrosinase.  Further, they found that Sox10 is required in 
addition to Mitf for expression of Tyrosinase and proper melanocyte development. 
The authors suggest that this demonstrates marked interspecies differences between 
the role of Sox10 in mouse melanocyte development compared to its role in zebrafish 
melanophore development.  However, we felt that insufficient evidence exists from 
either organism for this proposal to be considered conclusive.  Data from mouse has 
been generated almost entirely in vitro and remains to be tested in vivo.  In zebrafish, 
there is a lack of molecular data which is directly comparable to the mouse work.  In 
further exploring the role of Sox10 in melanophores, we also hoped to help resolve 
some of the controversy surrounding this current data.
6.2 A Testable Model
We began with a testable model for the role of Sox10 in melanophores.  This 
model was adapted from one proposed by Kim et al. (2003) for the role of Sox10 
in sympathetic neuron development in mouse (Figure 1.04).  The first relationship 
described by our adapted model for the role of Sox10 in melanophores is that of Sox10 
directly regulating expression of mitfa.  This had been established conclusively in 
zebrafish (Elworthy et al. 2003) and is well supported by data in both mouse and 
human (Britsch et al. 2001, Potterf et al. 2001, Bondurand et al. 2000, Lee et al. 2000, 
Potterf et al. 2000, Verastegui et al. 2000).  In zebrafish, it was demonstrated that 
sox10 mutants lack expression of mitfa and that overexpression of sox10 RNA in the 
embryo will induce expression of mitfa.  Further, Sox10 can activate expression from 
the mitfa promoter via Sox10 binding sites within that promoter (Elworthy et al. 2003). 
From our model we then made several predictions.  First, that Sox10 would also, 
simultaneously to activating mitfa, repress expression of melanophore differentiation 
genes.  Following on from this, we predicted that Sox10 would be downregulated 
in differentiating melanophores and expected that this downregulation would be 
necessary for melanophores to differentiate.  The model also predicts that Mitfa will 
be responsible for the downregulation of Sox10.  We were able to test most of these 
predictions during our work presented here.
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6.2.1 Mitfa Regulates Melanophore Specific Genes
Work from Elworthy et al. (2003) suggests that the only necessary role that Sox10 
performs in melanophores is to activate expression of mitfa.  Overexpression of mitfa 
in the neural crest of embryos which are mutant for sox10 or mitfa, rescued similar 
numbers of melanophores in the same proportion of embryos of either genotype.  Work 
in mouse fibroblasts and in chick, zebrafish and medaka found Mitf to be sufficient to 
drive expression of melanogenic enzymes and melanogenesis in these models (Lister 
et al. 1999, Tachibana et al. 1996, Béjar, Hong and Schartl 2003, Planque et al. 1999), 
supporting the hypothesis that Mitf alone is sufficient for melanocyte differentiation. 
In addition, a great deal of evidence exists from both mouse and human that shows 
Mitf is able to activate expression from Tyrosinase (Yasumoto et al. 1997, Yasumoto et 
al. 1994, Bentley, Eisen and Goding 1994, Ganss, Schütz and Beermann 1994), Tyrp1 
(Bertolotto et al. 1998, Yasumoto et al. 1997, Lowings, Yavuzer and Goding 1992, 
Jackson et al. 1991), Dct (Budd and Jackson 1995, Jackson et al. 1992, Bertolotto 
et al. 1998, Yasumoto et al. 1997, Yokoyama et al. 1994) and Silver (Du et al. 2003) 
promoters.  However, there is also evidence to suggest that Mitf may not be sufficient for 
melanocyte differentiation.  Mitf expressed alone in mouse neural tube explants is not 
sufficient to drive expression of Tyrosinase and development of pigmented melanocytes 
(Hou, Arnheiter and Pavan 2006).  In this case, Sox10 is required in addition to Mitf 
for Tyrosinase expression.  Sox10 is also implicated in the expression of Dct in that 
it can bind to (Britsch et al. 2001, Potterf et al. 2001), and activate expression from 
(Jiao et al. 2004, Ludwig, Rehberg and Wegner 2004), the Dct promoter in mouse. 
However, Hou et al. (2006) demonstrated that whilst Sox10 may be able to activate 
Dct expression it is not necessary for Dct expression.
Our model implicitly predicts that Mitfa will be sufficient to drive expression of 
melanophore differentiation genes and it was necessary to test this prediction before 
we could test whether Sox10 was able to inhibit expression of the same genes.  We 
injected mitfa RNA or mitfaw2 RNA into one cell stage sox10t3 mutant embryos and 
found that mitfa, but not mitfaw2, induced detectable expression of dct, silva, tyrp1b 
and tyrosinase six hours after injection.  This evidence shows that Mitfa can induce 
expression of all of our marker genes.  In support of this conclusion we were able to 
demonstrate again, using a similar method, that tyrp1b expression is Mitfa dependent. 
Injection of sox10 RNA into wild type embryos will induce mitfa expression after 
six hours and tyrp1b after 10.5 hours, whereas induction of tyrp1b expression in this 
way fails in mitfaw2 mutants.  This demonstrates that Sox10 activates expression of 
mitfa in wild type embryos and Mitfa in turn activates expression of tyrp1b.  This 
explains the delay in tyrp1b expression as compared to mitfa expression after injection 
of sox10 RNA into wild type embryos.  Further, our evidence suggests that Mitfa 
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may not simply induce expression of dct, silva, tyrp1b and tyrosinase but that it may 
induce expression of these genes directly.  We know that activation of mitfa by Sox10 
is direct and that mitfa mRNA is present six hours after injection with sox10 RNA; we 
see similarly rapid activation of our marker genes in embryos after injection with mitfa 
RNA suggesting a similarly direct relationship.
Ideally, further experiments would be carried out to confirm our findings.  To demonstrate 
that marker gene expression after injection with mitfa RNA was Sox10 independent 
we injected mitfa RNA into embryos for a heterozygous sox10t3 incross.  In the cases of 
dct, silva and tyrp1b the results were clear: significantly more than 75 % of embryos in 
each case expressed the marker gene so we knew that even embryos without functional 
Sox10 were able to express each gene.  The case was less clear cut for tyrosinase 
where the number of tyrosinase expressing embryos was not significantly different 
from 75 %.  However, induction of our markers was not fully penetrant even in wild 
type embryos where only 85 % of injected embryos expressed tyrosinase.  We felt 
that the 27 % of embryos that did not express tyrosinase was not enough to represent 
the 25 % of embryos that should be mutant plus a large enough percentage of wild 
type embryos that we also expected not to express tyrosinase.  Ideally we would have 
liked to genotype these embryos to definitively verify our result but we were unable to 
do so.  This was partly due to the poor quantity and quality of DNA obtainable from 
young embryos which had been processed for ISH.  However, this was exacerbated by 
the nature of the mutation in sox10t3, a fairly large transposon insertion in the sox10 
gene which also contains repeat elements (Carney 2003).  This makes it difficult to 
genotype even untreated embryos at 3 dpf (T. Carney, personal communication).  An 
alternative approach that may prove easier would be to optimise primers and PCR 
conditions to genotype embryos from a different sox10 mutant, for example sox10m618 
which has a point mutation.  The experiment could then be repeated in this line to fully 
verify our result.
Our results outlined above support the prediction that Mitfa is sufficient, at least does not 
require Sox10, to induce expression of all of the genes we studied and leaves open the 
possibility that it is sufficient to induce many other melanophore differentiation genes. 
However, this does not exclude the possibility that other proteins may be required for 
the induction of melanophore specific genes by Mitfa or to enhance the induction of 
those genes.  For example, Mitfa will often work as a heterodimer with various partner 
proteins (see 1.2.1i), so perhaps there are co-factors present in the early embryo that 
are equivalent to ones that would normally exist in the developing neural crest, and 
are needed to allow Mitfa to induce gene expression in our experiments.  For example, 
Lef1 might be such a co-factor and we know that it is expressed ubiquitously at the 4 
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cell stage when it could alter the results from our RNA injection experiments and in 
the neural crest at 18 hpf where it might function in normal neural crest development 
(Dorsky et al. 1999).  If other factors are required for Mitfa-dependent gene expression, 
then whilst Mitfa may be necessary it may not be entirely sufficient to induce target gene 
expression.  This would be difficult to test using our methodology but may be testable 
using in vitro transcription from, for example, the dct promoter.  Looking for changes 
in levels of transcription in the presence and absence of Mitfa and various possible 
co-factors such as Tfe3 or Lef1 would differentiate between Mitfa being necessary or 
sufficient for melanophore marker gene expression.  What we have been able to show 
is that Mitfa can induce target gene expression in zebrafish even in the absence of 
functional Sox10.  This is contrary to evidence from mouse which suggests that Mitfa 
activation of Tyrosinase is Sox10 dependent.  Thus, if we ignore the weaknesses in the 
mouse data as data collected primarily in vitro, our results add support to the conclusion 
drawn by Hou et al. (2006) that there are significant interspecies differences between 
the regulation of melanocyte development in mouse and zebrafish.
At this point it is interesting to note a difference between our model and that proposed 
by Kim et al. (2003) for sympathetic neuron differentiation.  In their model, Sox10 
promotes expression of two transcription factors, Mash1 and Phox2b.  Downstream of 
these two genes is Phox2a, another transcription factor.  In our model, we know that 
Sox10 promotes expression of Mitfa and we might expect that downstream of Mitfa 
there will be another transcription factor, transcription factor X.  The only transcription 
factor that we can identify that has been proposed to be downstream of Mitf is an 
example from mouse.  Tbx2 is a T-box transcription factor which is not expressed in 
melanoblast precursor cells but is expressed in melanoblasts and melanocytes (Carreira 
et al. 1998).  The same group who cloned and described the expression of Tbx2 went on 
to demonstrate that the Tbx2 promoter contains an Mitf recognition sequence to which 
Mitf binds in vitro.  Further, Mitf is able to activate expression from the Tbx2 promoter 
in cell culture (Carreira, Liu and Goding 2000).  This evidence makes Tbx2 an excellent 
candidate for transcription factor X in our model.  However, zebrafish have two Tbx2 
genes, tbx2a and tbx2b, neither of which has been shown to be expressed in the neural 
crest or neural crest derived melanocytes (Thisse and Thisse 2004).  In addition, as 
described above, there is a great deal of evidence to suggest that Mitfa is itself able to 
directly regulate melanophore differentiation genes such as dct.  It would be valuable to 
explore this possibility further in zebrafish by analysing the promoters of our melanophore 
marker genes in search of Mitfa responsive M-boxes for example.  Even without this 
evidence however, we feel able to suggest that there may be no transcription factor X 
in melanophores.  Our model for the role of Sox10 in melanophore development is 
therefore simpler in this respect than that for its role in neuron development.
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6.2.2 Sox10 Inhibits Melanophore Specific Genes
We have established that Mitfa is able to induce expression of dct, silva, tyrp1b 
and tyrosinase.  Our model predicts that Sox10 will have an inhibitory effect upon 
the expression of these genes.  Two kinds of experiment provided data testing this 
part of the model.  In the first set of experiments, we made observations of the 
expression of endogenous dct, silva, tyrosinase, tyrp1b and melanin in sox10t3, mitfaw2 
and sox10t3;mitfaw2 mutants.  We saw that in mitfaw2 embryos, where Sox10 is still 
expressed but Mitfa is not functional, all of our melanophore markers were expressed. 
However, expression was extremely weak and was only seen in a very small number 
of cells in a premigratory neural crest position; indeed tyrp1b was hardly expressed at 
all.  This was consistent with a lack of any residual melanised cells in these mutants. 
In sox10t3 embryos, where Sox10 is not functional and mitfa is not expressed, our 
markers were expressed more strongly and in more cells than in mitfaw2 embryos, 
though expression was still weak when compared to wild type expression.  However, 
now we were also able to observe residual cells which were able to express melanin, 
presumably as a result of the stronger residual expression of our melanophore marker 
genes.  Observations in sox10t3;mitfaw2 embryos confirmed that double mutants had 
the same phenotype as sox10t3 homozygous embryos indicating that the residual 
expression seen was mitfa independent.  From these observations we concluded that 
expression of dct, silva, tyrosinase and tyrp1b is derepressed in the absence of Sox10. 
Thus, in wild type embryos we suggest that Sox10 would normally function to repress 
expression of those genes and inhibit melanophore development.  This work does not 
test whether Sox10 directly binds to and inhibits expression from the various marker 
gene promoters.  It could be that Sox10 indirectly mediates repression by promoting 
expression of other factors which, in turn, repress expression.  Of our markers, only 
Dct expression has been looked at in Sox10 mutant mice.  Here Dct expression was lost 
altogether suggesting that similar derepression of melanocyte markers may not occur 
in the absence of Sox10 in mouse (Britsch et al. 2001, Potterf et al. 2001, Southard-
Smith, Kos and Pavan 1998).  However, this could be an artefact of the relatively poor 
sensitivity of whole mount ISHs in mouse.  It would be interesting to look for Silver 
expression in Sox10 mutant mice as zebrafish expression of silva appears stronger than 
the other markers and therefore, if it is derepressed Silver might be easier to detect in 
mouse.  Careful RT-PCR analysis excluding material from parts of the embryo which 
are not affected by loss of Sox10, such as the PRE, might also reveal more.
Our second approach to exploring some of the genes Sox10 may be able to regulate 
in zebrafish melanophores involved RNA injection into one cell stage embryos and 
assaying by ISH for induced gene expression.  Despite evidence from mouse which 
implies that Sox10 is able to induce expression of Tyrosinase and Dct (Hou et al. 2006, 
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Britsch et al. 2001, Potterf et al. 2001, Jiao et al. 2004, Ludwig et al. 2004) we found 
no evidence to suggest a direct positive relationship in zebrafish between Sox10 and 
any of the melanophore markers we used.  We have shown that injection of mitfa RNA 
robustly induces expression of all of our marker genes and we were still able to induce 
expression of all of our markers by injection of mitfa into sox10t3 mutant embryos. 
Whilst this does not show that Sox10 is not able to positively regulate these genes, 
it does suggest that it is not required for their induction.  In fact we have generated 
evidence to suggest that Sox10 may actually have a negative effect on melanophore 
marker gene expression.  We know that Sox10 is able to induce expression of mitfa 
(Elworthy et al. 2003) and that Mitfa is able to induce expression of melanophore 
marker genes.  Therefore, if Sox10 has no inhibitory effect on marker gene expression, 
injection of sox10 RNA should result in expression of mitfa and of our marker genes. 
We were able to induce expression of mitfa at 6 hpf by injection of sox10 RNA but of 
our four marker genes none were expressed at 6 hpf and only tyrp1b was expressed 
at 10.5 hpf.  It could be that levels of induced Mitfa in this experiment only get high 
enough to induce expression of tyrp1b and that lower levels are not sufficient for dct, 
silva and tyrosinase expression.  However, we found that mitfa RNA injected with 
sox10 RNA still only resulted in induced expression of tyrp1b suggesting that this is 
not the case.  We concluded that under the conditions used, Sox10 is able to inhibit 
Mitfa-dependent expression of dct, silva and tyrosinase.  The rapidity with which 
Sox10 is able to inhibit expression of our marker genes suggests direct relationships 
between Sox10 and the marker genes.  This remains to be tested but could provide 
some interesting data about the various promoters.  It would be valuable to analyse the 
promoter sequences of our marker genes and discover whether there are Sox10 binding 
sites present within them.  ChIP assays could be used to determine whether Sox10 
does in fact bind to these sequences.  Subsequent in vitro work using the promoters 
to drive reporter gene expression might confirm whether Sox10 exerts a positive or 
negative regulatory effect on the promoters and determine the effect of Sox10 on Mitfa 
dependent promoter activation.
Further investigation of the different promoters would be interesting for a second reason. 
Each of our different markers showed differences in their expression patterns in sox10t3 
and mitfaw2 embryos.  This is most striking in the case of tyrp1b where expression was 
considerably weaker than that of the other markers in sox10t3 embryos and almost 
entirely absent from mitfaw2 embryos.  This suggested that tyrp1b expression may be 
more dependent upon mitfa expression than the other genes are and/or that factors other 
than Sox10 are more important in repression of its expression than for the repression 
of our other markers.  Supporting this suggestion, we also found a lack of repression 
of tyrp1b by Sox10 in our RNA injection experiments.  Rather than the effect of Sox10 
167
Chapter 6
repression only being weaker for tyrp1b than the other markers, as we saw in mutant 
embryos, here we saw an apparently complete lack of tyrp1b repression by Sox10. 
This difference in effects is probably due to differences between the environment of 
the early embryo as compared to that in the developing neural crest.  For example, if 
factors other than Sox10 are important for tyrp1b repression these genes are likely to 
still be expressed in the neural crest of sox10t3 embryos and maintain some repression 
of tyrp1b.  However, it is possible that they will not be expressed in the early embryo 
to repress tyrp1b expression in our RNA injection experiments so that we see tyrp1b 
expression after injection of sox10 RNA.
silva also has a particularly striking expression pattern, particularly in sox10t3 embryos, 
in that it is expressed in more cells which extend over a larger area of the embryo than 
the other markers.  Expression of silva also appears to persist slightly longer so that 
more embryos at later stages still express it.  This is in contrast to tyrp1b expression 
and suggests that the relative importance of different factors in silva regulation will 
contrast with those important in tyrp1b regulation.  Our results suggest that Mitfa is 
less important for driving silva expression than for driving expression of the other 
markers.  They also suggest that Sox10 may be more important than other factors 
to repress silva expression.  tyrosinase differs from the other markers in that it is 
expressed more strongly in mitfaw2 embryos than are the other markers.  tyrosinase 
is expressed more strongly and over a longer time period in sox10t3 as compared to 
mitfaw2 embryos, so it is still likely that we are observing derepression of tyrosinase 
in the absence of Sox10.  The strength of expression in mitfaw2 mutants suggests 
that Sox10 is less able to repress expression of tyrosinase than it is able to repress 
expression of the other markers.  However, if this were the case we might expect 
tyrosinase to be expressed more than the other markers in sox10t3 embryos, which it 
is not.  This implies that there may be another layer of complexity in the regulation 
of tyrosinase expression not seen for the other markers.  The data described thus far 
would fit with a model whereby Sox10 is able to repress expression of tyrosinase but it 
also indirectly promotes tyrosinase expression via both factor Y and Mitfa.  In sox10t3 
embryos Sox10 is not expressed so neither is factor Y and consequently tyrosinase 
is derepressed.  In mitfaw2 embryos Sox10 is expressed so factor Y would also be 
expressed and be able to promote tyrosinase expression despite the lack of functional 
mitfa and the fact that Sox10 is also weakly repressing such expression.  Thus, we see 
more tyrosinase expression in these embryos than we would predict if factor Y were 
not involved.
We know that sox10t3 embryos do not express mitfa and by looking at sox10t3;mitfaw2 
embryos we have shown that the expression of marker genes seen in these embryos is 
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mitfa independent.  Yet we do still see expression of our markers in sox10t3 mutants. 
Therefore, we suggest that there is a pathway by which these genes can be activated 
which does not involve Mitfa.  We observed that residual cells expressing marker 
genes or melanin develop in an anterior to posterior fashion, much as they would in 
a wild type embryo.  This suggests that the means by which our marker genes are 
activated in mutant embryos may play a role in normal development too.  Without 
Mitfa expression, activation of our marker genes is very weak and we know that other 
genes important for melanophore survival, such as c-kit, cannot be detected by in situ 
hybridisation (Dutton et al. 2001).  The means by which our marker genes are activated 
in mutant embryos must be less efficient in the absence of Sox10 and Mitfa and is 
not sufficient for expression of all important melanophore genes.  Perhaps another 
transcription factor is involved which acts synergistically with Mitfa to enhance target 
gene expression well above what either factor could achieve individually.  For example, 
Mitf and Lef-1 can act synergistically to activate high levels of expression of Dct in cell 
culture when individually activation is only weak (Yasumoto et al. 2002).  Thus there 
is the possibility that Lef1 could activate expression of dct in sox10t3 embryos despite 
the lack of Mitfa.  Indeed, lef1 is expressed in the zebrafish neural crest at 18 hpf and 
in early development (Dorsky et al. 1999).  Later stages have not been examined so 
we cannot know whether expression persists.  Nevertheless, expression at 18 hpf is 
appropriate for activating melanophore marker genes and so Lef1 remains a candidate 
for promoting melanophore marker gene expression in the absence of Mitfa.
Our observations of marker gene expression in sox10t3 mutants also support previous 
data about the fate of neural crest cells in these embryos.  Data from zebrafish and mouse 
show that there is increased cell death in the neural crest of sox10 mutants (Dutton 
et al. 2001, Kapur 1999, Southard-Smith et al. 1998).  They suggest that crest cells 
which fail to specify die by apoptosis.  We observed a decrease in the number of cells 
positive for melanophore marker genes from approximately 36 hpf.  This is consistent 
with the timing of cell death in zebrafish observed in single cell labelling and TUNEL 
experiments.  Our close observations of the residual melanised cells in sox10t3 mutants 
showed the usual morphology of these cells to be small, punctuate and blebbed.  We 
also observed the collapse of a larger cell to adopt this apoptotic morphology.  These 
observations are consistent with loss of unspecified neural crest cells by apoptosis, 
though it is interesting to note that these unspecified cells have been able to produce 
melanin, a characteristic of differentiating melanophores.  It would be interesting to look 
for co-localisation of TUNEL labeling and residual pigment to confirm that residual 
pigmented cells are the remains of apoptosed pigmented crest cells.
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6.2.3 Sox10 and Xanthophore Development
Melanophores are not the only pigment cells which seem to partially differentiate 
in sox10t3 embryos; xanthophores can also be observed in these embryos though 
they are abnormal and disappear between 35 hpf and 45 hpf (Dutton et al. 2001). 
Based on this observation we wondered whether Sox10 might perform similar 
roles in both melanophores and xanthophores and therefore whether we might see 
residual xanthophore gene expression in sox10t3 embryos.  We looked at expression 
of xanthophore markers gch, xdh and paics in sox10t3 embryos and found that we 
could observe residual expression of all of the xanthophore markers we used in sox10t3 
mutants.  As with the melanophore markers, the xanthophore markers were expressed 
in cells in a premigratory neural crest position.  We suggest that the similarities in the 
expression patterns of these two sets of markers shows that Sox10 may have a similar 
role in xanthophores as melanophores, to repress differentiation genes and development. 
This possibility is more difficult to investigate in xanthophores than melanophores 
because far less is known about xanthophores.  For example, there is no clear candidate 
for a master regulator of xanthophore development, i.e. a xanthophore equivalent 
of Mitfa.  Recent work has demonstrated that both Pax3 and Pax7 are key genes in 
xanthophore development (Minchin and Hughes 2008).  Whilst Pax7 is expressed in 
xanthophores it is expressed later than xanthophore markers such as xdh, indicating 
that it is not required for xanthophore specification.  However, morpholino knockdown 
of Pax3 results in a loss of cells expressing a number of xanthophore markers and a 
loss of xanthophores, suggesting that it is a xanthophore specification factor.  However, 
knockdown of Pax3 also disrupts enteric neuron development and Minchin et al. (2008) 
also found that whilst loss of Pax3 does not disrupt sox10 expression prior to 18 hpf, it 
does disrupt sox10 expression from approximately 25 hpf.  This suggests that the role 
of Pax3 in the neural crest is more complex than that of Mitfa since it is required for 
maintenance of sox10 expression in late neural crest.  This makes it unlikely that Pax3 
is a master regulator of xanthophore development in quite the same way as Mitfa is in 
melanophore development.  It would be interesting to examine the expression pattern 
of pax3 in sox10t3 mutants to learn more about the relationship between sox10 and 
pax3 and whether Sox10 also influences Pax3 expression.  Sox10 and Pax3 have been 
shown to be able to function together to drive mitfa expression in vitro (Bondurand et 
al. 2000, Potterf et al. 2000), perhaps they have dual functions, both to regulate each 
other and to drive expression of xanthophore differentiation genes such as gch and xdh 
together.  However, it also remains possible that an as yet undiscovered xanthophore 
specific transcription factor exists downstream of both Sox10 and Pax3 so that they 
indirectly influence the expression of xanthophore differentiation genes.
Additional complexity is added to the xanthophore story because expression of the 
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most broadly expressed xanthophore marker, gch, is known to overlap with expression 
of melanin in wild type embryos and xdh expression overlaps with mitfa expression 
(Parichy et al. 2000b).  So, are the gch and xdh expressing cells in sox10t3 embryos 
melanoblasts, xanthoblasts or perhaps a pigment cell precursor which has been unable 
to become specified as one cell type and so expresses genes indicative of more than one? 
gch and silva have particularly broad residual expression domains in sox10t3 embryos 
and it seems unlikely that they do not overlap.  This provides some, weak, support for 
the idea of a pigment cell precursor.  Further work to confirm that paics expression does 
not overlap with either mitfa or melanin expression would be important to provide a 
definitive xanthophore marker.  This could then be followed by a series of double ISHs 
with melanophore and xanthophore markers in sox10t3 embryos.  Although this might 
prove difficult due to the low levels of residual expression in these embryos, it could 
identify cells which express markers indicative of both cell types.  Such cells might 
represent pigment cell precursors that are normally only present transiently in wild 
type embryos but which, in the absence of Sox10, are unable to differentiate further 
and get stuck in this precursor state.  Alternatively such cells may never be present 
in wild types and are only observed here because crest cells have developed entirely 
abnormally in the absence of functional Sox10.
Our own work provides another clue that the residual cells in sox10t3 embryos may 
have more potential to differentiate into multiple cells types than was previously 
anticipated and therefore could represent a pigment cell precursor.  We were able to 
drive expression of sox10 from a Dct promoter in sox10t3 embryos and rescue all kinds 
of pigment cells.  One might expect that cells which are expressing dct are specified as 
melanoblasts.  However, this experiment suggests that in sox10t3 mutants these cells are 
not committed to one fate and are still flexible enough to generate other pigment cell 
types if their situation changes, i.e. if they begin to express sox10.  This is consistent 
with the fact that neural crest cells appear to fail to become specified; in the case of 
the melanophore this means failing to express mitfa, and die by apoptosis (Dutton 
et al. 2001).  This is despite the fact that, as we have described, these cells are able 
to express several melanophore markers and produce melanin.  This work suggests 
that Sox10 maintains cells in a multipotent state but that Sox10 is also required to 
ensure that cells become properly committed to the melanophore fate.  This would be 
consistent with our model for the role of Sox10 in melanophore development and with 
the model proposed by Kim et al. (2003) for its role in sympathetic neurons.  It would 
be interesting to repeat the experiment driving sox10 expression in the Dct-expressing 
crest cells of sox10t3 mutants and looking for other neural crest derivative markers to 
determine whether this phenomenon extends beyond pigment cells.  Can we rescue 
other neural crest derivatives such as enteric neurons by expressing sox10 in this way? 
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This may provide some interesting insight into neural crest development in wild type 
embryos.  If we found that the dct expressing cells in a sox10t3 mutant are restricted to 
form pigment cells, this would be supportive of a progressive fate restriction model of 
neural crest development (Le Douarin and Dupin 2003).  It might also help us to think 
about questions such as ‘When does a cell become committed to a particular cell type?’ 
‘Is a wild type cell expressing dct still malleable in its final fate?’  
The results and ideas described above are reminiscent of recently published data about 
zebrafish ltk.  ltk is expressed transiently in the neural crest between 18 hpf and 28 hpf 
and then from 30 hpf onwards in iridophores (Lopes et al. 2008).  It is proposed that 
ltk has a role in the specification of iridophores (Lopes et al. 2008).  More interesting 
in terms of our work, Lopes et al. (2008) also looked at the expression of ltk in sox10 
mutants.  They found that in these mutant embryos ltk was expressed in an increased 
number of cells in a premigratory neural crest position.  The pattern is remarkably 
similar to that which we see for our melanophore and xanthophore markers.  Lopes 
et al. (2008) showed that the ltk expression domain was more anterior than that of 
early crest markers such as snail2 and foxd3 and therefore that ltk expressing cells 
could no longer be described as early crest but were actually developmentally older 
cells.  Whilst in wild type embryos the expression of ltk and sox10 do not usually 
overlap, in sox10 mutants many cells can be observed which express both sox10 and 
ltk.  The authors suggest that these cells may be multipotent pigment cell precursors 
caught in what would normally be a transient state.  It would be extremely interesting 
to perform further double ISHs, in various combinations, to determine whether ltk-
positive cells are also positive for melanophore and xanthophore markers and to 
discover if expression of these markers ever overlaps with sox10 expression in sox10 
mutant embryos.  If this were found to be the case it would provide further support 
for the concept of a multipotent precursor which is able to give rise to all the different 
pigment cells.
6.2.4 Sox10 is Downregulated in Melanophores
We have been able to show that Sox10 can repress expression of melanophore marker 
genes in RNA injection experiments and that the same genes are derepressed in 
embryos which lack functional Sox10.  This supports our model which predicts that in 
vivo, Sox10 is able to inhibit melanophore development.  Therefore, for development 
to proceed, our model predicts that Sox10 will have to be downregulated.  Previous 
studies had suggested that sox10 mRNA is lost from differentiating cells (Dutton et 
al. 2001) and that the sox10 promoter is switched off in melanophores as they develop 
(Carney 2003).  Our data show that both Sox10 protein and sox10 mRNA are indeed 
switched off in melanophores as they differentiate.  This verifies earlier observations, 
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provides a more detailed picture of Sox10 downregulation in melanophores and 
provides evidence in support of our model.  We found that Sox10 and sox10 begin to 
be lost from approximately 33 hpf.  sox10 is lost rapidly and at a constant rate from 
pigmented melanophores.  Sox10 is only lost slowly at first suggesting that cells might 
first lose sox10 expression and then lose Sox10 protein expression.  However, loss of 
Sox10 then accelerates until eventually very few, and finally no pigmented cells can 
be observed expressing it.  The pattern of loss of sox10 is consistent with simple 
degradation of the mRNA if it is not being replaced by subsequent transcription of 
the gene.  The sigmoid curve seen for loss of Sox10 expressing melanophores is more 
consistent with controlled breakdown of the protein in the cells.  This could suggest 
that the timing of loss of Sox10 is important.  Perhaps Sox10 must be present long 
enough to ensure that it has induced high enough levels of Mitfa but not so long 
that it inhibits differentiation longer than is necessary.  Alternatively, perhaps Sox10 
is used to delay differentiation in particular cells until it is appropriate for them to 
differentiate.  We did not observe anything to suggest that Sox10 is shuttled between 
the nucleus and the cytoplasm, as has been described in mouse cell culture (Rehberg 
et al. 2002).
Data from other organisms does not always correlate with our own.  As we would 
expect if our model extends to the role of Sox10 in human melanocytes, melanocytes 
from primary human skin cultures do not express Sox10 (Cook et al. 2005).  However, 
Sox10 is expressed in mouse melanocyte and melanoma cell lines (Southard-Smith et 
al. 1998, Khong and Rosenberg 2002, Kamaraju et al. 2002) and in mouse melanocytes 
in vivo from embryonic stages until at least P6 (Osawa et al. 2005).  Sox10 expression 
is lost from melanocyte stem cells however.  This supports other work in mouse that 
suggests Sox10 may be important for melanocyte differentiation and that it may need 
to be lost for cells to maintain a stem cell-like state in this model organism (Osawa et 
al. 2005, Hou et al. 2006).  This is quite opposite to the role that we suggest it plays in 
zebrafish melanophores.  However, current data from mouse is not exhaustive since 
results have usually been obtained as a by-product of working to answer different 
questions.  In addition, much of the work has been carried out in vitro and in immortal 
cell lines with all of the caveats that this entails.  We have endeavoured to provide 
comprehensive in vivo data about Sox10 expression in zebrafish melanophores.  We 
suggest that it would not be wise to draw firm conclusions about similarities and 
differences between zebrafish and mouse until similar studies have been conducted 
in vivo in mouse.  Such a study should be specifically designed to document Sox10 
and Sox10 expression in all kinds of mouse melanocytes over an extended timecourse 
from melanoblast to pigmented melanocyte at closely spaced intervals.
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It is perhaps surprising that Sox10 is expressed at all in pigmented zebrafish 
melanophores given that we have shown it is able to inhibit melanophore gene 
expression.  Kim et al. (2003) were able to demonstrate that levels of Sox10 alter 
its ability to perform its different functions.  In sympathetic neurons, whilst low 
levels of Sox10 are enough to initiate expression of Mash1 and Phox2b they are not 
enough to repress expression of Phox2a.  Kim et al. (2003) saw comparatively normal 
expression of Mash1 and Phox2b in Sox10 heterozygotes but found that Phox2a was 
precociously expressed.  We predicted that a similar mechanism might be at work in 
melanophores so that initially, high levels of Sox10 promote expression of mitfa and 
inhibit expression of melanophore marker genes.  As Sox10 is downregulated there is 
still high enough levels to maintain expression of mitfa, although this may no longer be 
necessary.  However, levels may now be too low to maintain repression of melanophore 
markers and we begin to see expression of these genes and overt differentiation 
despite the persistent Sox10 expression that we have observed in pigmented cells. 
Our immunofluoresence results are not quantitative and do not enable us to test this 
hypothesis.  Nonetheless, we were able to use a different technique to begin to test 
this hypothesis.  We injected mitfa RNA together with decreasing quantities of sox10 
RNA and found that at lower levels, sox10 was no longer able to repress Mitfa induced 
expression of our marker genes.  It would be important to push this experiment further 
to really test our hypothesis.  For example, it would be valuable to find the minimum 
sox10 dose required to repress expression of marker genes.  We would expect this to 
be higher than the minimum dose required to initiate mitfa expression.
Having established that Sox10 is downregulated in melanophores as they differentiate it 
became important to test whether this downregulation was necessary for melanophores 
to differentiate.  We set about making a transgenic line called Tg(Dct;CFP-sox10) 
which used 3.6 kb of the mouse Dct promoter to drive expression of a CFP-sox10 
fusion in melanophores.  We were able to successfully generate a construct for this 
purpose and demonstrate that the CFP-sox10 fusion was functional by rescuing 
pigment cells in sox10t3 mutants.  We went on to produce 11 different lines from our 
construct.  CFP was visible in the founders and in the F1 generations of these lines. 
Unfortunately, CFP was not visible in the F2 generations of these lines and from this 
we had to conclude that the whole CFP-sox10 fusion was not expressed at significant 
levels, rendering these lines useless for our intended experiment.  The hypothesis that 
Sox10 downregulation is necessary for melanophore differentiation therefore remains 
to be tested.  As we discussed in Chapter 4, this could be achieved using transgenic 
approaches or by in vitro analysis to test the activity of the promoters for our marker 
genes with different concentrations of Sox10 and Mitfa.
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We cannot give a definitive explanation as to why visible CFP was lost in the F2 
generation of our Tg(Dct;CFP-sox10) fish.  One possibility was that the transgene was 
somehow destroyed or lost from the genome, by chromosomal rearrangements for 
example.  However, we were able to rule this out by positively genotyping multiple 
fish from the F1 generation as containing the transgene.  Whilst F2 progeny from 
these fish were negative for CFP by visual inspection, they too tested positive for our 
transgene.  Another possibility was that since our promoter was not an endogenous 
zebrafish promoter it was targeted for silencing.  We also feel that we can rule out this 
and any other effects which might have occurred due to the promoter we used because 
an equivalent number of lines were generated which expressed only CFP from the same 
mouse Dct promoter and none of these display silencing in the F2 generation.  Some 
recent work has described silencing of ubiquitous zebrafish promoters in particular 
organs but this differs from our transgenics in that silencing occurs in earlier generations 
and is organ specific (Thummel, Burket and Hyde 2006).  We hypothesise that the 
explanation for the silencing we have observed could lie with the CFP-sox10 fusion 
part of the construct.  Apart from the obvious variability in integration sites in each 
individual line, this is the only consistent difference between our Tg(Dct;CFP-sox10) 
and Tg(Dct;CFP) lines and we did not observe silencing of any of our Tg(Dct;CFP) 
lines.  Alternatively, we also found that vector sequences were incorporated into the 
genomes of Tg(Dct;CFP-sox10) fish but not in any of the five Tg(Dct;CFP) fish we 
genotyped.  This vector incorporation was unexpected and this could also be linked to 
the transgene silencing that we have observed.
Despite the disappointment with the Tg(Dct;CFP-sox10) lines, we did successfully 
generate several useful lines which express CFP primarily in melanoblasts, 
Tg(Dct;CFP).  These lines could be useful tools for the study of melanophore 
development for anything from sorting melanophores from embryos to tracking cells 
in vivo and in vitro.  In addition, one of the lines had an interesting, ectopic, expression 
pattern.  In this line CFP was expressed exclusively in xanthophores.  Given the lack 
of xanthophore markers described, further characterisation of this line may provide 
another useful tool, this time for the study of xanthophores.
6.2.5 Mitfa Can Regulate sox10
The final prediction from our model was that Mitfa would be the transcription 
factor that downregulates Sox10.  We had initially intended to test this prediction by 
overexpressing mitfa RNA in embryos and looking to see whether this delayed sox10 
expression.  However, in other experiments exploring which melanophore specific 
genes Mitfa can regulate we found that injection of mitfa RNA into one cell stage 
embryos actually induced expression of sox10.  We went on to demonstrate in similar 
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experiments that Mitfa can activate expression from 7.2 kb of the zebrafish sox10 
promoter.  In silico investigation of that 7.2 kb section of the zebrafish sox10 promoter 
revealed six potential Mitf binding sites within the promoter.  There is no evidence for 
any positive feedback relationship between Sox10 and Mitf in the literature, perhaps 
largely because such a relationship has not been looked for.  Yet, the data presented here 
certainly suggest that Mitfa is able to regulate Sox10.  A positive relationship whereby 
Mitfa induces expression of sox10, however, seems unlikely as we would expect this 
to result in ever increasing levels of sox10 and mitfa in cells when we know that sox10 
is downregulated as melanophores differentiate.  We suggest that in the neural crest 
in vivo, Mitfa may not positively regulate sox10, as has been demonstrated in our 
RNA injection experiments, but that in the neural crest this is a negative relationship, 
as predicted by our model.  The early embryo is a very different environment to the 
developing neural crest and this could alter the way that different transcription factors 
perform.  If particular factors were missing from or present in the early embryo as 
compared to the neural crest, the function of Mitfa could be altered so that whilst 
it may repress sox10 expression in the crest, it is able to activate sox10 expression 
in the early embryo.  It would be very interesting to dissect the sox10 promoter and 
determine which the important Mitfa binding sites are.  A starting point would be to 
inject mitfa RNA into Tg(-4.9sox10:GFP) embryos and look for GFP induction.  The 
sox10 promoter used in this transgenic line has only some of the Mitfa binding sites that 
are present in the line we used originally and so this experiment might narrow down 
which binding sites are important.  In vitro dissection of the promoter will narrow it 
down further and should provide more information as to whether Mitfa does indeed 
repress or promote expression of sox10.
6.2.6 Pax3
We have begun to explore a model for how Sox10 might function in zebrafish 
melanophore development.  We have considered a very simplified model with a 
limited number of variables.  As we begin to learn more about this simplified network 
it becomes appropriate to expand it and to look at how other factors might fit into 
the network.  For example, Pax3 is a paired box transcription factor and mutations 
in this gene are associated with WS1 and WS3 resulting in similar symptoms as do 
mutations in SOX10 and MITF in humans (Tassabehji et al. 1992).  In fact, Pax3 is 
intimately connected with Mitf and Sox10 in other ways.  Pax3 binding sites have been 
identified in mouse and human MITF promoters and in vitro and in vivo activation of 
expression from these promoters by PAX3 has been demonstrated (Bondurand et al. 
2000, Lee et al. 2000, Potterf et al. 2000, Verastegui et al. 2000, Watanabe et al. 1998). 
Work in mouse and human cell culture studies have also found that SOX10 and PAX3 
act synergistically to activate expression from the MITF promoter (Bondurand et al. 
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2000, Potterf et al. 2000) although others have found that in human cells, activation by 
SOX10 is not affected by co-expression of PAX3 nor by the loss of the PAX3 binding 
site (Lee et al. 2000, Verastegui et al. 2000).    However, given that mitfa expression is 
lost entirely from sox10 mutant zebrafish Pax3 is unlikely to be sufficient to promote 
mitfa expression in zebrafish.
The role of Pax3 in adult mouse melanocyte stem cell differentiation has been described 
in a similar network to the one we are exploring for Sox10 in zebrafish melanophores 
(Lang et al. 2005).  In adult mouse melanocyte stem cells, Pax3 functions both to promote 
and to inhibit the differentiation of melanocyte stem cells.  The authors identified Pax3 
positive neural crest-derived cells in adult mouse hair follicles.  Using an Mitf promoter 
fragment attached to a reporter they showed that at least in vitro Pax3 can activate 
expression of Mitf.  In similar experiments they showed that Sox10 and Mitf are able 
to induce melanocyte differentiation by synergistically activating the Dct promoter. 
Under the same conditions that Pax3 is able to activate Mitf, Pax3 attenuates Sox10/
Mitf induced Dct reporter expression and inhibits melanocyte differentiation.  In fact, 
their work suggested that Pax3 and Mitf actually compete to bind the Dct promoter. 
Pax3 inhibition is relieved when it is displaced by activated β-catenin which then 
allows the melanocytes to fully differentiate.  These findings support a general model 
for development whereby a single factor can both promote and inhibit differentiation 
to maintain cells in a state where they are poised to differentiate as Sox10 appears to 
do in our model.  It is also plausible that Pax3 and Sox10 could both function in a more 
complex network in zebrafish to regulate melanophore development together.
Study of Pax3 in relation to melanophore development in zebrafish is complicated 
slightly, both by the fact that zebrafish have two Pax3 orthologues, pax3 and pax3b, 
and by the fact that they have multiple pigment cell types.  pax3 and pax3b are both 
expressed in the premigratory neural crest but not in migrating cells (Minchin and 
Hughes 2008).  Further information about pax3b is not available but morpholino 
knockdown of pax3 causes a reduction in xanthophore number.  There is also an early 
decrease in migrating cells which express melanophore markers, indicating a delay 
in melanophore migration which could disguise a potential delay in melanophore 
specification too.  Later there is an increase in melanophore number which corresponds 
in severity to that of the reduction in xanthophore number (Minchin and Hughes 
2008).  The authors suggest that their results would be consistent with the presence of 
a chromatoblast in which Pax3 drives xanthophore fate specification whilst inhibiting 
melanophore specification (as it does in the mouse) so that in the absence of Pax3, 
xanthophores are reduced in number and melanophores are increased in number.  The 
obvious importance of Pax3 in xanthophore specification is demonstrated in this paper, 
177
Chapter 6
together with evidence pointing towards the likely existence of chromatoblasts.  The 
work also hints at a potential role for Pax3 in melanophores.  It will be interesting 
to discover where this work leads.  Might Pax3 in zebrafish both promote and 
inhibit melanophore development as it does in mouse?  This would certainly not be 
incompatible with our model for the role of Sox10 in these cells.  To learn more about 
how Pax3 might fit into our model it would important to find out how whether Pax3 
is required along with Sox10 for mitfa induction and whether it can directly affect the 
expression of our melanophore markers, perhaps by using an approach involving RNA 
injection experiments.  Alternatively, the melanophore phenotype in pax3 morphants 
might be an indirect effect of a primary role in xanthophores which results in the loss 
of potential for cells to become xanthophores in the absence of Pax3.  It would then 
become particularly interesting to learn how Pax3b functions in the neural crest, since 
it could be that the role of zebrafish pax3b is more specific to melanocytes and more 
equivalent to the role of Pax3 in mouse melanocytes.
6.3 Summary – A New Testable Model
We sought to explore the role of Sox10 in melanophore development by testing a model 
adapted from one for the role of Sox10 in mouse sympathetic neurons (Kim et al. 2003). 
We have succeeded in testing many aspects of this model.  We knew previously that 
Sox10 activates expression of mitfa (Elworthy et al. 2003).  Our data fully supports the 
conclusions drawn from Elworthy et al. (2003) that, in contrast to mouse, this is the 
only necessary role that Sox10 plays in melanophores.  Whilst Sox10 does not appear 
to be required for the expression of any melanophore differentiation genes it does 
have a second role in melanophores.  We have provided evidence in support of the 
hypothesis that Sox10 additionally inhibits melanophore development by inhibiting 
expression of genes downstream of Mitfa.  Although further investigation is required, 
it appears that high levels of Sox10 may be required for this to occur, thus, Sox10 can 
still be present in pigmented melanophores.  We have been able to document accurately 
that Sox10 and sox10 are downregulated in melanophores over time.  We were unable 
to test whether this downregulation is necessary for melanophores to differentiate but 
have found no evidence to the contrary.  We have also generated some interesting data 
which shows that Mitfa can regulate expression of sox10.  Our model predicts that this 
should be a negative relationship and whilst our experiments suggest the opposite is 
true, we believe that this possibility still remains open.
Our work has provided supporting evidence and answers for many of our hypotheses 
and questions but has also opened up new avenues for enquiry.  We propose a new 
testable model (Figure 6.01) to describe the role of Sox10 in melanophores.  The new 
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Figure 6.01 A new testable model
We have demonstrated that many of the predictions from our original model (A) hold 
true.  However, we have also found that that model was an over simplification of 
the genetic network involved in melanophore differentiation.  We suggest here some 
modifications to that model which make a new testable model that may mimic the in 
vivo network more closely (B, see text for details).
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model is simplified in that there is no intermediate transcription factor X between 
Mitfa and the melanophore marker genes dct, silva, tyrosinase and tyrp1b.  Although 
the concept of an intermediate transcription factor remains plausible, and we keep 
an open mind, there is currently no necessity for this extra factor and so we discard 
it from our model.  In addition, we have provided evidence to suggest that activation 
of our melanophore specific genes by Mitfa is rapid and therefore likely to be direct. 
Overall, however, our new model actually depicts a more complex genetic network 
than our original model due to the inclusion of a number of different external factors. 
From our studies of the expression patterns of our marker genes and from our RNA 
injection experiments we concluded that Sox10 and Mitfa were not the only factors 
that influenced the expression of our melanophore marker genes.  Some of these 
other, unidentified, factors will have positive regulatory roles and others may have 
negative regulatory roles.  We believe that the balance of which factors are most 
important, including Sox10 and Mitfa, will vary between the different markers (Figure 
3.17).  We have suggested, from work in mouse and zebrafish, that Pax3 may be one 
transcription factor involved but further evidence will need to be gathered in zebrafish 
to corroborate this suggestion.  Detailed analysis of the promoters of our melanophore 
markers will reveal potential transcription factor binding sites and subsequent analysis 
of these will reveal which are the most relevant in vivo and so which transcription 
factors can be added to our new model.  We also include a number of other factors 
in our new model which regulate the expression of Sox10 and Mitfa.  We know that 
Sox10 is downregulated in differentiating melanophores and that Mitfa continues to 
be expressed.  However, recent preliminary work using mathematical modelling to 
examine our original model has shown that a simple feedback loop between Sox10 and 
Mitfa would never resolve itself so that Sox10 expression is lost and Mitfa expression 
remains (Andrea Rocco, personal communication).  Thus, unless a short burst of Sox10 
expression is enough to ensure persistent mitfa expression, it would be necessary for 
some other factors to also promote mitfa expression.  Rocco also tested a mathematical 
model where a positive feedback loop is set up between Mitfa and another transcription 
factor, Lef1 for example.  In such a model, Sox10 induces expression of Mitfa which in 
turn induces expression of Lef1; Mitfa and Lef1 then reciprocally promote each others 
expression so that Mitfa can repress expression of Sox10 without subsequent loss of 
its own expression.  We can use the results from mathematical modelling to define the 
important parameters and characteristics of our regulatory network and direct further 
in vivo experiments.  The results of these experiments can then feed back into the 
mathematical modelling allowing us to refine our model for the genetic regulatory 
network involved in zebrafish melanophore development.
We have tested our original model and provided evidence to support many of its 
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predictions.  As is often the case in science however, this new knowledge poses many 
more questions than it answers and has provided many new lines of enquiry.  Sox10 
does not perform a single role in melanophores and it does not function in a simple 
genetic network either.    Instead, our data suggests that it performs a number of roles 
in this cell type and that the genetic network surrounding it is more complex than we 
had first imagined.  Further studies will need to take a much broader perspective when 




Appendix A – Reagents
Oligos
  BS1  AAC AAA AGC TGG AGC TCC ACC G
  CFP-F GCA GAA GAA CGG CAT CAA
  CFP-R GGT GCT CAG GTA GTG GTT GT
  Linker 1 CGG GCG CCC TCG AGT CCG GAA TCG ATA CCG GTG TCG ACG GCC
  Linker 2 GTC GAC ACC GGT ATC GAT TCC GGA CTC GAG GGC GCC
  S19  GCA GCA AGA GCA AAC CGC ACG
  S21  ACC TAC CGA AGT CAC CTG TGG 
  S22  GAT ATT GAT CCG CCA GTT TCC
  SeqCFP GGT CTT GTA GTT GCC GTC GT
  SPACER1 CTG GAT ATC GAT TGA GGC
  SPACER2 GCC TCA ATC GAT ATC
  Spacerprimer GAG GGC CTG GAT ATC GAT TGA
  TYR1  AAG GCT CTT GGA TAC GAG TAC GCC
Annealing Buffer
5 ml Tris HCl pH 7.5, 10 ml NaCl, 1 ml 0.5 M EDTA, 34 ml DEPC treated H2O
Hybridisation Mix (for 50ml)
Formamide  25 ml
20x SSC  12.5 ml
Heparine (5 mg/ml) 0.5 ml
tRNA (50 mg/ml) 0.5 ml
Tween20 (20 %) 0.25 ml
Citric acid (1 M) 0.46 ml
Sterile water  10.7 ml
NBT-BCIP Buffer
0.1 M Tris-HCl pH 9.5 at 20 °C, 0.1 M NaCl
Embryo Medium (50x stock)
250 mM NaCl, 8.5 mM KCl, 16.5 mM CaCl2, 16.5 mM MgSO4
For 1x stock make up 200 ml 50x stock and 1 ml methylene blue in 10 L
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LacZ Staining Solution
In 500 ml PBS pH 7.4-7.5: 2 mM MgCl2, 0.01 % Sodium deoxycholate, 5 mM 
K3Fe(CN)6, 5 mM K4Fe(CN)6, 0.02 % Nonidet P-40
Genomic DNA Extraction Buffer
10 mM Tris pH 8.2, 10 mM EDTA, 200 mM NaCl, 0.5 % (v/v) SDS, 200 μg/ml 
Proteinase K
Embryo Genomic DNA Extraction Buffer
10 mM Tris pH 7.5, 10 mM EDTA, 200 μg/ml Proteinase K
Restriction Enzymes and Buffers Used
NEB Buffers
Buffer 1: 10 mM Bis-Tris-Propane-HCl, 10 mM MgCl2, 1 mM Dithiothreitol, 
pH 7.0 at 25 °C
Buffer 2: 50 mM NaCl, 10 mM Tris-Hcl, 10 mM MgCl2,1 mM Dithiothreitol, 
pH 7.9 at 25 °C
Buffer 3: 100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2,1 mM Dithiothreitol,
pH 7.9 at 25 °C
Buffer 4: 50 mM Potassium Acetate, 20 mM Tris-Acetate, 10 mM Magnesium Ac-
etate, 1 mM Dithiothreitol, pH 7.9 at 25 °C
Promega Buffers
Buffer A: 6 mM Tris-HCl, 6 mM MgCl2, 6 mM NaCl, 1 mM Dithiothreitol, pH 7.5 at 
37 °C
Buffer B: 6 mM Tris-HCl, 6 mM MgCl2, 50 mM NaCl, 1 mM Dithiothreitol, pH 7.5 
at 37 °C
Buffer C: 10 mM Tris-HCl, 10 mM MgCl2, 50 mM NaCl, 1 mM Ditiothreitol,
pH 7.9 at 37 °C
Buffer D: 6 mM Tris-HCl, 6 mM MgCl2, 150 mM NaCl, 1 mM DTT, pH 7.9 at 37 °C













































































































































































































































Appendix B – Residual Melanophore Counts in sox10t3 Mutant 
Embryos
Embryos were tracked individually at different time points.  We scored each embryo for 
prescence or absence of melanised cells in each somite.  The data from each embryo are 
represented here in tables.  Each table corresponds to one embryo, blue coloured boxes 
indicate that there was at least one melanised cell in the corresponding somite, a blank 
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